




A thesis submitted for the degree of
Doctor ofPhilosophy
Pablo Nart Pehalver (DVM)




Escherichia coli 0157:H7 causes serious human disease including
haemorrhagic colitis and haemolytic uraemic syndrome. Ruminants and
in particular cattle are a reservoir of infection, though colonised animals
are clinically asymptomatic. Recent research has established that the
terminal rectum is the predominant colonisation site for
enterohaemorrhagic E. coli 0157:H7 in cattle. Thus the main goals of the
PhD project were to understand the carriage and persistence of E. coli
0157:H7 in the bovine host, through examination of faecal shedding
patterns and gastrointestinal tract tissues in experimentally infected
calves. A marked bacterial tropism for the terminal rectum was
confirmed while other minor carriage sites were identified. E. coli
0157:H7 induced histopathological alterations of the rectal mucosa and
cannot be considered as a commensal. The pathological changes
included a local infiltration of neutrophils and production of rectal
mucosal IgA responses against E. coli 0157:H7 antigens. The work
presents evidence of strong local IgA immune responses directed against
membrane protein components, Type Ill-secreted proteins, 0157
lipopolysaccharide and H7 flagellin. This study has sought to elucidate
the specifc mucosal immune responses against E. coli 0157:H7 outer
membrane porin C, and in particular, against the sections of the protein
situated on the external surface of the bacterial membrane. While there
were consistent immune responses against the whole membrane protein,
purified peptides of the external areas of the porin failed to elicit
detectable mucosal immune responses. The identification of pathological
changes and local host responses to E. coli 0157:H7 colonisation of the
I
terminal rectum confirms that pathological changes previously reported
with E. coli 0157 in the intestine, are also found in the rectum. The
results offer the first step in the development of a means to control
carriage of this organism by cattle. The results will be important for the
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Escherichia coli are phylogenetically one of the 130 species of the family
Enterobacteriaceae, phylum Bacteroides. Structurally they are Gram
negative, rod-shaped bacteria, propelled by flagella and capable of
expressing fimbriae. Biochemically they are facultative anaerobes,
capable of growing fermentatively on carbohydrates. E. coli is classified
by lipopolysaccharide (O) and flagellar (H) antigens that define
serogroups (O antigen only) or serotypes (O and H antigens) (Garrity et
al., 2001). E. coli are a genetically diverse species that includes non¬
pathogenic and pathogenic variants. E. coli is a consistent member of the
normal flora of a mammalian gastrointestinal tract, and in particular of
the mucus layer of the colon. In the immunosuppressed host or when
gastrointestinal barriers are breached commensal strains of E. coli can
cause infection. Moreover, a number of E. coli strains have acquired
several virulence factors capable of producing a variety of pathological
changes in animals and humans.
Both diversity and pathogenicity are the result of two evolutionary
processes: mutation and lateral DNA transfer (Ochman and Davalos,
2006). Mutation is the sporadic introduction of single-nucleotide
substitutions or deletions of various sizes in the genome, which are
transmitted vertically to successive generations, and result in a clonal
population (Denamur and Matic, 2006). Horizontal transfer involves the
exchange of DNA between different E. coli strains or between another
species and E. coli. Three mechanisms are responsible for the movement
of DNA between bacteria: (i) conjugation mediated by a pilus and usually
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of extrachromosomal DNA such as a plasmids (ii) transduction by viruses
commonly resulting in integration of pathogenic determinants of toxins,
persistence or immune modulation factors, and (iii) transformation or
uptake of external DNA from the environment (Thomas and Nielsen,
2005). The transfer DNA can become incorporated in the recipient. As a
consequence, lateral transmissions produce genetic similarities between
distinct branches of the phylogenetic tree, thus making possible similar
pathological mechanisms in phylogenetically unrelated bacterial clones
(Wirth et al., 2006).
Different clinical syndromes are usually recognised: pneumonias/sepsis
in poultry, meningitis/sepsis and urinary tract infection in humans and
diarrhoea in a variety of mammal species (Kaper et al., 2004). These
syndromes can be associated with different E. coli pathotypes, combining
different E. coli lineages that use a common set of virulence factors
(Marrs et al., 2005). The first three extraintestinal syndromes mentioned
above are caused by one pathotype each, while different pathotypes can
cause diarrhoea in a variety ofmammal species (Stenutz et al., 2006).
Efforts to elucidate the factors involved in the pathogenesis of these
infections of considerable medical importance are discussed in
subsequent sections.
1.1.1. Diarrhoeagenic Escherichia coli
Although some pathotypes cause disease at extra-intestinal sites, e.g.
Uropathogenic E. coli (UPEC) (Svanborg et al., 2006), Avian Pathogenic E.
coli (APEC) (Ron, 2006) and E. coli Neonatal Meningitis (NUMEC)
(Bonacorsi and Bingen, 2005), most Extraintestinal Pathogenic E. coli
2
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strains (ExPEC) are opportunistic, and the site of invasion is not the site
of initial colonisation. In contrast, the majority of E. coli enteric
pathotypes enter the host with food and are capable of colonising the
intestines causing diarrhoea (Nataro and Kaper, 1998).
Intestinal pathogenic strains of E. coli, are divided into six different
pathotypes based on their shared disease mechanisms: enteropathogenic
(EPEC), enterotoxigenic (ETEC), enteroinvasive (EIEC), enteroaggregative
(EAEC), diffusely adherent (DAEC) and enterohaemorrhagic (EHEC).
Common attributes of mucosal pathogenic bacteria are the ability to
colonise the host epithelial surface, multiply and cause damage (Robins-
Browne and Hartland, 2002). E. coli diarrhoeagenic strains have a
diverse range of adhesive structures to facilitate colonisation ranging
from fimbrial structures (all types) to a highly developed attaching
system, (EPEC and EHEC) requiring a type III secretion system (TTSS).
Following successful colonisation the strategies of pathogenic E. coli to
multiply and cause diarrhoea extend from enterotoxin production (EAEC
and ETEC), to invasion (EIEC) or effacement of the enterocyte microvilli
(EPEC and EHEC) (Nataro and Kaper, 1998). The different categories of
diarrhoeagenic E. coli and their main characteristics will be discussed in
detail in this section.
Enteropathogenic E. coli was the first pathotype to be described (Bray,
1945), and is an important cause of infantile diarrhoea in developing
countries (Simpson et al., 2006). EPEC strains are also a common cause
of diarrhoea in rabbits, pigs and ruminants (Wales et al., 2005a). To
colonise the gastrointestinal tract EPEC binds tightly to the host
3
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intestinal mucosa by way of a type three secretion system (TTSS, the
mechanism is described in more detail in section 1.2.1) causing
characteristic attaching and effacing (AE) lesion. In addition a type IV
pilus called the bundle-forming pilus (BFP) mediates interbacterial
adherence (Nougayrede et al., 2003). AE lesions are characterised by
destruction of the enterocyte apical microvilli, alterations of the
cytoskeleton and electrolyte transport of the host cell, which leads to
increased permeability and loosening of the tight junctions (Stein et al.,
1996; Yuhan et al., 1997). Recent research has determined that EPEC
inhibits the Na+-Glucose cotransporter (SGLT-1) in a TTSS dependent
manner in biopsy explants (Dean et al., 2006). SGLT-1 is considered the
major water pump in the small intestine and accounts for up to 50% of
the daily uptake of fluid (Loo et al., 2002). The inactivation by EPEC of
this water absorption system could result in a potent diarrhoeagenic
mechanism, in particular considering that an increase of just 10-15% of
stool water contents is enough to produce diarrhoea in humans (Fischer
et al., 2001). The identification of this mechanism could explain the
resultant onset ofwatery diarrhoea after EPEC intestinal colonisation,
although further work in vivo is needed to fully validate this finding.
Enterotoxigenic E. coli infection is the most common type of
colibacillosis of piglets and neonatal calves, and it is the main cause of
diarrhoea among travellers and children in the developing world (Nagy
and Fekete, 2005; Qadri et al., 2005). For the three species, colonisation,
without major intestinal morphological change, is mediated by fimbriae,
and secreted enterotoxins are responsible for increased in intestinal
secretion. In pigs, the most common pathogenic strains are 0138, 0139
4
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and 0141. Their attachment to the porcine gastrointestinal tract is
mediated by F16ab fimbriae and their main virulence factor is Shiga
toxin 2e (Stx 2e). The action of Stx2e results in damage to endothelial
cells lining the small arteries and arterioles of the gut and brain causing
oedema in the submucosa of the gut and infarction and malacia in the
brain stem (Moxley, 2000). In calves and humans the toxins produced by
ETEC are classified into two groups: heat-labile (LT) and heat-stable (ST)
enterotoxins (Al-Majali et al., 2000a; Wolf, 1997). ETEC strains might
express LT or ST or both. While STa is mostly isolated from calves (Al-
Majali et al., 2000b), diarrhoea caused by ETEC in humans has much in
common with cholera illness. LT toxin, found predominantly in human
ETEC isolates, is 80% homologous at the amino acid level to cholera
toxin (Spangler, 1992). The A subunit is responsible for the en2ymatic
activity of the toxin, by permanently activating the adenylate cyclase
leading to increased secretion of chloride from mucosal epithelial cells
(Sears and Kaper, 1996). A number of variants of the ST toxin can cause
diarrhoea by activating guanylate cyclase and resulting in chloride and
bicarbonate secretion (Vaandrager et al., 2000).
Enteroinvasive E. coli share identical pathogenesis to Shigella species
and together they form the distinctive Shigella/EIEC pathotype (Ina et
al., 2003). Shigella strains, historically classified in a different genus
because of their medical importance, are currently considered E. coli
clones (Lan and Reeves, 2002; Pupo et al. 2000). Unlike other EIEC
strains, Shigella species carry Shiga toxin type 1 (Stx 1) (Hale, 1991).
Strains of this pathotype follow a characteristic mechanism of epithelial
cell penetration, lysis of the endocytic vacuole, intracellular
5
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multiplication, movement through the cytoplasm and transverse
dissemination to neighbouring enterocytes through their lateral
cytoplasmic membranes (Parsot, 2005). Most EIEC pathogenesis results
from plasmid-encoded type III secretion systems (Nataro and Kaper,
1998) although Shigella infection can also induce acute renal failure and
haemolytic uraemic syndrome (HUS) (Houdouin et al., 2004).
Enteroaggregative E. coli is a recently defined diarrhoeal pathogen in
multiple human population groups (Huang et al., 2006). There is no
defined set of virulence elements associated with EAEC strains, and
currently they are defined as E. coli lacking LT or ST toxins and adhering
to human epithelial cells (Hep-2 cells) in a layered pattern (Harrington et
al., 2006). EAEC pathogenesis involves adherence to the terminal ileum
and colon mucosa mediated by aggregative adherence fimbriae (AAFs)
resulting in characteristic mucus aggregates of bacteria and
inflammation (Huang et al., 2006). Many strains harbour the plasmid
encoded Pet toxin and can elaborate ShETl enterotoxin, the former also
present in most Shigella flexneri strains (Eslava et al., 1998; Henderson
et al., 1999). Current data suggest that there is not a single set of
virulence elements associated with all EAEC strains, and it has been
proposed to reserve the term "typical EAEC" to strains harbouring the
AggR protein, which controls a collection of genes that contribute to
fimbrial biogenesis (Kaper et al., 2004).
Diffusely adherent E. coli is based on a phenotype that adheres to the
surface of Hep-2 cells with a distinct pattern of dispersed adherence
without aggregation. They have been implicated in diarrhoea of children
6
1.Introduction
under 1 year of age in a limited number of reports (Le Bouguenec, 1999;
Nataro and Kaper, 1998; Scaletsky et al., 2002) and evidence of DAEC
pathogenicity is less clear than for EAEC (Huang et al., 2006; Robins-
Browne and Hartland, 2002). Over 75% of the strains produce the
F1845 fimbrial adhesin which binds to the brush border-associated
decay-accelerating factor (DAF; CD55) as a receptor (Peiffer et al., 2000).
Impairment of the microvilli associated hydrolases, sucrase-isomaltase
and dipeptidylpeptidase IV following DAEC infection was suggested by
the same group of workers as a possible pathological mechanism for
DEAC induced diarrhoea (Peiffer et al., 2001).
Enterohaemorrhagic E. coli strains are characterised by inducing AE
mucosal lesions and the production of Shiga toxin (Stx), also known as
verocytotoxin (VT) (Frankel et al., 1998). Stx is the main bacterial
virulence factor responsible for EHEC pathogenecity in humans (Nataro
and Kaper, 1998). These cytotoxins are transported by neutrophils (Te
Loo et al., 2001), and bind to the glycosphingolipid globotriaosylceramide
receptor Gb3 which is found abundantly on human renal tissue
(Lingwood, 2003). The Stx A subunit cleaves a single adenine residue
from the 28S rRNA component of the host ribosome, producing inhibition
of protein synthesis (Sandvig, 2001), and acts on endothelial cells of
blood vessels predominantly in the intestinal submucosa and in the renal
glomeruli (Nakao and Takeda, 2000). Endothelial heterogeneity in Shiga
toxin receptors and responses may explain the particular involvement of
the kidney (Obrig et al., 1993; Ohmi et al., 1998). Histopathologically,
EHEC pathology is a thrombotic disorder, characterised by microvascular
thrombi (Inward et al., 1997). This finding is supported by recent
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research which suggested that prothrombin abnormalities might precede
initial renal injury, and that renal insufficiency is secondary to fibrin
thrombi deposition (Chandler et al., 2002; Tarr et ah, 2005). The specific
host mechanisms leading from Stx mediated injury of the vascular
endothelium to thrombotic microangiopathy and renal injury remain to
be elucidated.
1.1.2. E. coli 0157:H7
Most of the worldwide disease caused by STEC is related to the E. coli
0157:H7 strain, while approximately up to a third of the outbreaks are
attributed to non-0157 isolates such as 026, Olll, 0128, and 0103
(Bettelheim, 2000; Hussein and Omaye, 2003). Phylogenetically,
enterohaemorrhagic E. coli 0157:H7 is considered to have evolved from
an EPEC 055:H7 strain by acquiring the Shiga toxin 2 (Stx2) genes,
then the plasmid p0157 and shifting its antigen structure from 055 to
0157 (Feng et al., 1998; Reid et al., 2000). Unlike the majority of other E.
coli strains, E. coli 0157:H7 does not usually ferment sorbitol, making
sorbitol-MacConkey (SMAC) agar the medium of choice to isolate this
organism in clinical and experimental specimens. Nevertheless, sorbitol-
positive isolates of E. coli 0157 have been described regularly in clinical
and animal isolates and constitute a significant problem for diagnosis
(Brunder et al., 2006). E. coli 0157:H7 strains also harbour a
pathogenicity island termed tellurite resistance- and adherence- island
(TIA), which confers resistance to tellurite, resulting in the additional
selective isolation medium cefixime-tellurite sorbitol-MacConkey agar
(Tarr et al., 2000). Toxin production and 0157 antigen can be detected
by a variety of immunoassays and molecular methods (Lukinmaa et al.,
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2004), but bacterial culture, demonstration of toxic effects on Vero cells,
and genomic profiling by Pulsed Field Gel Electrophoresis (PFGE) are
strongly recommended to facilitate typing and epidemiological
investigations (Centers for Disease Control and Prevention, 2006;
Gautom, 1997).
1.2. EHEC Virulence and colonisation factors
In EHEC evidence shows that virulence genes are inserted into diverse
chromosomal loci among various serotypes, suggesting that each
pathotype has emerged independently multiple times within E. coli by
horizontal transmission (Wieler et al., 1997). EHEC strains are able to
cause disease by the expression of multiple virulence factors (VFs) the
most relevant of which are described in the following sections.
1.2.1. The Locus of Enterocyte Effacement
The Locus of Enterocyte Effacement (LEE) is a 43.3 kilobase pair (kb)
chromosomal insertion with 54 open reading frames, that encodes for a
group of factors required for the intimate attachment of the bacteria
(Perna et al., 1998). The expression of these factors results in the
hallmark of EPEC and EHEC infection: attaching and effacing lesions
(AE) on the apical surfaces of host cells (Nataro and Kaper, 1998). This
pathogenicity island has a lower guanidine-cytosine percentage (38.3%)
than the rest of the bacterial genome which may indicate a different
species origin (Elliott et al., 1998), and recent bioinformatics analysis has
postulated lambda phage origins (Tobe et al., 2006). Originally described
for EPEC strains, this morphologic alteration of the host cell is also
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present when EHEC adheres to cell lines (Nicholls et al., 2000) and has
also been reported in experimentally and naturally infected animals in
various animals such as cattle (Hall et al., 1985; Moxley and Francis,
1986; Pospischil et al., 1987; Schoonderwoerd et al., 1988; Janke et al.,
1989, 1990; Pearson et al., 1989; Dean-Nystrom et al., 1997; Naylor et
al., 2005a), dogs (Janke et al., 1989), goats (Barlow et al., 2004), mice
(Nagano et al., 2003), sheep (Wales et al., 2001a; Wales et al., 2005b),
pigs (Helie et al., 1991; Neef et al., 1994; Higgins et al., 1997, Dean-
Nystrom et al., 2000), rabbits (Peeters et al., 1984) and poultry (Fukui et
al., 1995). Even though the resultant phenotype is similar, there are
numerous differences in structure and regulatory inputs that suggest a
tighter regulation of this large genetic element in EHEC than in EPEC
strains (Spears et al., 2006). LEE is considered essential for EPEC/EHEC
colonisation of the host (Nataro and Kaper, 1998), particularly in the
bovine species. Signature-tagged mutagenesis and defined LEE deletions
within 026 and 0157 strains have shown the relevance of the LEE for
colonisation in cattle (Dziva et al., 2004; Naylor et al., 2005b; van Diemen
et al., 2005), and occasionally, atypical LEE negative EHEC strains have
been isolated in human patients with severe disease (Elliott et al., 2001).
A plasmid-encoded adhesin designated STEC autoagglutinating adhesin
(Saa) has been identified in strains lacking the LEE, and this adhesin is
now used routinely for characterisation of EHEC virulence factors
(Nielsen and Andersen, 2003; Paton and Paton, 2002). Also, recent in
vitro studies demonstrated the epithelial cell invasion of several EHEC-
LEE negative strains, suggesting for these clones an alternative invasive
mechanism to the customary membrane adherence (Luck et al., 2005).
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Studies have shown that LEE genes are activated upon cell contact
(Beltrametti et al., 1999; Wolff et al., 1998) and regulated by a quorum
sensing mechanism through the E. coli regulator A (QseA) (Sperandio et
al., 2002). The inducer has not been biochemichally identified yet, but is
encoded by a member of the luxS gene family (Sperandio et al., 2003;
Surette et al., 1999). The main consequence following LEE activation and
protein secretion is the intimate attachment of the bacterium to the
eukaryotic cell together with effacement of the enterocyte brush border
leading to the formation of AE lesions. Through EspA, a TTSS nano-
syringe, the bacterium injects its own receptor Tir, which binds to the
bacteria outer membrane intimin, triggering the rearrangement of the
epithelial cell actin and the formation of pedestal-like formations on the
apical membrane of the mucosal epithelium (Vallance and Finlay, 2000;
Figure 1-1). The ultimate benefits of this action for the bacteria may be
varied; it may obtain access to cellular nutrients, enhance its
persistence, or help the bacteria to avoid host immune responses.
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Figure 1-1. Main proteins involved in the formation of the attaching-








The LEE contains 54 open reading frames organised into five operons,
that encode components of a TTSS an organelle that spans the two
membranes of the bacterium, and transfers proteins into the cytosol of
the host cell (Mota et al., 2005). LEE operons 1 to 3, are highly conserved
between EPEC and EHEC (Elliott et al., 1998; Jarvis et al., 1995), and
encode several components of the TTSS, amongst others the translocated
effector proteins EspH (Tu et al., 2003) and EspZ (Kanack et al., 2005).
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LEE 4 genes encode for the regulator SepL (O'Connell et al., 2004) the
needle EscF (Wilson et al., 2001), effectors such as EspF (Deng et al.,
2005) and EspG (Ritchie and Waldor, 2005) and the translocators A, B
and D. EspA forms an extension to the EscF that enters the host cell
membrane via a pore formed by EspD and EspB (Yip and Strynadka,
2006). Regulated by its own promoter, the mitochondrial associated
protein (MAP) is associated with filopodia formation (Kenny et al., 2002).
LEE 5 encodes for effectors like the translocated intimin receptor (Tir)
(Kenny, 2002) and the bacterial outer membrane adhesin intimin (Louie
et al., 1993). So for all the LEE-encoded effectors translocated by the
TTSS into the host cell, only TIR is indispensable for AE lesion formation
(Spears et al., 2006).
1.2.2. Shiga toxins
Shiga toxins (Stx) are members of a family of plant and bacterial protein
toxins that affect the translational machinery of the host cell, by
removing a specific adenine base from the 28 S rRNA of the 60S
ribosomal subunit of the parasitised eukaryotic cell (Endo et al., 1987).
Stx are encoded in the genome of heterogenic lambdoid phages that when
undergoing the lysogenic cycle, break the bacterial cell envelope causing
the release of the toxin (Unkmeir and Schmidt, 2000). Stx are produced
by EHEC isolated from human and non-human sources, Shigella
dysenteriae type 1, and also occasionally, by Citrobacter freundii,
Enterobacter cloacae, Aeromononas hydrophila, Aeromononas caviae and
Shigella flexneri (Cherla et al., 2003; Sandvig, 2001). The Stx group
contains two variants called Stx 1 (also termed verocytotoxin 1: VT1 or
Shiga-like toxin: SLT1) and Stx2 (VT2, SLT2). Stxl is identical to shiga
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toxin of S. dysenteriae type 1, whereas Stx2 is structurally and
immunologically distinct (Fraser et al., 2004). These groups are
composed of different variants or alleles, Stxl type consists of Stxl,
Stxlc, and Stxld and the Stx2 group comprises Stx2, Stx2c, Stx2d,
Stx2dactivatable, Stx2e, and Stx2f (Friedrich et al., 2002). The bacteria
can harbour more than one Stx-encoding bacteriophage and therefore
produce more than one type of Stx (Nakao and Takeda, 2000). The Stx
type of the infecting strain can influence the prognosis of the infection in
gnotobiotic pigs (Donohue-Rolfe et al., 2000) and people (Jure et al.,
1998; Karch et al., 2006; Werber et al., 2003) with strains that produce
Stx 2 perceived as more virulent, than bacteria that produce both Stxl
and Stx2, or Stxl. Some studies have indicated that among the different
alleles stx2e can be considered to be of low pathogenecity, irrespective of
the presence of other factors (Orth and Wurzner, 2006), while variants
Stx2, Stx2c and Stx2d are associated with increased severity of disease
and likelihood of progression to acute renal failure (Bielaszewska et al.,
2006; Friedrich et al., 2002) in German patients. Although, there are
reports that these associations have exceptions (Cimolai et al., 1994;
Jelacic et al., 2002).
The only naturally occurring diseases in animals associated with Shiga
toxin producing E. coli (STEC) are swollen head syndrome (SHS) in
chickens, caused by Stx2y (Parreira and Yano, 1998; White et al., 1990)
and oedema disease in piglets caused by Stx2e (Marques et al., 1987). In
chickens the cytotoxic effect of the toxin has been described only in vitro
(Salvadori et al., 2001). In pigs, the action of Stx2e toxin results on
endothelial cells in small arteries and arterioles in the gut and brain
14
1.Introduction
causing vascular damage in the gut and brain and death (Moxley, 2000).
Nevertheless, serotyping and molecular profiling of isolates of E. coli-
producing Stx2e from humans and pigs demonstrated that the strains
that cause human disease are different from the strains that cause
oedema disease in pigs (Sonntag et al., 2005), thus suggesting a non-
porcine origin for the occurance of this toxin in humans.
Shiga toxins are composed of two structures; the A subunit carries the
enzymatic activity, while the B subunit binds the toxin to the membrane
receptor Gb3 in humans or Gb4 in pigs (DeGrandis et al., 1989; Jacewicz
et al., 1986). The sites of pathology correlate with the presence of the
toxin receptor glycolipid in humans, pigs and in the rabbit experimental
model (Boyd et al., 1993; Lingwood, 1996; Zoja et al., 1992). In cattle, a
major EHEC reservoir, Stx does not produce clinical disease despite the
regular detection of shiga toxins in their faeces (Hyatt et al., 2001; Van
Donkersgoed J. et al., 1999). Gb3 is present in both small and large
intestinal mucosa (Hoey et al., 2002) but not in the vascular endothelium
of cattle (Pruimboom-Brees et al., 2000). Interestingly work carried out
with cell cultures of bovine intestinal epithelial cells exposed to Stx,
showed the toxin localised in the lysosomes, in contrast with its
restriction to endoplasmic reticulum in green monkey kidney Vero cells,
a pathway that may inactivate Stx in the bovine species (Hoey et al.,
2003). In the same work, no cytotoxicity was observed when bovine
intestinal cells where challenged with doses of VT1 10,000 fold higher
than the CD50 for Vero cells, confirming remarkable differences in cell
sensitivity to the toxin. Spontaneous curation of Stx genes have been
reported in bacteria shed in faeces during human infection (Mellmann et
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al., 2005) and in vitro culture (Murase et al., 1999) . These findings may
imply that the selective advantage that VT-encoding bacteriophages can
provide to EHEC strains benefit the bacteria in other environments are
still to be determined. Thus, the different pathology that shiga toxin
induces in humans, pigs and rabbits, prevents the development of a
suitable animal model, thus hampering the studies of human
pathogenesis, which are now restricted to in vitro studies and clinico-
pathological observations (Bielaszewska and Karch, 2005).
1.2.3. Other E. coli 0157:H7 virulence factors
Of the shigatoxin-producing E. coli (STEC) the most studied is 0157:H7
(Naylor et al., 2005a). Genetic analysis has shown that nearly 20% of the
E. coli 0157:H7 chromosome is not present in the benign laboratory
strain K-12 MG1655 (Hayashi et al., 2001), and has probably been
acquired through horizontal gene transfer (Reid et al., 2000). Such
additional genes may be part of possible pathogenicity islands (PAIs),
present in pathogenic strains but often not present in non-pathogenic
clones, which like the LEE, carry virulence determinants and are inserted
in excision tRNA loci and show a lower G:C content (Hacker et al., 2003).
Sequencing of two epidemic strains, EDL 933 (Perna et al., 2001) and the
Sakai strain (Hayashi et al., 2001) has led to the determination of several
PAIs , some of these islands are described below.
Non-LEE encoded effectors: During the last two years the field of E. coli
effectors has moved forward very quickly widening our knowledge of the
pathological mechanisms observed during EHEC infection. These newly
described lambdoid encoded effectors are translocated by the TTSS into
16
1.Introduction
the eukaryotic cell and include Cif, Espl, TccP and EspJ (Garmendia et
al., 2005). Cif blocks the cell cycle at the Gap2/Mitosis transition and
induces the formation of stress fibres (Marches et al., 2003). Espl
localises in the Golgi apparatus of the host cell and mutants of this gene
show reduced colonisation efficacy in the C. rodentium mouse model
(Mundy et al., 2004a). It has been found more commonly in patients than
asymptomatic carriers (Mundy et al., 2004b). TccP is a protein that links
Tir to the host cell actin cytoskeleton inducing actin polymerisation in a
phosphorylation independent manner (Garmendia et al., 2004). EspJ is
an effector not required for AE formation in vivo. However, experimental
infections with EspJ mutant strains of E. coli 0157:H7 in lambs and of C.
rodentium in mice increased the persistence of the bacteria in the
intestinal tract in these species (Dahan et al., 2005).
Plasmid p0157 is a 90Kb extrachromosomal element composed of four
operons and 84 ORF's (Makino et al., 1998). The following p0157
determinants and proteins have been implicated in E. coli 0157
pathogenesis. The espC-O gene encodes for a type II secretion system
(SS), a highly specific apparatus that spans the periplasmic
compartment, able to assemble a pilus (Schmidt et al., 1997). This type II
SS is responsible for the secretion of toxins such as Stce, a Cl-esterase
inhibitor capable of suppressing the classic complement pathway in vitro
(Grys et al., 2005; Lathem et al., 2004). The operon hly encodes for the
synthesis and transport of enterohaemolysin, a pore-forming cytolysin,
proven to be cytotoxic in bovine, ovine and human cells, (Bauer and
Welch, 1996). Some workers have suggested that the role of this toxin is
to provide a source of iron for the bacterium (Torres and Payne, 1997).
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The toxB gene is highly conserved amongst E. coli 0157 strains (Tozzoli et
al., 2005) and influences the expression of the LEE resulting in reduced
adherence of the bacteria in vitro (Tatsuno et al., 2000). Nevertheless,
recent experiments with toxBmutants failed to show significant
differences in their colonisation capacity in sheep and cattle (Stevens et
al., 2004). (iv) The p0157 plasmid also encodes for other determinants
that are considered putative virulence factors, including two enzymes, a
catalase-peroxidase (KatP) (Brunder et al., 1996) considered part of the
bacterial system of defence against oxidative stress (Farr and Kogoma,
1991; Spiro, 2006), and a serine-protease (EspP) that cleaves human
coagulation factor V and to which there is an immune response in
convalescent children (Brunder et al., 1997).
These plasmid determinants are heterogeneously distributed amongst
0157 and other EHEC strains. The hly operon is present in almost all
0157 strains, and is considered the best marker for detecting the
presence of p0157. EspC-O, KatP and EspP are found in 50% of the
clones (Caprioli et al., 2005). No correlation has been found between the
presence of the genes and illness severity (Welinder-Olsson and Kaijser,
2005).
1.2.4. E. coli 0157:H7 adhesins
Mechanisms of intimate cellular adhesion leading to AE formation have
long been known. Despite this the initial adherence step before close
intercellular contact is not well understood (Nataro and Kaper, 1998). A
number of putative adhesin factors including type IV fimbriae, outer
membrane proteins and flagellae have been described for E. coli
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0157:H7. Analysis of the putative fimbrial operons from sequenced
0157:H7 strains showed that several are likely to be cryptic with
expression only demonstrated for three, one of which termed F9, has
been reported to be needed for successful colonisation (Low et al., 2006b;
van Diemen et al., 2005). In vitro studies and animal challenges with an
F9 0157 mutant concluded that this adhesin is not involved in the rectal
tropism (Low et al., 2006a). E. coli 0157:H7 cannot express common type
1 fimbriae due to a conserved deletion in the fimA promoter region (Roe
et al., 2001). In vitro studies of adherence to culture HeLa cells with
mutagenised E.coli 0157:H7 clones identified increased adherence in
strains with increased expression of the outer membrane protein A
(OmpA) (Torres and Kaper, 2003). This protein has also been involved in
E. coli K-1 invasion of brain endothelial cells through its adhesion to the
gp96 receptor in cases of neonatal meningitis (Prasadarao, 2002). In vivo
work in cattle with isogenic deletion mutants to study their capacity to
colonise the terminal rectum, found that the only virulence factors that
had a significant impact in the bovine terminal rectum colonizing
capacity of the bacteria were intimin, Tir and p0157, while Stx and
haemolysin did not (Sheng et al., 2006a). A similar work carried out to
study the role of flagellin, reported for both the mutant and the parent
strain, a similar efficacy to colonise the bovine gastro intestinal tract
(Dobbin et al., 2006). While Tir and intimin are pivotal in the intimate
attachment of the bacteria to the mucosal epithelium, the function of
pO!57 in colonisation is not well understood.
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1.3. Overview EHEC in humans
Our current understanding of the epidemiology of EHEC strains in
humans is constrained by two issues. One is the lack of a clear
proportional relationship between the prevalent EHEC animal strains
and those that cause more frequent disease in humans (Kuhnert et al.,
2005; Pearce et al., 2006; Roldgaard et al., 2004). The other, is that the
incidence of non-0157 human infections is underestimated by detection
costs and isolation complexity associated with the numerous potential
serotypes involved (Fairbrother and Nadeau, 2006; Johnson et al., 2006).
Both restrictions are difficult to resolve given the complexity of reservoirs
and transmission modes of this pathotype and the number of strains
involved.
There are over 250 different O serotypes, ofwhich more than one
hundred have been associated with human disease ranging from
diarrhoea to HUS (Johnson et al., 2006) (un updated list can be accessed
at: http://www.microbionet.com.au/vtectable.htm). While strain
0157:H7 is the predominant EHEC serotype in the United States,
Canada and the United Kingdom and the clone most commonly
associated with HUS (Nataro and Kaper, 1998), non-0157 serotypes may
account for up to 20-50% of the cases in the United States (Brooks et al.,
2005) and United Kingdom (Kleanthous et al., 1990). In contrast, other
countries around the world report higher incidences of non-0157
induced human disease such as Denmark (75% of STEC associated
diarrhoeas originated from non-0157 cases), Spain (78%), Finland (53%),
Czech Republic (57%), Belgium (63%), Chile (63%) and Australia (69%)
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(Johnson et al., 2006) Singularly, New Zealand has never reported the
isolation of E. coli 0157 from clinical isolates (Brooks et al., 1997) or
meat (Bennett and Bettelheim, 2002). Different regulations between
countries on statutory surveillance, notification and detection methods
precludes meaningful comparisons of these incidence figures.
Amongst the most common non-0157 serotypes causing human disease
in Europe are 026:H11/HNM, O103:H2, Oil 1:HNM, and 0145:HNM
(World Health Organization, 1998) with 026:H11 reported as the most
common non-0157 isolate from HUS cases (Gerber et al., 2002;
Misselwitz et al., 2003). It is commonly accepted that due to the
availability of selective isolation media, laboratory detection favours E.
coli 0157 (Goldwater and Bettelheim, 1998; Thorpe et al., 2002). The
importance of adequate strain identification was demonstrated during an
outbreak in Washington State where rapid outbreak recognition and
control prevented an estimated 800 cases (Bell et al., 1994). To achieve a
complete response international networks such as Med-Vet-Net and
Enter-Net in Europe, Australia and Japan, and the Food-borne Diseases
Surveillance Network (FoodNet) of the Centre for Disease Control in the
USA, play an important role in harmonisation of protocols, rapid
reporting and promoting concerted programmes for research and
surveillance.
Since the first association between E. coli 0157:H7 and thrombotic
microangiopathy (Karmali et al., 1983; Riley et al., 1983), the incidence
reported by the Department of Environment, Food and Rural Affairs in
the UK and the Centers for Disease Control and Prevention in the USA of
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the disease attributable to this strain in particular, and to the other
EHEC serogroups, has stabilised to 1.6 and 2.5 cases per 100,000
population in the UK and USA since the years 1995 and 2001
respectively (Brooks et al., 2005; Department for Environment, Food and
Rural Affairs, 2005; Rangel et al., 2005). The incidence in Scotland has
also stabilised in the last decade, although the number of human cases
stabilised around 4.0 per 100,000 population, twice the annual incidence
rate for England and Wales (Locking et al., 2006). These overall trends
suggest that the systematic preventive approach to food hygiene
established by Hazard Analysis and Critical Control Points (HACCP) and
detection systems such Health Protection Scotland and PulseNet in the
USA for the molecular subtyping of EHEC in humans, food, water, and
the environment, are starting to be effective (Gerner-Smidt et al., 2005).
Enterohaemorrhagic E. coli was first recognised as a cause of illness in
1982 (Riley et al., 1983). It is a zoonotic disease and ruminants are its
principal reservoir, although EHEC strains can be found in numerous
animal species (Naylor et al., 2005a) including asymptomatic human
carriers (Stephan and Untermann, 1999; Wilson et al., 1998). Infection is
restricted to humans who commonly develop afebrile haemorrhagic
colitis and HUS which is characterised by renal failure,
thrombocytopenia and microangiopathic haemolytic anaemia (Amirlak
and Amirlak, 2006). A limited number of HUS cases have been associated
with acute urinary infection with EHEC strains (Starr et al., 1998).
Frequent extrarenal abnormalities include neurological damage, colonic
necrosis, myocardial dysfunction and pancreatitis (Brandt et al., 1994;
Gerber et al., 2002; Taylor et al., 1986). Necropsy and histological studies
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have also reported that the kidney, followed by the large bowel, the
central nervous system, the heart and the pancreas are the organs more
affected, thus corroborating the clinical findings (Gallo and Gianantonio,
1995).
1.3.1. E. coli0157:H7 in humans
E. coli 0157:H7 is one of the most notorious serotypes amongst
verocytotoxigenic E. coli. It is associated with serious human disease and
infection can result not only in diarrhoea but haemolytic-uraemic
syndrome and death (Karch et al., 2005). E. coli 0157:H7 was first
recognised as a cause of illness in 1982 during an outbreak of severe
bloody diarrhoea, where infection was traced to the consumption of
contaminated hamburgers ( Centers for Disease Control and Prevention,
1982). Since the first description of this illness, infections have been
reported from more than 30 countries on six continents (Thorns, 2000).
During the initial years of reporting, E. coli 0157:H7 outbreaks were
predominantly foodborne and often involved insufficiently cooked, ground
beef contaminated during the slaughter process (Slutsker et al., 1998).
Raised awareness and increased surveillance led to an increase in
clinical cases and to the identification of diverse contamination sources.
E. coli 0157 excreted in animal faeces and occasionally spread by
manure fertilisation can also contaminate farm products, such as
unpasteurised apple juice (Hilborn et al., 2000), pasteurised (Goh et al.,
2002) and unpasteurised milk (Liptakova et al., 2004), alfalfa sprouts
(Breuer et al., 2001), as well as soil (Mukherjee et al., 2006) and water
(Friedman et al., 1999). Transmission may also occur by person to
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person spread (Willshaw et al., 2001) including asymptomatic carriers
(O'Brien et al., 2001a; Strachan et al., 2006), airborne dispersion (Varma
et al. 2003), and has occurred in laboratories (Public Health Laboratory
Service, 1996). Infectious dose is low and it has been estimated that a
few hundred bacteria may produce infection in humans and cattle
(Besser et al., 2001; Tuttle et al., 1999).
The majority of human cases are sporadic and the source of infection is
generally unknown (Naylor et al., 2005b), although most major outbreaks
in the USA and UK can be linked to E. coli 0157 tainted food (O'Brien et
al., 2001b; Rangel et al., 2005). In Scotland, although one of the
deadliest outbreaks in the world occurred in Lanarkshire in 1996, and
was linked to contaminated meat (Cowden et al., 2001), the majority of
cases of E. coli 0157 now appear as sporadic cases (Evans et al., 2000;
Locking et al., 2006). The main risk factor identified in several studies
suggest that these scattered cases are the result of environmental
contact with animal faeces (Coia et al., 1998; Locking et al., 2006;
O'Brien et al., 2001a) through water, soil and direct contact with animals
(Solecki et al., 2007; Strachan et al., 2006). Therefore, an important
issue for prevention of human infection through either food or
contaminated environment must be to understand and control E. coli
0157 carriage in animals.
1.4. Overview EHEC in animals
The common features that characterise the heterogeneous EHEC
pathotype are lack of specific host or niche and ubiquitous distribution
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in ruminants. EHEC strains have been isolated consistently in countries
from all continents, including Europe (Ammon, 1997; European Food
Safety Agency, 2007), USA (Centers for Disease Control and Prevention,
2007; Gerner-Smidt et al., 2006), Argentina and Brazil (Guth et al.,
2003), Africa (Raji et al., 2006), India (Wani et al., 2003), Thailand
(Panutdaporn et al., 2004), Australia (Cobbold and Desmarchelier, 2001)
and China (Zhou et al., 2002). Ruminants are considered the main
reservoir for EHEC strains (Kaper et al., 2004; Naylor et al., 2005a),
although EHEC strains have been detected in a variety of animals, such
as; pigs (Fratamico, et al. 2004), wild deer (Asakura et al., 1998), pigeons,
gulls and broilers (Kobayashi et al., 2002), rabbits (Garcia and Fox,
2003), and zoo ungulates (Leotta et al., 2006). E. coli 0157 has also been
found in a similar wide range of animal species including pigs (Aktan et
al., 2004), deer (Asakura et al., 1998), wild birds, rodents (Nielsen et al.,
2004a), chickens (La Ragione et al., 2005), ducks (Leclercq and Mahillon,
2003), wild rabbits (Scaife et al., 2006), healthy and sick commercial
rabbits (Blanco et al., 1996), horses (Chapman, 2000), earthworms
(Williams et al., 2006), slugs (Sproston et al., 2006), and houseflies
(Kobayashi et al., 1999). Although there is circumstantial evidence of
transmission of E. coli 0157 from wild rabbits (Scaife et al., 2006) and
birds (Ejidokun et al., 2006) to humans, most authors agree that these
species act predominantly as mechanical vectors or as reservoirs for
ruminant infection (Alam and Zurek, 2004; Cizek et al., 1999; LeJeune et
al., 2004; Rice et al., 1995; Sanderson et al., 2006).
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1.4.1. Cattle as reservoirs
Over 400 EHEC strains have been isolated from cattle (Gyles, 2007)
many of which are found simultaneously in a herd. One major study
detected up to 170 different EHEC strains circulating in a single cohort
of 49 healthy cattle (Shaw et al., 2004). Several studies have described
within herd epidemiology and shedding of EHEC strains. In a
longitudinal study based on 12 strains, environmental transmission
accounted for 60% of all infections, while calf-to-calf transmission
explained the other 40%. Shedding was sporadic with the same strain
detected in the same animal weeks apart (Liu et al., 2005; Pearce et al.,
2004a). Duration for individual infection was established at 3-5 days on
average depending on the strain (Liu et al., 2005). Remarkably, E. coli
0157 strains can persist on farms for up to two years (Shere et al.,
1998). These findings confirm the relevance of cattle as a major reservoir
of EHEC strains, many of which coexist within the same herd for long
periods. Infection in cattle is usually short and can recur indicating
either reinfection or shedding periods with bacterial numbers too low to
be detected.
The amount of research published during the last thirty years on E. coli
0157:H7 has promoted this serotype to the de facto group model. In the
bovine species, E. coli 0157:H7 estimates from field studies report great
variability in point prevalence. Values observed range from 0% to 57%
(Callaway et al., 2005; Khaitsa et al., 2006; Meyer-Broseta et al., 2001;
Vidovic and Korber, 2006), and excretion is more prevalent among calves
aged 3-16 months (Garber et al., 1995; Paiba et al., 2003; Rugbjerg et
al., 2003). Estimates from slaughterhouses reflect similar wide
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prevalence values from 3% to up to 37.5% (Fukushima and Seki, 2004).
Similar prevalence rates of up to 58% have been reported for non-0157
STEC strains (Hussein, 2006).
These prevalence surveys are based on cross sectional studies, which
describe carriage status at a particular point in time, and can only
provide a static view on the infectious process dynamics. In contrast,
longitudinal analysis involves observations of the same individuals and
farms over long periods, recording the temporal order of events and is
more informative to study transmission dynamics than cross sectional
studies, because they can track changes at group and individual level.
Several studies involving cohort, or panel, cross-sectional studies have
been published (Cho et al., 2006; Dopfer et al., 2006; Ezawa et al., 2004;
Sanderson et al., 2006; Schouten et al., 2005). These works report that
faecal shedding of E. coli 0157:H7 is limited to a few individuals and
farms separated by periods of low prevalence or absence of infection.
Mathematical analysis of a large two year cross-sectional survey of 481
farms showed that, the best theoretical distribution to reproduce E. coli
0157 prevalence values, incorporated a subset of highly infectious
animals. These animals with a high level of carriage are about 20% of the
colonised population and account for 80% of the transmission (Matthews
et al., 2006a). Targeted measures aimed at preventing infection in the 5%
of individuals with the highest overall infectiousness would reduce the
number of secondary cases a single infected case will cause, reducing the
reproduction ratio [or Ro) below one, therefore eliminating the infection
from the herd (Matthews et al., 2006b; Woolhouse et al., 1997).
Significantly, a cohort study carried out on naturally infected animals
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reported a small proportion of the infected animals becoming persistent
high shedders (E. coli 0157:H7 bacterial counts above 103 colonies
forming unit per gram of faeces, CFU g-1) for at least fifteen days
(Cobbold et al., 2007; Robinson et al., 2004). Slaughterhouse studies
have, to a degree, confirmed these predictions by identifying between
3.7% (Low et al., 2005c) to 1.86% (Omisakin et al., 2003) of animals as
high shedders. It must be noted that these abattoir studies lack
longitudinal data to allow discrimination between different stages of
animal infection (variation within animals) and genuine animal variation
in the ability to carry and shed the bacteria (variation between animals).
E. coli 0157 seasonal shedding variability remains controversial, with
some studies reporting a higher prevalence in summer and autumn
(Lahti et al., 2003; Tutenel et al., 2002), while others described a higher
winter prevalence (Ogden et al., 2004; Shere et al., 1998) and some
failing to detect such seasonal trend (Alam and Zurek, 2006; Dopfer et
al., 2006; Mechie et al., 1997).
1.4.2. Other ruminants
EHEC prevalence surveys in sheep and goats offer similar ranges to those
reported for the bovine species (Beutin et al., 1993; Fegan and
Desmarchelier, 1999; Urdahl et al., 2001; Vettorato et al., 2003; Zweifel
et al., 2004) and show that small ruminants can be considered a
significant public health hazard. Most ovine strains are host specific
(Beutin et al., 1997; Djordjevic et al., 2004) and a number of them have
been linked to human disease (Bettelheim et al., 2000b; Orden et al.,
2003). EHEC strains are three to four fold more prevalent in sheep and
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goats than in cattle in Denmark (Beutin et al., 1993)and Serbia (Cobeljic
et al., 2005), while sheep are considered greater EHEC spreaders than
cattle in Australia (Gyles, 2007) and the main source of E. coli 0157:H7
environmental contamination in Scotland (Strachan et al., 2005).
Sheep are a known reservoir of E. coli 0157 and this strain is better
adapted to persist in sheep than are other common pathotypes of E. coli
(Cornick et al., 2000). Sheep can shed E. coli 0157:H7 in amounts
exceeding 103 CFU g1 (the threshold for cattle to be considered a super
shedder) (Cornick et al., 2000; Matthews et al., 2006b; Ogden et al.,
2005). Bacterial numbers have been reported highest in faeces, and as in
cattle, rectal localisation has been described (Grauke et al., 2002; Wales
et al., 2001a).
1.4.3. Pigs
Pigs can also act as asymptomatic carriers of EHEC strains, including
0157 (Kaufmann et al., 2006), 026 (Leomil et al., 2005), Olll (Notario et
al., 2000), O103 (Aktan et al., 2004), and 0145 (Krause et al., 2005). Pigs
have been found to shed E. coli 0157:H7 up to 104 CFU g-1 (Cornick and
Helgerson, 2004) with a reported persistence of up to two months in
experimentally challenged pigs (Booher et al., 2002), and several studies
have identified pigs as a risk factor for herds being STEC 0157 positive
(Eriksson et al., 2005; Schouten et al., 2004). Faecal carriage of strain
0157 in pigs at slaughter ranges from 0.2% to 2% in Europe (Bonardi et
al., 2003; Chapman et al., 1997; Heuvelink et al., 1999; Johnsen et al.,
2001), 2% in Japan (Nakazawa and Akiba, 1999) and USA (Feder et al.,
2003), to 3.3% in China (Zhou et al., 2002) and up to 10% in Chile (Borie
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et al., 1997). Prevalence reports on farms ranges from 0.1% in Sweden
(Eriksson et al., 2003) to 2.1% in Mexico (Callaway et al., 2004) and up to
8.9% in some states of the USA (Doane et al., 2007). To the present date
there are only two reports, one in the USA and one in Italy of E. coli
0157:H7 human outbreaks being associated with pigs (Conedera et al.,
2007; Jay et al., 2007; Solecki et al., 2007). In addition, a clonal
relationship by colony blot hybridisation and PFGE has been reported
among 0157 isolates obtained from HUS cases and pigs in Chile (Rios et
al., 1999), while a recent study in Switzerland isolated three serotypes
previously reported in human STEC causing HUS (09:H-, 026:H-, and
O103:H2) in faeces from slaughtered pigs (Kaufmann et al., 2006).
Therefore, it may be possible for an undetermined number of human
cases to have originated from contact with pig faeces, and risk may be
related to geographical differences in pig husbandry and slaughtering
practices, or to lack of adequate source identification.
1.5. E. coli 0157:H7 bovine colonisation
It is commonly agreed that E. coli 0157 is not pathogenic for cattle over 1
week of age (Dean-Nystrom et al., 1999; Garber et al., 1995), although it
may cause diarrhoea in experimentally challenged newborn (<36 h old)
colostrum deprived calves (Brown et al., 1997; Cray Jr. and Moon, 1995)
and at <12 h old can develop severe, often fatal, diarrhoea accompanied
by AE lesions (Dean-Nystrom et al., 1997). The resistance of calves and
older animals to E. coli 0157:H7 infection may be explained by the lack of
vascular receptors for Shiga toxins. This absence of Stx specific Gb3
receptors makes the bovine species inherently insensitive to the toxin
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(Pruimboom-Brees et al., 2000). Thus the general consensus is that in
naturally colonised cattle E. coli 0157:H7 behaves as a commensal, a
type of symbiotic relationship in which the bacteria benefits from the
association while cattle are not affected (Cray, Jr. and Moon, 1995;
Pruimboom-Brees et al., 2000; Wray et al., 2000).
1.5.1. Site of colonisation
Initial experimental challenges in weaned calves reported a variety of
gastrointestinal colonisation sites. An early study carried out in
experimentally challenged calves and adult cattle detected consistently
higher E. coli 0157:H7 numbers in the contents of the large intestine and
faeces (Cray, Jr. and Moon, 1995). In contrast, another study reported
the bacteria predominantly in the gastrointestinal contents of the rumen,
with comparatively lower numbers obtained from cultures of tissue
washings (Brown et al., 1997). The finding lead the authors to suggest
that the predominant localisation of E. coli 0157:H7 was in the contents
of the forestomachs rather than on the mucosal surfaces of the large
intestine. A more recent study in adult cattle, confirmed the inconsistent
culture of E. coli 0157:H7 from gastrointestinal tissues, and reported the
bacteria to be most prevalent in the lower gastrointestinal digesta,
specifically the caecum, colon, and faeces. In consequence, the authors
proposed the colon contents as the main site for E. coli 0157:H7
persistence and proliferation (Grauke et al., 2002). Interestingly, a
histopathogical study made in high shedding animals reported the
rectum as the major site of colonisation followed by the colon (Dean-
Nystrom et al., 1999). In summary, two of these studies report a
predominantly E. coli 0157:H7 colonic localisation and found the highest
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numbers in the faeces. All three, except the study carried out on high
shedders, failed to demonstrate any evidence of mucosal colonisation or
AE lesions in infected animals.
Recently the terminal rectum was identified as the principal site for E.
coli 0157:H7 colonisation in cattle and independent of tissue bacterial
loads (Naylor et al., 2003a). This important finding has been fully
corroborated by similar studies carried out on feedlot cattle (Cobbold et
al., 2007; Lim et al., 2006), and by evidence that direct application to the
rectum was more successful in achieving long-term colonisation of calves
than oral challenge (Sheng et al., 2004). Support for the importance of
terminal rectum colonisation also comes from a recent abattoir study in
naturally colonised animals where the terminal rectum was colonised in
15 out of 16 E. coli 0157 positive animals (Low et al., 2005).
Nevertheless, it is apparent that the colonisation of other sites situated
higher up in the intestinal tract may occur, and their relevance for
sustaining infection has not been studied previously.
1.5.2. Histopathology in cattle intestine
The distinguishing histopathological feature of E. coli 0157:H7 infection
in cattle is the attaching and effacing (AE) lesions, characterised by
elimination of the microvilli and intimate enterocyte attachment (Dean-
Nystrom et al., 1999). This characteristic alteration of the enterocyte
morphology has been reported to be accompanied by an increase in
neutrophils and eosinophils in the lamina propria of the large intestine
(Woodward et al., 1999), colon and caecum (Dean-Nystrom et al., 1999),
gall bladder (Stoffregen et al., 2004), and sections of ligated ileal loops
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(Sandhu and Gyles, 2002). This type of inflammatory reaction has been
described in the intestinal tract exclusively for experimental infections of
gnotobiotic, neonatal or immunosuppressed calves. In weaned calves an
eosinophilic infiltrate has been reported only for the perianal skin and in
areas where AE lesions were present (Pohlenz and Dean-Nystrom, 2004).
All these studies are based on qualitative estimations, with no internal or
external controls. No detailed pathological studies have been carried out
in the terminal rectum, the main area of E. coli 0157:H7 colonisation in
the bovine species beyond the original study performed by Naylor et al.
(2003).
1.5.3. Immune responses to E. coli 0157:H7
Serological responses against E. coli 0157:H7 bovine infections have been
reported in the scientific literature. A seroprevalence study in the USA,
reported the prevalence of anti 0157 antibodies at 83% in calves and
100% in herds (Laegreid et al., 1999). Increased serum levels of IgG but
not IgM were described for three out of six experimentally challenged
calves. In contrast, the same study did not detect raised IgG titres in
three dry cows (Wray et al., 2000). In another study, increased serological
IgG responses against E. coli 0157 LPS and shigatoxin 2 were detected
following experimental infection of four calves and six steers, but in this
work the serological responses were not correlated with elimination of
infection. In a rechallenge study carried out in four weaned calves,
reinfection with the same strain resulted in lower levels of shedding
(Cray, Jr. and Moon, 1995). Neutralizing anti-shigatoxin IgGl antibodies
were present in 84.0% (189/225) of colostrum samples and in 93%
(37/40) of sera from heifers from randomly chosen cows in Germany
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(Pirro et al. 1995). Colostrum administration from dams with antibody
titres against E. coli 0157 in sera effectively elevated serum antibodies to
E. coli 0157 LPS in neonatal calves, even though no protection assays
were undertaken in this study (Widiasih et al., 2004a). Overall, these
results support the theory that in cattle there are serological IgG
responses against E. coli 0157:H7 colonisation and the latter work
suggests that STEC exposure of cows is widespread. To date, studies
have not been undertaken to detect mucosal immune responses to E. coli
0157:H7 gastrointestinal colonisation.
1.6. Control strategies in the animal reservoir
The remarkable variety and high prevalence in ruminants of EHEC
strains makes attempting to reduce their overall population an
unattainable goal, thus the efforts to protect public health against these
human pathogens should concentrate on blocking transmission
pathways by improving food and water safety (Gannon, 1999; World
Health Organization, 2001). It is possible that targeted interventions in
the animal reservoir against E. coli 0157:H7 could significantly reduce
the number of human cases, as most outbreaks are linked to both this
strain and ruminant sources (O'Brien et al., 2001a; Rangel et al., 2005).
A number of possible interventions including the use of antibiotics,
vaccination, bacteriophages, competitive exclusion, water hygiene,
changing dietary practices and good animal management can potentially
reduce the numbers of pathogenic bacteria that enter the food chain and
environment and will be briefly described in the following sections.
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1.6.1. Direct application of antibactericidials to the terminal rectum
Following the recent determination of the terminal rectum as the
principal site of E. coli 0157 in cattle, two different treatments based on
the principle of the direct application of antibactericidals to this area
have been tested in cattle: a lytic bacteriophage and the antiseptic
Chlorhexidine. In both cases, the treatment initially reduced bacterial
levels but did not prevent ensuing E. coli 0157:H7 carriage. Although
none of the treatments consistently cleared the bacteria from cattle, both
were successful in reducing the shedding levels from 104 - 105CFU g-1 of
E. coli 0157:H7 to below 103 log values on day 1 after treatment (Naylor
et al., 2007; Sheng et al., 2006b). The phage was administered a further
three times but failed to produce any further reductions in shedding.
Several reasons could explain the partial success of the antibactericidals
including; inability of the treatment to eliminate all the bacteria,
recolonisation of the terminal rectum from bacteria originating from other
sites situated higher up in the gastrointestinal tract, or bacteria shedding
from these sites. The direct rectal application of these treatments had a
beneficial therapeutic effect by eliminating the animals considered as
high shedders. Further improvements in product choice or
administration methods may better the current results, and offer a viable
control option to maintain "E.coli 0157:H7 clean" herds. Alternatively,
the use of these methods prior to transport could limit the transmission




A successful vaccine should induce reductions in shedding to levels so
that the on farm transmission of the pathogen ceases. The exclusively
gastrointestinal location of E. coli 0157:H7, requires a vaccine to induce
specific secretory immunoglobulin A responses as well as high colostral
IgG 1 responses to prevent intestinal colonisation of both adult and
newborn calves (Stevens et al., 2002). Several groups are currently
developing E. coli 0157:H7 vaccines for cattle. In an interesting study
carried out by the National Institute of Animal Health, in Japan,
intranasal administration of recombinant intimin mixed with E. coli heat-
labile enterotoxin as adjuvant, induced elevated IgA-specific antibody in
the nasal secretion and saliva of calves and elevated IgGl-specific
antibody level against the intimin in the sera and colostrum of cows
(Yokomizo et al., 2002). Although no trial was conducted to asses the
protection of this vaccine, several studies suggest that intimin is an
important antigen for any vaccine formulation. Immunisation of pregnant
swine with purified E. coli 0157:H7 intimin induced serum and
colostrum antibodies in the dams, and an increase in resistance to
colonisation and intestinal damage in suckling piglets (Dean-Nystrom et
al., 2002). Intimin-specific immune responses prevented bacterial
colonisation of the mouse gut by Citrobacter rodentium, a related
enteropathogen used as EHEC and EPEC models of intestinal
colonisation (Ghaem-Maghami et al., 2001). A recent vaccine trial based
on secreted proteins (Tir, EspA, B, D and P) of the Type III system used
by E. coli 0157:H7 for intestinal colonisation failed to reduce significantly
the numbers of bacteria shed on faeces on 218 pens of feedlot cattle in




A number of studies have proposed the use of probiotics and
bacteriophages to control E.coli 0157:H7 in ruminants. Neomycin
administration has been reported to decrease faecal shedding in cattle
(Edrington et al., 2003; Ranson et al., 2003), although given the current
concern on the spread of antibiotic resistance, it is unlikely that the
prophylactic use of antibiotics would ever be approved. Various E.coli
0157:H7 specific bacteriophages have been isolated by different
researchers, but all showed low in vivo effectiveness when administered
orally (Bach et al., 2002; Kudva et al., 1999; Tanji et al., 2004).
Competitive inhibition with other bacteria is a well established technique
for reducing Salmonella species colonisation in poultry and recently
approved by the FDA for its use (Nisbet, 2002). At least two studies have
been published in which different bacterial isolates that were determined
to inhibit E.coli 0157:H7 in vitro were given orally to calves and reduced
the levels and duration of carriage (Ohya et al., 2000; Zhao et al., 1998).
These studies were carried out in a limited number of animals and larger
field studies are needed to prove a real impact of probiotic bacteria on the
ecology of E.coli 0157:H7 in the cattle population.
1.6.4. Diet and fasting
There are conflicting reports regarding the effects of changes in the diet
on faecal shedding of E. coli 0157:H7. While some studies suggest that
grain feed often used to maximise growth efficiency, can increase
shedding ((Dargatz et al., 1997; Diez-Gonzalez et al., 1998), others found
no difference in amount or duration of shedding between animals fed
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grain or forage diets (Buchko et al., 2000; Hovde et al., 1999; Magnuson
et al., 2000) and the effect of forage feeding remains an area of
contention amongst researchers (Callaway et al., 2003).
Fasting cattle before abattoir transport is a common practice to reduce
soiling of the hides, which are considered the principal source of carcass
contamination (Gannon, 1999). To our knowledge, no study has detected
any relation between fasting and E. coli 0157:H7 shedding in cattle
(Brown et al., 1997; Cray Jr. et al., 1998; Harmon et al., 1999) or sheep
(Kudva et al., 1997)
1.6.5. Management
Identified environmental farm factors that influence E. coli 0157:H7
transmission in cattle include manure processing and handling practices
(Kudva et al., 1998; Rasmussen and Casey, 2001) and contamination of
water troughs, where the bacteria can remain infectious for ten months
(LeJeune et al., 2001). Tainting ofwater tanks has been consistently
associated with E. coli 0157:H7 presence in the herd by different
researchers (Meyer-Broseta et al., 2001; Smith et al., 2005; Van
Donkersgoed J., et al. 2001).
1.7. Conclusion and aims
E. coli 0157:H7 remains a substantial risk to public health despite
considerable research and public health efforts since its first
identification as a human pathogen in 1982. The illness this organism
causes is serious and sometimes fatal, and largely untreatable. In
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consequence, reducing the morbidity and mortality depends greatly on
preventing infections. Cattle are considered a primary reservoir of EHEC
bacteria, and particularly, of E. coli 0157:H7 one of the most pathogenic
and prevalent of the EHEC strains. Therefore, an important issue for
prevention of human infection must be to understand and control E. coli
0157:H7 carriage in the bovine host.
The aims of this study is to understand the carriage and persistence of E.
coli 0157:H7 in cattle. At the beginning of this project, it was clear that
E. coli 0157:H7 colonisation is associated with the terminal rectal
mucosa. However, the reasons for such a tropism, the relevance of other
potential colonisation sites in the gastrointestinal tract, the attachment
mechanisms operating, and details of host-pathogen interactions were
unknown.
The objectives of this study are (i) to confirm the terminal tropism of E.
coli 0157:H7 in cattle in a larger number of animals; (ii) to study the
shedding patterns and bacterial distribution in both faeces and
gastrointestinal contents; (iii) to determine the importance if any of other
sites in the gastrointestinal tract for E. coli 0157:H7 carriage; (iv) to
confirm epithelial attachment at the rectum by transmission electron
microscopy; (v) to define the mechanisms of adherence to the
gastrointestinal epithelium; (vi) to determine if colonisation of the
terminal rectum in cattle induced pathology in terms of microscopic and
ultrastructural change to the epithelium; (vii) to determine if colonisation
of the terminal rectum induced mucosal innate or acquired immune
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2. Material and Methods
2.1 Bacterial strains
The challenge strain of E. coli 0157:H7 was ZAP 198 isolated from a
human patient in Washington State (USA) were cattle were establish as
the source of the outbreak, and used previously in experimental studies
(Naylor et al., 2003b). ZAP 198 has been naturally cured of the shiga-
toxin (Stx2) cariying bacteriophage and the strain was selected for
spontaneous resistance to nalidixic acid to facilitate recovery from faeces
and tissues. ZAP 198 possess genes for enterohemolysin, intimin-y,
EspA and EspB. For preliminary examination of adaptative responses
whole cell extracts of E. coli K12 MG1655 ZAP 185 (Blattner et al., 1997)
and E. coli 026 ZAP 194 (Pearce et al., 2006) were used as controls in
Western blots. The protein content was 5 mg gram1, determined with
BCA Protein Assay Kit (Pierce, USA) according to the manufacturer's
instructions. The colorimetric absorbance was read at wavelength of 562
nm in a Dynex Revelation 4.02 Spectrophotometer (Dynex Technologies).
Their main characteristics and sources are listed in Table 2-1.
Table 2-1. Bacterial strains
Strain Description Source/Reference
ZAP 185 E. coli K12 MG1655 (Blattner et al. 1997)
ZAP 194 E. coli 026 (Pearce et al. 2006)
ZAP 198 E. coli 0157:H7 VT1-
VT2-
(Ostroff et al. 1990)




2. Material and Methods
2.2 Animal groups and bacterial challenges
Experimental procedures (authorised by Home Office licence 60/3179)
were carried out at the Moredun Research Institute. Prior to experimental
challenge faecal samples were taken at least twice from each calf and
confirmed negative for E. coli 0157:H7 by immunomagnetic separation
(IMS). The challenge E. coli 0157:H7 ZAP 198 was grown overnight in
Luria Bertani (LB) broth at 37°C, with aeration, and diluted in sterile PBS
to achieve an inoculum of 109 CFU of E. coli 0157:H7 per animal in a
total volume of 10 ml. The 10 ml oral inoculum was administered into
the rumen to the calves via stomach tube and washed down with 500 ml
sterile PBS, or by direct administration through a cannula placed on the
dorsal rumen and sutured to hide of dorsolateral abdominal wall in six
calves. Rectal challenge was carried out by loading a large cotton swab,
consisting of 2 cm long wad, with the challenge inoculum followed by
repeated direct application to the mucosal surface of the recto-anal
junction until exhaustion of the 10 ml inoculum. Five groups of weaned
calves were used for the various aspects of the work described in this
thesis.
Group 1. Fifty-four, weaned, Holstein-cross calves were reared
conventionally on a farm. The animals were aged between 8 to 14 weeks
on arrival and were then penned individually for the study. Calves were
fed concentrate twice daily and had access to ad lib hay and water. Feed,
water and bedding were provided separately for each animal to minimise
cross contamination and each was haltered to reduce the opportunity for
faecal-oral transmission. On a single occasion 10 ml of inoculum was
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administered by three different routes, 24 calves were challenged via the
rectal route, 6 intraruminally through a cannula placed through the
paralumbar fossa on the dorsal rumen, and 24 by oral administration via
stomach tube on a single occasion. Initial screening of newly arrived
calves by IMS detected one animal as shedding E. coli 0157:H7.
Unfortunately, the exact number of E. coli 0157:H7 was impossible to
determine due to the presence of sorbitol fermenting colonies.
Group 2. Eight weaned Holstein-cross calves reared conventionally on a
farm and aged between 7 to 12 weeks were used. Calves were housed
together and fed concentrate twice daily and had access to ad lib hay and
water. Animals were challenged four times with x 109 CFU (day 0), 1* 1010
CFU (day 7) and 2xl0"> CFU of E. coli 0157:H7 on days 35 and 36.
Group 3. Four weaned Holstein-cross calves reared conventionally on a
farm and aged between 8 to 14 weeks were orally challenged via stomach
tube on a single occasion with x 109 CFU for ultrastructural
investigations.
Group 4. Due to the shortage of fresh mucosal tissues at the end of the
PhD period, additional samples for antibody detection assays were kindly
donated by Dr. T. McNeilly from a separate experiment. Six weaned
Holstein-cross calves reared conventionally on a farm and aged between
7 to 11 weeks were orally challenged via stomach tube with x 1010 CFU of
E.coli 0157:H7. Rectal swabs, nasal secretions and serum samples were
taken 4 days pre and 2 weeks post-challenge. These samples had
confirmed IgA and IgGl serum and rectal mucosal antibody responses
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against 0157 and H7 antigens measured by Enzyme -linked
immunosorbent assay (ELISA) methods and results have been described
elswhere (McNeilly et al., 2007).
Group 5. Five, unexposed, culture negative calves of similar age, breed
and background were used as controls for the histopathological and
immunological studies.
2.3 Bacterial detection in faeces, gastrointestinal
contents and post-mortem tissues
Faecal samples were collected upon defecation from the animal following
stimulation of the anal sphincter, the faecal surface was sampled with
wooden spatulas and then the core exposed for sampling. Shedding was
regularly monitored by faecal culture. E. coli 0157:H7 per gram of faeces
or per square centimetre ofpost-mortem tissue was enumerated using the
following procedures: Ten grams of faeces or gastrointestinal contents
were serially diluted in PBS using 10 fold steps. Squares of
gastrointestinal tissue samples were put into 5 ml of PBS, vortexed for 60
s, and the supernatants serially diluted ten fold in PBS. 100 pi aliquots of
the serial dilutions were cultured onto sorbitol MacConkey agar (SMAC,
Oxoid) containing 15 pg ml-1 of nalidixic acid (Sigma-Aldrich) in triplicate
for faecal samples or duplicate for tissue washings. After overnight
incubation at 37°C non-sorbitol fermenting colonies were counted and
one colony from each sample tested using a latex agglutination test kit
(Oxoid) for 0157 lipopolysaccharide. Plates with less than one hundred
colonies were counted manually, an automated system (Acolyte) was
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used to enumerate plates with over a hundred colonies. The minimum
detection level was 33 colonies per g 1 of faeces.
2.4 Rectal biopsy
Rectal biopsies were taken under local anaesthesia achieved by epidural
administration of 1/2 ml of Lidocaine (Lignol, Arnolds,) into the
intercoccygeal space between C1-C2. The biopsies were excised from the
terminal rectum by using forceps and scissors, to minimise animal
discomfort specimen size consisted of small pieces of rectal mucosa
weighing between 50 and 75 mg (3/4 mm2). The tissues were placed in
self sealed plastic bags and were immediately frozen by immersion of the
sample in liquid nitrogen and stored at -70 °C.
2.5 Intestinal mucosa, serum and saliva collection
The following samples were collected from the groups described
previously in section 2.2.
Group 1: A total of 22 animals from group 1, still shedding two weeks
post-initial challenge, were examined post-mortem and various tissue and
contents samples (described in section 2.7) collected from the
gastrointestinal tract for bacterial counts. Rectal mucosa (weighing
approximately 2 g) was excised at post-mortem examination from 9
animals, frozen by inmersion of the sample in liquid nitrogen and stored
at -70°C. Rectal biopsies were also taken from 11 of these animals pre-
challenge and on two further occasions at 6 and 12 days after challenge
and processed for histological examination (Annex Table V). Six animals
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were challenged rectally and five orally. Serum samples were collected
pre-challenged and at post-mortem.
Group 2: A total of 32 rectal mucosal biopsy samples were collected at
28 days pre-challenge and 6, 34 days post-challenge and during post¬
mortem examination at day 54. On the first three occasions, tissue was
excised under local epidural anaesthesia, i.e. before initial challenge and
on two further occasions at 6 and 34 days after challenge. The last
samples were taken during post-mortem examination.
Group 3: Sections of rectal mucosa were excised post-mortem and tissues
fixed and processed for electron microscopy and immunogold labelling as
described in section 2.12.
Group 4: Nasal secretions were collected by placing one regular size
non-applicator tampon (Lillets, Accantia, Birmingham, UK) into the
nostril of each calf for approximately 10 mins. Nasal secretions were
subsequently expelled by squeezing within the barrel of a 20ml syringe.
Rectal swabs were collected by gently swabbing the last 3/4 centimetres
of the rectal mucosa. The cotton swab was then placed in lm of PBS, and
spun to remove the gross particulate portion. The supernatant was
collected and stored at -20°C. Serum samples were collected 28 pre-
challenge, 14, 35 and 49 days post-challenge.
Group: 5 Sections of rectal mucosa were excised post-mortem and two
sets of tissues taken for histology or freezing at -70°C in liquid nitrogen.
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2.6 Generation of rectal mucosal extracts
After thawing, 50-75 mg of the biopsy or rectal mucosal tissue removed
at post-mortem was mixed with 1 ml of ice cold phosphate buffered saline
(PBS, pH 7.2) and protease inhibitor cocktail (Roche) in RiboLyzer™
tubes (Hybaid, United Kingdom), and then processed in a Hybaid
RiboLyzer™ for 10 s at 5.5 ms b The supernatant of the resultant extract
was twice removed and centrifuged at 2,000 x g to remove the tissue
remnants. The protein content was standardised to a final concentration
of 5mg/ml for group 1 and 3 mg/ml for group 2.
2.7 Necroscopy
A sample of naturally voided faeces was collected prior to euthanasia of
these animals with intravenous pentobarbitone (140mg/kg,
J.M.Loveridge Ltd). Once death was confirmed, a blood sample was taken
by incising the jugular vein while the animal was hanging from a hoist.
First, a circular cut was made around the anus, taking care to leave the
anal sphincter intact. The subsequent cuts free the anus, rectum and
bladder from surrounding tissue. Then, the skin and abdominal muscles
were incised along the ventral midline, and the pelvic cavity was accessed
from the abdominal cavity by cutting the peritoneum. The rectum was
sectioned between two ligatures and separated from the rest of the
gastrointestinal tract, the urinary bladder was removed. The rest of the
gastrointestinal tract, from the distal colon to the oesophagus was
removed from the carcass and placed over a table. The contents were
then sampled from: rumen, gallbladder, jejunum, ileum, caecum,
proximal colon, spiral colon, distal colon, and at four different levels of
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the rectum (20, 10 and 5 centimetres before the pectinate line that
delimits the end of the rectal mucosa). Two sets of tissues for histology
and for bacterial counts were taken at: rumen, jejunum, ileum, caecum,
ilocaecal valve, proximal colon, proximal colon patch, spiral colon, distal
colon and at proximal, mid, distal and terminal rectum (20, 10, 5 and 1
centimetres from the pectinate line, Figure 2-1).
Figure 2-1. Sampling sites for collection of contents and tissues
Contents
Tissues
R Rumen SC Spiral colon
J Jejunum DC Distal colon
I Ileum R20 20 cm from terminal rectum
ICJ lleo caecal junction R10 10 cm form terminal rectum
PCP Proximal colon patch R5 5 cm from terminal rectum
PC Proximal colon TR Terminal rectum
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2.8 Fixatives, solutions and media
The list of tissue fixatives, solutions and media used is presented in
Tables 2-2, 2-3 and 2-4. All solutions were made up in dH20 and
sterilised by autoclaving at 15 pounds per square inch for 20 mins prior
to use.
Table 2-2. Tissue fixatives
Fixative Composition
4% w/v 900 ml of PBS were pre-heated at 60° in a Duran bottle and 40g of
Paraformaldehyde paraformaldehyde (PFA) added inside a fume cupboard. The mix
was left on the heating/stirring block until total solution, and stored at
4° for up to 15 days.
Zinc Salts Fixative Tris-Calcium acetate buffer (Trizma base 12.1 g calcium acetate
0.5g, distilled water up to 1,000ml) was made and pH adjusted to 7 -
7.4, followed by the addition of 5g each of Zinc chloride and Zinc







137mM NaCI, 10mM Na2HP04 2.7mM KCI, 1.4mM K2HP04, adjusted





(TBE) 108 g Tris base. 55 g Boric acid. 9.3 g Na4EDTA. Add dH20 to 1
liter. pH 8.3
PBS, 0.5% Tween® 80 and 0.5 M NaCI
10x TBE 1 litre contained 0.9 M Tris base, 0.9 M boric acid and 0.02 M EDTA
(disodium salt) dissolved in dH20
10x loading For nucleic acid gel electrophoresis contained 15% (w/v) Ficoll with 0.25
buffer % (w/v) bromophenol blue and 0.25 % (w/v) xylene green.
Ethidium Stock solution of 10 mg ml"1, dissolved in dH20 and stored at room
bromide temperature in the dark.
Scott's tap Magnesium sulfate, 200 g/l, sodium bicarbonate, 20 g/l, and
water preservative.
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Lysis buffer 10 mM Tris-HCL (ph 7.5), 0.5 mM PMSF, aprotinin 0.5 pg/ml
Sarkosyl 100 mM NaCI, 10nM Tris-HCI ph 8.0, 0.5 mM PMSF, aprotinin 0.5 pg,
buffer 0.5% N-lauroylsarcosine (Sigma)
TBF1 30 mM KOAc, 100 mM RbCI , 10 mM CaCI , 50 mM MnCI , 15 % (v/v)
2 2 2
glycerol, adjusted to pH 5.8 with acetic acid
TBF2 10 mM MOPS, 10 mM RbCI , 75 mM CaCI , 15 % (v/v) glycerol,
2 2
adjusted to pH 8.0 with KOH
Table 2-4. Media
Media Composition
Luria Contained Difco Bacto tryptone (10 g), Difco Bacto yeast extract (5 g) and
Bertani NaCI (10 g) dissolved in 1 I dH20. The pH was adjusted to 7.2 with 5 N
broth (LB) NaOH and the media autoclaved (20 lb/in2, 120°C for 15 mins).
LB Agar LB broth was converted to solid media by adding Difco agar (15 g 1-1) prior
to autoclaving.
SOC The medium contained Difco bacto-tryptone (20 g), Difco yeast extract (5
g), NaCI (10 mM), KCI (2.5 mM), MgCI2 (10 mM), MgS04 (10 mM) and
glucose (20 mM) dissolved in 1 litre of dH20.
LBC LB Agar containing 25 pg/ml of Chloramphenicol
LBK LB Agar containing 12 pg/ml of Kanamyacin
LBA LB Agar containing 12 pg/ml of Ampicillin
2.9 Histopathological studies
Tissues taken at post-mortem examination for histopathology were
immediately fixed in 4% paraformaldehyde or Zinc salts and sections
staining performed on 5 pm sections on labelled glass slides. Sections
were first hydrated in descending xylene and alcohol solutions (100%,
90%, 80%, 70%, and 50%), stained with the appropriate technique and
rehydrated in ascending alcohol solutions clear with xylene and a
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protocols described below and a coverslip was mounted in a solvent-
based medium (Table 2-5). Due to logistical constraints, histological
examination was limited to the first thirteen of twenty two calves sampled
for tissue counts from group 1.
Table 2-5. Histochemical stains
Staining Procedure
Hematoxylin- 1. Immerse sections in Harris Hematoxylin (Cell Path) for 1 min.
and-eosin
2. Rinse with water.
3. Exchange tap water until the water is clear.
4. Immerse sections in Eosin stain for 1-2 mins.
5. Rinse with water.
6. Exchange tap water until the water is clear.
Toluidine Blue 1. Stain in 0.5% Toluidine Blue in HCI pH 0.3 for 1 hour (Philip Harris).
2. Wash briefly in water.
Results: Mast cells appeared deep purple. The background is pale blue
colour with nearly no nuclear staining.
Carbol 1. Nuclei were stained with haematoxylin for 1 min.
Chromotrope 2. Rinse with water.
3. Stained for 1 hour in Carbol chromotrope solution (Sigma), 0.5%
chromotrope 2R in 1% phenol.
4. Rinse with water.
5. Results eosinophil granules, bright red. Nuclei blue.
2.10 Immunohistochemistry
For immunoperoxidase staining deparaffinised and rehydrated sections
which were mounted onto Sequenza slide racks (Thermo Electron,
formerly Shandon) and treated as follows: To block endogenous
peroxidases, 3% H2O2 was added to each section and sections were
incubated at room temperature for 5 mins. To block non-specific binding,
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a 25% solution in TBS of goat serum was added for 30 mins. Primary
antibody was then added at a 1:1,000 dilution and incubated at 4°C
overnight. The primary antibody was detected using EnVision™/HRP
Detection System Peroxidase/DAB (Dako) used accordingly to
manufacturers instructions. Briefly, secondary peroxidase-conjugated
anti-rabbit goat raised antibody diluted to 1:1,000 was added for 30
mins, followed by 3,3'-diaminobenzidine (DAB) substrate in chromogen
and incubated for 7.5 mins. Finally, slides were counterstained with
Haematoxylin (CellPath) for 30 s, rinsed in distilled water and blueing
achieved by immersion in Scott's tap water substitute solution (Sigma-
Aldrich) for 1 mins followed by a rinse with distilled water. Sections were
dehydrated in ascending alcohol solutions and a cover slip added over a
solvent-based mountant solution. The total amount of reagent used per
slide was 100 pi. Working dilutions of all reagents were made in TBS. On
each stain run two types of controls were used . As a non-reagent
negative control, one section in each run was incubated with PBS lacking
the primary antibody.
For immunofluorescence microscopy sections were first dewaxed in
xylene and rehydrated with serially graded ethanol dilutions in water.
The sections were incubated in Sequenza racks with rabbit anti-0157
polyclonal antibody (Mast-Assure) at 1 in 100 dilution of PBS for 30 mins
at room temperature. Sections were then trated with fluorescein
isothiocyanate (FITC) conjugated goat antirabbit antibody (Mast-Assure)
at a 1 in 1,000 dilution in PBS for 30 mins. Cover slips were added after
application of Fluorescence Mounting Media (Dako). For confocal
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microscopy tissue was examined with a Zeiss 510 confocal microscope
with a 63x objective lens.
In each immunostaining run negative/positive control slides were
included. As a non-reagent negative control, one section was incubated
with PBS lacking the primary antibody. A positive control specimen using
a tissue known to contain the antigen was also included in each assay
for E. coli 0157:H7 and a positive internal control using lymphoid follicles
as normal elements that express the antigen of interest, was used to
asses MHC class II expression.
2.11 Antibodies
The antibodies used for immunohistochemistry, immunoblotting and
ELISA are listed in Table 2-6.
Table 2-6. Antibodies















Monoclonal mouse anti- (3-
chain MHC II SW.73.2
Moredun Research Institute





Goat anti-rabbit IgG 10nm gold
labelled antibody
British Biocell 1/500
Mouse anti-bovine IgA Dako 1/500
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Two different techniques were used to identify E. coli 0157:H7: (i)
conventional transmission electron microscopy (TEM) on reprocessed
tissues from paraffin blocks and (ii) gold labelling and TEM on tissues
specifically fixed for immunolabelling, in order to improve the quality of
the samples. For conventional TEM, areas of three tissue sections from
two animals from group 1 with the highest density of E. coli 0157:H7
attached (identified by IFA) were circumscribed and the tissue in the
matching areas of the paraffin blocks excised precisely and reprocessed
for TEM as described elsewhere (Wales et al., 2001a). In brief, three such
regions from two animals were then deparaffinised with xylene,
rehydrated in graded dilutions of ethanol, and post-fixed in osmium
tetroxide. After dehydration in graded dilutions of acetone, the samples
were infiltrated and embedded in Araldite. Seven ultrathin sections (80
nm) were cut from each of the three regions identified above and
mounted on copper grids (Agar Scientific). Random regions negative for E.
coli 0157:H7 microcolonies were similarly processed, and no AE lesions
were detectable by TEM
Immunogold labelling was carried out in samples from the only two
successfully colonised animals out of four challenged specifically for
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electron microscopy examination from group 3. Terminal rectum tissues
were fixed in 2% formaldehyde and 0.1% glutaraldehyde and labelling of
bacteria was made with the same primary antibody used for light
microscopy, with a secondary goat anti-rabbit IgG lOum gold labelled
antibody (British Biocell, 1:500 for 60 mins at room temperature). As a
non-reagent negative control, one section was incubated with PBS
lacking the primary antibody. Specimens were viewed on a Philips CM 12
transmission electron microscope.
For scanning electron microscopy (SEM), all specimens were placed in a
solution of 3% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH =
7.3) overnight and then immersed in 2% guanidine hydrochloride and 2%
tannic acid for a second night. They were subsequently post fixed in 2%
osmium tetroxide in distilled water for 8 hours. Dehydration in graded
concentrations of acetone (50%, 70%, 90%, 100%) was followed by
critical point drying using carbon dioxide. After they were mounted on
aluminium stubs, the specimens were sputter coated with 20 nm
gold/palladium and viewed with a Hitachi S4700II field emission
scanning electron microscope using appropriate settings. Digital images
were recorded using Hitachi FE PCSEM 3.2. Images were processed with
PaintShop Pro (Jasc Software).
2.13 Tissue and bacterial counts
Cell counts were made of total granulocytes, eosinophils, mast cells and
yd T cells in the lamina propria of the rectum. Total granulocyte numbers
were counted in sections stained with hematoxylin and eosin, mast cells
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from sections stained with toluidine blue (0.5% in 0.5N HC1, pH 0.5) for 1
hour (Enerback, 1966) and eosinophils in sections stained with carbol
chromotrope solution for 1 hour and counterstained for 10 s with
hematoxylin (Lendrum, 1944). IL A29 was used to detect the
gamma/delta (y6) T cell marker BoWCl (Howard et al., 1991) in
immunostained sections. Considering a power of 0.8 and 95%
significance level, counts were made on five fields on sections from two
different paraffin blocks. Counts were expressed as cells per 0.25 mm2-
2.14 Statistical analysis
E. coli 0157:H7 counts within faecal and tissue samples were calculated
by determining the mean plate count at the most relevant dilution for
each sample, and by multiplying the dilution factor to convert to CFU g1
(faeces or GIT contents) or CFU cm 2 (mucosal samples). The
concentration (CFU g 1 plus 1) was logio transformed. Student's T-test
was used to compare means of samples, with a paired T-test being used
where a natural pair existed. The chi-square test was used to analyse
proportions. Where the numbers of observations were low in some
categories then Fisher's exact test was used. The Kappa test was used to
qualify the level of agreement, where the null hypothesis is that there is
no more agreement than might occur by random chance. Data was
processed using Excel (Microsoft) and Minitab (Minitab Inc) software. The
applicability and suitability of the tests were discussed with Dr. Iain
McKendrick and Dr. Jill Sales (Biomathematics and Statistics, Scotland
Research Institution).
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2.15 Antigens
Whole cell samples of E. coli 0157:H7 ZAP 198, E. coli 026 ZAP 194 and
E. coli K12 ZAP 185 were prepared from overnight LB broth cultures,
followed by 2 consecutive 4,000 x g for 5 min. and resuspension in PBS,
and sonicated on ice twice for 10 s at 15 microns with 10 s pauses
(Soniprep 150, MSE).
Bacterial membranes and cytoplasmic proteins preparations of E. coli
0157:H7 ZAP 198 were obtained by harvesting bacteria in mid-log phase
after overnight growth in LB broth. Bacteria was pelleted by
centrifugation (13,000 x g for 5 min) and resuspended in 8ml of lysis
buffer, freeze-thawed four times in dry ice, and sonicated on ice twice for
10 s at 15 microns with 10 s pauses (Soniprep 150, MSE). Whole
bacteria and cell envelopes were removed by centrifugation (2 x 5,000 for
10 min at 4°C). The supernatant containing the cytosolic soluble proteins
and the insoluble inner and outer membrane proteins was removed, and
ultracentrifugated for 1 hour at 50,000 x g at 40C to pellet the
membranes. The resultant supernatant containing the cytoplasmic
proteins was collected and concentrated to 0.5 ml with 100 Kda
molecular weight cut-off centrifugal filter devices (Millipore Corporation).
The membrane pellet was washed twice and resuspended in 0.5 ml of
lysis buffer.
Lysates of E. coli 0157:H7 ZAP 198 were made by two methods:
Trypsinisation of whole cell samples for 45 mins at 70°C with Sequencing
Grade Modified Trypsin (Promega). Proteinase K treated lysates were
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prepared by diluting 5 jug of crude bacterial protein into 8 pi of SDS-
PAGE lysis buffer and 3 pi of reducing agent per gel lane. The preparation
was incubated with 176 pi of proteinase K (25 mg/ml, specific activity: >
30U/mg) (Roche) at 60° C for 1 hour.
Supernatants containing Type III secretion system proteins were
produce by growing bacteria in minimal essential medium modified with
25 mM HEPES (Sigma-Aldrich) to an optical density of 600 nm.
Suspensions were centrifuged at 4,000 x g for 10 min. The supernatant
was filtered and the proteins were precipitated by the addition of 10%
trichloroacetic acid with overnight incubation at 4 °C, followed by
centrifugation at 4,000 x g for 30 min. The protein pellet was suspended
in 1.5 M Tris (pH 8.8) and after addition of sample buffer, the proteins
were analysed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and silver staining as previously published
(Kenny and Finlay, 1995).
E. coli 0157:H7 LEE4 mutants were used as negative controls and
obtained from stocks of previously published work (Naylor et al., 2005b).
Flagellin was purified by dissociation of the flagella from bacteria by
adjusting the pH of the bacterial suspension to 2.0 with 1 N hydrochloric
acid for 30 min. Bacteria devoid of flagella were harvested by
centrifugation at 5,000 x g for 30 min. The supernatant containing
flagellin was centrifuged at 100,000 x g for 1 h at 4°C, and the
supernatant was adjusted to pH 7.2 with 1 N sodium hydroxide. Flagellin
was precipitated by incubation with 2.67 M ammonium sulfate for 16 h
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at 4°C and collected by centrifugation at 15,000 x g for 15 min. The
precipitate was re-suspended in distilled water and dialysed in tubing
with a 50,000-molecular-weight cutoff against running water at 4°C for
24 h (Sherman et al., 1988). This protocol results in the purification of
flagellin monomers, which spontaneously repolymerise into flagellar
filaments at neutral pH (McNeilly et al., 2008).
0157 Lipopolysaccharide (LPS) was obtained from commercial sources
(List Biological Laboratories).
Outer membrane porin C (OmpC) external loops 1, 2, 4, 5 and 6 were
solid-phase synthesised to a purity of >70% (Thermo Electron
Corporation). The sections were between 12 to 17 amino acids long, and
contained the external hairpin connecting the anti parallel beta strands
that form the main barrel of the porin. Peptides (lmg/ml) were dissolved
in PBS and stored at -20°C.
Cytoplasmic preparations were kindly supplied by D. Wang and secreted
proteins and flagellin preparations were kindly donated by S.P. McAteer
(Zoonotic and Animal Pathogens Laboratory, University of Edinburgh)
2.16 Protein determination
To determine sample protein concentration a Pierce Coomassie Protein
Assay Kit (Pierce Biotechnology) was used according to the
manufacturer's instructions. The colorimetric absorbance was read at a
wavelength of 562 nm in a Dynex Revelation 4.02 (Dynex Technologies)
Spectrophotometer.
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2.17 ELISA
E. coli 0157 LPS and H7 flagellin preparations were used to coat ELISA
plates to determine mucosal and serological IgGl and IgA antibody titers.
To coat ELISA plates (Thermoelectron 3455) 0157 LPS (List Biological
Laboratories) was conjugated to polymyxin B as previously described
(Currie and Poxton, 1999). Wells were coated overnight at 4°C with 1 pg
of H7 and 0157 LPS in 0.05 M Carbonate buffer, pH 9.6. After washing
two times with PBS pH 7.4 containing 0.05% Tween® 20 (PBS/T20),
blocking was performed with 3 % fish gelatin (Sigma G7765) followed by
sequential incubation with dilutions of primary antibody for 1 hour at
37°C in PBS/NaCl/T80. The primary antibody was used at a
concentration of 0.5 mg/ml of total protein for rectal extracts and to a
dilution of 1/5 for sera IgA and 1/100 for sera IgGl. The secondary
sheep anti bovine IgA or IgGl HRP conjugated (Serotec) antibody was
then added (1/1,000 PBS/NaCl/T80) for 1 hour at 37°C, and Sigma Fast
OPD added until colour developed. Between each incubation, plates were
washed six times with PBS/T. Finally, the reaction was stopped with 25
pi of 3M sulphuric acid (Fisher S/9160/PB15) and the O.D. readings
obtained at 492 nm. For each plate, four wells were incubated with
PBS/NaCl/T80 alone (negative control). Each sample was analysed in
duplicate and final absorbance calculated by subtracting the average
absorbance of the negative controls. A pool of rectal extracts from three
positive animals from Group 1 with detectable histological lesions and
previously found to be positive by immunoblotting, were used as a
positive controls. A similar system was used to detect OmpC external
loop peptides (1 pg per well in 0.05M Carbonate buffer) were used to coat
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the plates to detect the presence of mucosal and serological IgG 1 and IgA
antibody responses. Primary antibody was used at the following
dilutions: Nasal secretions 1:10, rectal swabs 1:10 and serum at 1:100
dilutions. The ELISA had been previously developed by A. Flockhart.
2.18 Dot blots
10 |ug of each purified peptide were applied directly to a nitrocellulose
membrane (Invitrogen) as spots in eight serial dilutions from 1:1 to 1:32.
The membranes were incubated at room temperature with nasal
secretions (1:10), rectal swabs (1:10) and serum (1:100) diluted with PBS
to achieve the required concentrations. The membranes were rinsed in
PBS/NaCl/T80 and incubated with secondary anti bovine IgA or IgGl
HRP conjugated (Serotec) antibody at a dilution of 1:500 for 1 hour. The
membrane was washed again and the signal was detected using the ECL
system (Amersham Bioscience, Piscataway, NJ). The membranes were
exposed to the film for 15 s (Super RX, Fuji). Whole cell preparations of E.
coli 0157:H7 were used as a positive control, and PapB from E. coli
CFT073, a fimbrial regulator present only in uropathogenic isolates, was
used as a negative control.
2.19 One dimensional SDS-PAGE
For one dimensional SDS-PAGE (1-D SDS-PAGE), the bacterial antigen
was heated for 10 min at 70°C in loading buffer, 5 pi of SDS and 2 pi of
reducing agent (Invitrogen). Each lane was loaded with 5 pg of bacterial
protein and separated using 4%-12% NuPAGE Novex bis-tris gels (Novex,
62
2. Material and Methods
Invitrogen, USA) with NuPAGE MES SDS running buffer. Proteins in the
gel were visualised using Simply Blue stain (Novex, Invitrogen).
2.20 Two-dimensional gel electrophoresis
Two-dimensional (2D SDS/PAGE) separation of proteins was carried out
by isoelectric focusing using the ZOOM IPGRunner System followed by
separation by protein size on Bis-Tris Zoom gels SDS/PAGE utilizing the
NuPAGE Novex 4-12% Bis-Tris ZOOOM gels (Invitrogen) according to the
manufacturer's instructions. Interfering charged molecules and DNA
were removed using a 2-D Clean-Up kit (Ettan kit, Amersham) according
to the manufacturer's instructions. Sample loads were used as
recommended by the manufacturer (50 pg for Western blotting and 200
pg for staining). Samples were subsequently suspended in 155 pi of
buffer containing 20 mM DTT, 8M urea, 2% CHAPS and 2% ZOOM
carrier Ampholytes pH 3.5-10 (Invitrogen). IEF ph 3-10 strips were
rehydrated overnight with the sample buffer and isoelectric focusing
performed for 4 h at 500 V. Following protein separation by charge, the
IEF strips were incubated for 15 mins in reducing buffer (NuPAGE,
Invitrogen) followed by 15 mins in an alkylating solution at room
temperature. The resultant 2-DE SDS-PAGE gel was stained for protein
by Simply Blue stain (Novex, Invitrogen). Following the manufacturers
suggestions two sample loads were used, 100 pg of crude bacterial
protein for Immunoblotting and 20 pg for protein staining.
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2.21 Western blotting
Gels were transferred onto nitrocellulose membranes (Invitrogen) using a
semi-dry transfer apparatus at room temperature. After transfer the
membranes were incubated in PBS/NaCl/T80 buffer for 60 mins at room
temperature to block non-specific protein binding. The transferred
proteins were incubated with the supernatant from the mucosal extracts
(0.03 mg/ml of mucosal protein). Following three washes, the
membranes were incubated sequentially with mouse anti-bovine IgA
(Dako, USA, 1/500 in PBS/NaCl/T80), biotinylated goat anti-mouse
immunoglobulin (Dako 1/2500 in PBS/NaCl/T80) and streptavidin-
horseradish peroxidase (Dako, Streptavidin-HRP, 1/4000 in
PBS/NaCl/T80). The incubation steps were performed for 60 mins at
room temperature with three washes with PBS/NaCl/T80 between each
step. Peroxidase activity was revealed by chemiluminescence using ECL
reagent (Amersham Life Sciences, Bucks, UK). Control Western-blots
consisted of incubations with bovine rectal extract at the same
concentration from: a) pool of 3 animals with histopathological lesions
(positive controls): b) from unexposed animals (negative control); c)
Western blots in which no primary antibody was added.
2.22 Protein molecular weight marker
To determine the size of the proteins a SeeBlue Plus2 Pre-Stained
Standard (Invitrogen) marker with a molecular weight range of 4-250 kD
was used.
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2.23 MALDI-ToF/TOF mass spectrometry
Immunoreactive spots were overlapped to 2-D SDS/PAGE gels and the
matching protein identified and excised from 2-DE gels, destained and
digested overnight with 20pl of porcine trypsin solution at lpg/pl
(Trypsin Gold, Promega) resuspended in 50mM acetic acid and then
diluted in 40mM NH4HC03/ 10% ACN to 20pg/ml. Resultant digests
were analysed on a matrix-assisted laser desorption ionisation in tandem
time-of-flight spectrometry (MALDI-TOF/TOF) (Broker Ultraflex II
biospectrometry workstation, Applied Biosystems). The fragmentation
data obtained were handled using the MASCOT software package and a
Mowse score was calculated according with scores greater than 74
indicative of significant protein identity.
2.24 Plasmid and plasmid constructs
The main reagent in the gene replacement is the plasmid pIB307 (Figure
2-2). This replicon is unable to replicate over 28°C. The plasmid
restriction sites used in this study were SphI at 1523 bp, SacI at 1,484
bp, BamHl at 1,495 bp, and three more sites for Rsal at 315, 853 and
3890 bp.
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Figure 2-2. Plasmid plB307 size and homologous regions insertion sites
SphS(l&3)
The plasmids used in this work are listed in Table 2-7.
Table 2-7. Plasmids
Plasmids Description Source/Reference
plB307 4,288 bp. Low copy (6-8 (Blomfield et al., 1991)
copies/bacterium). Chloramphenicol
resistance cassette. Temperature
sensitive replicon, unable to replicate
over 28°C.
pPN1 5,288 bp. Formed after insertion into This thesis
the plB307 backbone of the 1,000 bp
right flanking region of ompC, amplified
using primers ompCRHFI and
ompCRHF2 (Table 2-10).
pPN2 6.421 bp. Formed after insertion into This thesis
the plB307-PN1 backbone of the 1,133
bp left flanking region of ompC
amplified using primers ompCLFIFI(f)
and ompCLHF2 (Table 2-10).
pPN3 10,251 bp. Formed after the insertion of This thesis
the 3,830 bp sacB-Kan cassette
between both ompC, homologous
flanking regions of PN2.
pKC11 plB307 with CFT073 lad and lacA (Holden et al., 2006)
regions, and sacB-Kan inserted
between lacIA
pCR4-TOPO 3,900 bp. Directional TOPO® Cloning (Shuman, 1992)
vectors. Confers Ampicillin resistance.
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EcoRI sites flank the PCR product
insertion site.
pET100-R 4,900 bp. Formed after insertion of the This thesis
right flank into the plB307 backbone
pET100-L 5,033 bp. Formed after insertion of the This thesis
left flank into the plB307 backbone
2.25 Plasmid purification
Plasmid DNA was purified from lysed bacterial pellets obtained from 1.5
ml of overnight cultures, using the Plasmid Mini-Prep Purification Kit
(Qiagen) following manufacturer's instructions.
2.26 Restriction digests
Restriction endonucleases were purchased from New England Biolabs
and used according to the manufacturer instructions (Table 2-8). 1 pi of
the enzyme was added to 50 pi volume containing dFhO, bovine serum
albumin (100 pg/ml) and different proportions of DNA suspension.
Digests were incubated at 37°C for the manufacturer's specified time.
DNA was purified using Qiaprep Spin DNA Miniprep purification kit
(Qiagen) according to the manufacturer's protocol and reconstituted in
30 pi of dH2Q.
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Table 2-8. Restriction endonucleases





Site (5' to 3')
Recognition
Site (3' to 5')
SamHI 3 37 2-12 hours GtGATCC CCTAGtG
SpHI 2 37 4-12 hours GCATGtC CtGTACG
Sacl 1 37 2-12 hours GAGCTtC CtTCGAG
EcoRI 1 37 1 hour GtAATTC CTTAAtG
Rsal 1 37 1 hour GTVAC CAtTG
To confirm that the plasmids have the desired construct a series of
diagnostic digests were performed as described in table 2-9.
Table 2-9. Diagnostic digests
4 |J| Plasmid preparation
1 Ml Enzyme
2 Ml 10x Buffer
2 Ml 10x BSA
11 Ml RNA/DNAse free water
2.27 Primers
Primers used in the study are listed in Table 2-10. The restriction enzyme
cutting sites are underlined.
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Table 2-10. Primers
Primer Sequence 5' 3' Paired Annealing Product
No. primer Temperature size (bp)
ompC flanking regions amplification
ompCRH CGGGATCCTCTCGATTGATATCGAACAA
F1 AGG








plB307 R GCTGTAACAAGTTGTCTCAGGTGT plB307 F 52.7 °C 500
sacB- CAGCTCTTTGAACATCAACGG
Kan F
sacB- CTTGGTAGCCATCTTCAGTTCC sacB-Kan F 54.8 °C 200
Kan R
ompC16 GGTAATACATTGACCACG








RW 2390 ACGGTCGCAAGAGTACACCA FW1131 54.0 °C 3,989
Detection of ompC deletion
FW 1301 GGTAAAGTAGACGGCCTGC
RW 1670 CGAAGAAGTCAGTGTTACGG FW1301 54.8 °C 370
69
2. Material and Methods
2.28 Schematic representation of gene ompC and primer
positions
An arbitrary bacterial DNA nucleotide upstream of the left flanking region
(for a detailed sequence see Table 14) was numbered as base number
one. The primer's name and position on the bacterial genome is specified
for each primer in Figure 2-3.
Figure 2-3. Starting point of primers replication on ompC gene and
flanking regions
ompC16 LHF1





fcight Flank (1.189 bp)
RW1670 RevS3 ompCRFIF2 ompC 3532
3' = Three prime end or tail end
5' = Five prime end or ligation end
2.29 Schematic representation of sacB-Kan insertion and
primer positions
The same first nucleotide is used for enumeration purposes in the
following diagram of the final construct with the exchanged region
inserted in place of the ompC gene (Figure 2-4). Insertion of the larger
(3,830 bp) sacB-Kan cassette changes the numeric labelling order for the
right flanking region nucleotides.
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Left Flank sacB-Kan 3.830 bp RightFlank





3' = Three prime end or tail end
5' = Five prime end or ligation end
2.30 Polymerase chain reaction conditions
Fifty microlitres amplifications were routinely carried out consisting of
the components listed in Table 2-11:
Table 2-11. PCR components
Double distilled H20 36 pi
10x PCR Buffer 5 pi
10x dNTP mix 5 pi
Primer A 5' 100 pmol in 0.5 pi
Primer B 3' 100 pmol in 0.5 pi
Taq DNA polymerase 2.5 U
Template Zap 198 2 pi
2. Material and Methods
Bacterial DNA templates were derived from boiled lysates of pure cultures
of strain E. coli 0157:H7 ZAP 198.
Reactions were carried out in a pre-heated PCR block (Thermoelectron
PX2 Thermal Cycler) at the times and temperatures listed in Table 2-12.
Steps 2-A were repeated 30 times. PCR products were purified using
MinElute PCR Purification Kit (Qiagen) as instructed by the
manufacturer.
Table 2-12. PCR conditions
Initialisation CD o 4 mins
Denaturation CD o 45 s
Annealing 54-60° 45 s
Elongation 72° 60 s
Final extension 72° 10 mins
2.31 De-phosphorylation 0f vectors
Plasmid vectors digested with restriction enzymes were treated with
shrimp alkaline phosphatase (SAP, Promega) to remove 5' phosphate
groups of DNA and aid cloning of inserts into the vector. Restricted vector
DNA was incubated at 37° C for 15 mins in 0.1 volume of lOx SAP buffer
and 1 unit of SAP (1000 i.u.) followed by 15 mins at 65° C to inactivate
the enzyme.
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2.32 Agarose gels for DNA
Agarose gels were used to separate and visualise DNA. Gels contained
between 0.75 and 2.0% agarose depending on PCR products fragment
size. 1 pi of ethidium bromide concentration was added to the gel for
visualisation.
2.33 DNA molecular weight markers
To determine the size of the PCR products, one of three molecular weight
DNA markers were run: X HincRll marker, 1,000 base and 100 base pair
marker (Invitrogen).
2.34 DNA purification from agarose gels
The DNA bands were excised with a scalpel after visualisation on a UV
transilluminator (UVP) and extracted using the QIAquick Gel Extraction
Kit (Qiagen) according to the manufacturer's instructions. Purified DNA
was reconstituted in 30 pi of dHhO.
2.35 DNA ligation
Ligations were carried out in dPbO by adding 5 units of T4 DNA ligase
(Biolab) DNA vector (50-100 ng) and 0.1 pi of 1Ox ligase buffer, in a final
volume of 10 pi, followed by overnight incubation at 15° C with an equal
molar ratio of DNA insert. The ligation reaction components are
presented in Table 2-13.
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Table 2-13. Ligation reaction components
1-7 pi Insert
1 Ml Vector
1 Ml 10x Buffer
1 Ml T4 ligase
0-6 Ml dH20
10 Ml Total volume
2.36 Topo cloning
The main characteristic of the system is the enzyme DNA topoisomerase,
which functions as both restriction enzyme and ligase. The pCR4-TOPO
vector was used as indicated in the manufacturer's instructions
(Invitrogen). A single 3'-A overhang to each end of the taq-amplified PCR
product was added to enable the direct ligation of the homologous
regions to the plasmid DNA using TA Cloning (Invitrogen) according to
the manufacturer's protocol.
2.37 Preparation of chemically competent cells
A single colony from an LB plate was inoculated into 5 ml of LB and
cultured overnight at 37°C with shaking at 200 rpm to an ODeoo of 0.9,
then 100 mis of fresh LB were then inoculated with 1 ml of overnight
culture and cultured to an OD600 of 0.4-0.6 (approximately 2.5 hours).
The suspension was cooled on ice for 30 mins and bacteria harvested by
centrifugation for 8 mins at 4,000 rpm in a chilled centrifuge followed by
suspension in ice cold TBF1 to a volume 0.4 times that of the initial
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culture. The suspension was chilled on ice for a minimum of 15 mins
and centrifuged at 4,000 g for 8 mins in a chilled centrifuged. The
supernatant was discarded and the bacteria suspended in TBF2 to a
volume of 0.02/0.04 of culture and left on ice for 30 mins. Aliquots of the
suspension (200 jul) were stored at -70°C.
2.38 Transformation of plasmid DNA by heat shock
10 jul of plasmid DNA was added to 200 pi of previously prepared calcium
competent cells and chilled on ice for one hour. Samples were then
transferred to a 42°C water bath for 60 s and subsequently chilled on ice
for two mins. 800 pi of super optimal broth with catabolite repression
was then added and the mix incubated for two hours at 28°C and finally
plated onto LBC plates and incubated overnight at 28°C.
2.39 Preparation of electro-competent cells
The final transformation for integration and gene replacement was made
with the E. coli 0157:H7 ZAP 198 strain. Bacteria were cultured
overnight at 37°C with shaking at 200 rpm to an ODeoo of 0.9. 100 mis of
LB were inoculated with 1 ml of overnight culture and cultured to an
OD600 of 0.4-0.6 (approximately 2.5 hours). The suspension was cooled
on ice for 30 mins and bacteria harvested by centrifugation for 8 mins at
4,000 rpm in a chilled centrifuge and suspended in 2 ml of ice cold 10%
glycerol. 1 pi of purified plasmid was added to a 45 pi aliquot of bacteria,
mixed gently and incubated on ice for 5 mins. The mix was transferred to
an electroporation cuvette (Flowgen) and electroporated at 2.5 kV. One
ml of LB was added and the suspension transferred to an Eppendorf
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tube, incubated at 37°C with shaking at 200 rpm for 2 hours and 400 jul
plated on LB agar with Chloramphenicol.
2.40 The predicted tertiary structure of OmpC and
selection of putative immunogenic peptides
The specific three-dimensional structure of the primary sequence of
amino acid molecules that compose OmpC was predicted from a
published OmpC E. coli 0157:H7 sequence (swissprot: locus
0MPC_EC057, accession Q8XE41, Table 2-14) by Swiss-Model
(http://swissmodel.expasy.org/), a protein structure homology-modelling
server. The tertiary structure was visualised with DeepView-Swiss-
PdbViewer 3.5 (Figure 2-5). Comparison of the predicted sequence was
made with recent published sequences of known structures in the
Protein Data Bank (Basle et al. 2006).
Table 2-14. E. coli 0157:H7 EDL933 amino acid OmpC sequence.
In grey precursor protein, underlined amino acid sequences of five external loops.
1 MKVKVLSLLV PALLVAGAAN AAEVYNKDGN KLDLYGKVDG LHYFSDDKSV DGDQTYMRLG
61 FKGETQVTDQ LTGYGQWEYQ IQGNSAENEN NSWTRVAFAG LKFQDVGSFD YGRNYGVVYD
121 VTSWTDVLPE FGGDTYGSDN FMQQRGNGFA TYRNTDFFGL VDGLNFAVQY QGKNGSVSGE
181 GMTNNGREAL RQNGDGVGGS ITYDYEGFGI GAAVSSSKRT DDQNSPLYIG NGDRAETYTG
241 GLKYDANNIY LAAQYTQTYN ATRVGSLGWA NKAQNFEAVA QYQFDFGLRP SLAYLQSKGK
301 NLGVINGRNY DDEDILKYVD VGATYYFNKN MSTYVDYKIN LLDDNQFTRD AGINTDNIVA
361 LGLVYQF
Perna et al., 2001
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Figure 2-5. OmpC hollow B-barrel fold. Image produced with Swiss-Pdb
viewer 3.5
2.41 Antibiotics
The list of antibiotics used during this work is presented in Table 2-15.
Table 2-15. Antibiotics
Antibiotic Solvent Stock concentration Final
concentration
Ampicillin dH20 10 mg ml"1 50 pg ml"1
Chloramphenicol Ethanol 25 ml"1 25 pg ml"1
Kanamycin dH20 10 ml"1 50 pg ml"1
2.42 Creation of the ompC deletion
The allelic exchange method was used to replace the ompC gene with a
sacB-kan marker cassette in E. coli 0157:H7 ZAP 198 to generate strain
E. coli 0157:H7 ZAP 1187. This technique has proved very successful in
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avoiding unwanted genetic rearrangements in "wild type" strains such as
E. coli 0157:H7 (Emmerson et al. 2006). The exchange process relies on
the steps described in Table 2-16.















Two regions homologous to the flanking regions of the target gene
and a sacB-kan cassette are cloned into the original temperature
sensitive (28°C), chloramphenicol resistant plasmid.
Introduction of the plasmid into electro-competent E. coli 0157:H7
receptor strain
Bacteria are grown at a temperature (42°C) that precludes plasmid
replication, while the use of Chloramphenicol rich media (LBC)
selects resistant bacteria in which the plasmid has been integrated
by recombination of homologous regions into the bacterial genome.
Bacteria are cultured at28°C in Kanamycin to induce plasmid
excision. A second round of allelic exchange between the plasmid
and the bacterial genome generates a plasmid containing the
original bacterial gene and flanking regions, and a bacteria with the
plasmid homologous regions and marker cassette.
Bacteria are replica-plated in Kanamycin (LBK) and LBC rich media.
Bacteria that grow exclusively on LBK have been successfully
exchanged.
The allelic exchange approach is based on the use of a temperature
sensitive plasmid vector containing a genetic marker that confers a
phenotype that can be selected for, and a multiple cloning site containing
several restriction sites, to allow the insertion of DNA fragments at these
locations. In this work we used plasmid pIB307, that codes for
chloramphenicol resistance and is unable to replicate autonomously over
28°C. In addition, this plasmid was further modified by the insertion of
two regions of approximately 1,000 bp, that are the amplified flanking
regions of the bacterial ompC gene targeted for replacement.
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These homologous regions are extended at each end by the addition of
sequences recognised by specific restriction enzymes, to allow their
insertion into the complementary fragments present in the original
plasmid vector (Sad 1,484, BamHI 1,495 and Sphl 1,523 bp). For this
project, the right flanking region was amplified with the addition of Sad
(5') and BamHI (3') sites, and cloned into pIB307 creating pPNl. The left
flanking region incorporated BamHI (5') and Sphl (3') sites and was
inserted into pPNl forming pPN2. Finally, the sacB-kan cassette was
inserted between both flanking regions at the BamHI site to create
construct pPN3. The diagram is represented in the scheme depicted on
Figure 2-6.
Figure 2-6. Plasmid construction
BamHI site
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This construct was then used to exchange the target gene and its
flanking regions by the plasmid homologous flanking regions and
cassette. The kan gene is inserted in the bacterial genome to facilitate the
selection of a kanamycin-resistant transformants lacking the
replacement gene. The sacB helps to identify subsequent excisions of the
marker cassette if required.
Plasmid pPN3 containing the ompC flanking regions and the marker
sacB-Kan and Chloramphenicol resistance cassettes was electroporated
into E. coli 0157:H7 ZAP198 (Figure 2-7a). Resultant transformants were
selected on LB (Luria-Bertani) containing chloramphenicol (LBC, 25
pg/ml) and incubated at 28°C. Resistant colonies were grown in LBC
broth (Luria-Bertani broth containing 25 pg/ml of chloramphenicol) at
42°C and subcultured three times more for 12 hours to obtain primary
plasmid integrates (Figure 2-7b). Further sub-culturing into LBK (Luria-
Bertani broth containing 50 pg/ml of kanamycin) at 28 °C selected for
plasmid excision where the ompC gene had been replaced by the sacB-
kan marker cassette (Figure 2-7c).
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DNA targeted for excision
I I p s-K KXXXXXXX Ch OOOOCKX*
I I r s-K r 1 1
i i p s-K P 1 1
k<VxVS<W Ch WxWxN P s-K D 1 1
Finally, the region exchanged is PCR amplified. The construct is validated
by verifying the loss of the plasmid to determine: (i) absence of ompC (ii)
presence of the sacB-kan cassette and (iii) correct location of the insert.
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Chapter 3
Enumeration of E.coli 0157:H7
in gastrointestinal tract
tissues, contents and faeces
following experimental
challenge of cattle via oral
and rectal routes
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3.1 Introduction
It is important to understand the shedding patterns of E. coli 0157:H7 to
identify possible intervention points that may decrease its prevalence in
cattle. The study of cattle shedding patterns could also help to prevent
human disease, in particular if we consider that high level excretion may
be a major risk factor for human exposure to this pathogen (Ogden et al.
2004; Omisakin et al., 2003).
Shedding of E. coli 0157:H7 from cattle has been frequently reported as
intermittent (Brown et al., 1997; Cray Jr. and Moon, 1995; Garber et al.,
1995; Liu et al., 2005; Pearce et al., 2004a; Robinson et al., 2004) and on
certain occasions the same strain has been detected in the same animal
weeks apart (Liu et al., 2005; Pearce et al., 2004a). The concentration at
which E. coli 0157:H7 is shed in faeces varies from animal to animal and
levels of up to 105-106 CFU g-1 ofwet faeces have been reported regularly
(Brown et al., 1997; Cray Jr. and Moon, 1995; Matthews et al., 2006b;
Omisakin et al., 2003). The duration of faecal shedding has been
estimated for experimental and naturally infected animals between 1 to
12 weeks (Cray Jr. and Moon, 1995; Rahn et al., 1997; Robins-Browne
and Hartland, 2002; Sanderson et al., 1999; Widiasih et al., 2004b) with
isolated individuals capable of sustaining high shedding levels for even
longer periods (Brown et al., 1997; Ohya et al., 2000). It is generally
agreed that weaned calves are more susceptible to colonisation and that
they shed E. coli 0157:H7 in their faeces with greater magnitude and
intensity than older cattle (Gannon et al., 2002; Garber et al., 1995;
Hancock et al., 1997; Nielsen et al., 2002; Rugbjerg et al., 2003). Besides
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age, a varied complexity of often-interrelated microbial, animal, herd,
environmental and production factors are known to influence to a lesser
extent bacterial shedding (Fitzgerald et al., 2003; Minihan et al., 2003;
Ogden et al., 2004; Van Baale et al., 2004).
Initial research aimed at identifying colonisation sites of naturally and
experimentally infected cattle, has reported the isolation of E. coli
0157:H7 from all areas of the gastrointestinal tract including
occasionally the tonsils and gall bladder (Brown et al., 1997; Cray Jr. and
Moon, 1995; Grauke et al., 2002; Jeong et al., 2007; Naylor et al., 2003a;
Stoffregen et al., 2004). Cray Jr. and Moon (1995) reported increased
numbers of E. coli Oi57:H7 from caecal contents to faeces. Brown et al.
(1997) reported the highest recovery rate in the contents of the
forestomachs. Stoffregen et al.(2004) and Jeong et al. (2007) cultured the
bacteria from rumen, large colon contents and bile of experimental and
naturally colonised animals. Grauke et al.(2002) using ruminal and
duodenal cannulae to sample live animals did not detect, after 34 days,
any bacteria in these areas of the gastrointestinal tract despite animals
shedding E. coli 0157:H7 in their faeces. The subsequent finding that E.
coli 0157:H7 colonises primarily the rectal anal junction of cattle focused
research on this site (Naylor et al., 2003a).
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3.2 Aims and objectives
1- To confirm in a greater number of animals the rectal tropism of E.coli
0157:H7 as originally reported.
2- To compare the similarities and efficiency of rectal inoculation versus
oral challenge in establishing E. coli 0157:H7 infection.
3- To investigate the possible colonisation of other sites situated rostraly
to the rectum in the intestinal tract, and any possible relevance for
sustaining infection.
To achieve these objectives the following approaches were taken:
Daily collection of the faeces from 54 challenged calves, for a minimum of
two weeks, followed by detection and enumeration of total bacteria in all
the samples.
A total of 22 animals were examined post-mortem and various tissue and
contents samples collected from the gastrointestinal tract for E. coli
0157:H7 bacterial counts.
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3.3 Results
A total of 54 animals (Group 1, section 2.2 Material and Methods, M&M)
were challenged with E. coli 0157:H7 either by oral administration or by
direct application of the organism to the recto-anal junction. From these
a total of 46 animals became colonised and a post-mortem was carried
out on 22 animals still shedding greater than 1 x 101 CFU g1 of E. coli
0157:H7 beyond day 14 post-challenge. Ten of these animals had been
challenged by direct rectal application and 12 by oral administration.
Initially six animals were cannulated and ruminally challenged. The
bacterial colonisation rates and persistence did not differ from the group
of orally challenged animals and this particular route was discontinued.
In this analysis, the data from ruminally challenged animals has been
included in the orally challenged group.
3.3.1 Shedding analysis
Faeces were obtained from each animal following stimulation of the anal
sphincter and separated into core and surface components. This was a
critical step in the bacterial detection system so that for each faecal
sample the surface and core samples could be cultured independently, as
it was assumed to be an indication ofwhether the majority of bacterial
contamination was arising locally at the rectum and terminal areas of the
distal colon (surface) or from higher sites in the GIT (core).
Arbitrary criteria were developed to categorise the experimental faecal
shedding data. Calves were classified as colonised when the bacterial
numbers were above 103 CFU g1 of E. coli 0157:H7 at day five. Persistent
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infection was when the shedding levels, for more than 50 % of samples,
were above 103 CFU g1 of E. coli 0157:H7, between days 5 and 14 and
still detectable at day 14 of those with successful uptake. Animals were
classified as specifically rectally colonised if the faecal surface counts
were at least 10 fold higher than in the core samples for more than 50%
of occasions between days 5 and 14. The entire data set and descriptive
statistics are presented in Annex Tables I and II.
In this categorisation from the 54 animals challenged, 22 out of 24
(91.7%) rectally challenged and 20 out of 30 (66.7%) calves either orally
or intraruminally challenged were considered successfully colonised. E.
coli 0157:H7 was detected for at least 14 days in 15 of 22 (68.2 %) in the
faeces of rectally challenged animals and 13 of 20 (65.0%) orally
challenged animals. Of these animals rectal colonisation was considered
established in 15 out of 15 (100.0%) rectally challenged and 11 of 13
(84.6.0%) orally challenged cases. Overall 77.8 % of 54 animals become
colonised, 66.7 % of the 42 shed the bacterium for at least 14 days, and
92.9 % of 28 were colonised by E. coli 0157:H7 in the terminal rectum
(Table 3-1). Additionally, case 684, which had been orally challenged, did
colonise and could have been considered rectally colonised, but it only
started shedding levels above 103 CFU g1 of E. coli 0157:H7 from day 13
to 21, and therefore it had to be categorised as non-colonised.
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Table 3-1. Analysis of E. coli 0157 colonisation, persistence and rectal
localisation in experimentally colonised calves
Rectal % Oral % Total
Colonised 22 24 91.7% 20 30 66.7 % 77.8 %
Persistence 15 22 68.2% 13 20 65.0% 66.7 %
Rectal Colonisation 15 15 100% 11 13 84.6% 92.9 %
Colonised: Shedding levels above 103 at day five, 10 fold or higher levels in
surface than core or persistence until day 9
Persistence: Shedding levels consistently (> 50 % of samples) above 103 between days 5 and 14 and still
detectable at day 14 of those with successful uptake.
Rectal Colonisation: Surface at least 10 fold higher than core for > 50% of samples between days 5 and 14
After the initial two days the shedding patterns with significantly higher
numbers (paired Student's T-test, p<0.001) present in surface samples
compared to core were seen for the two different challenge routes
(Figures 3-1 and 3-2). Interestingly, the faecal E. coli 0157:H7 counts for
the first two days were similar in core and surface samples for orally
challenged calves. In rectally challenged animals, higher numbers of E.
coli 0157:H7 CFU g1 were immediately detected in surface samples.
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Figure 3-1. Orally challenged calves. Daily group 1 mean of faeces surface
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Figure 3-2. Rectally challenged calves. Daily group 1 mean of faeces
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Highly statistically significant differences (p<0.001) were found between
surface and core counts for the whole dataset, and for the log-
transformed subset formed after excluding zero values, by two way
Student T-test respectively (Figure 3-3).
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Figure 3-3. Orally and rectally challenged animals. Daily group 1 mean of
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No statistically significant differences were found for surface or core
values, when the average daily shedding of orally challenged animals was
compared with animals that were administered bacteria rectally (p>0.14
and p>0.15 respectively) (Figures 3-4 and 3-5).
Figure 3-4. Orally versus rectally challenged animals. Daily group 1 mean
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Figure 3-5. Orally versus rectally challenged animals. Daily group 1 mean
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It is notable that, unlike the surface, the frequency distribution of core
CFU g 1 of E. coli 0157:H7 values in colonised animals is bimodal, with
the highest frequency at the zero interval and the second mode with 102
CFU g1 of E. coli 0157:H7 (Figures 3-6 and 3-7). Thus, the probability of
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Figure 3-6. Frequency distribution of E. coli 0157:H7 levels on the surface
of the faeces from colonised group 1 animals
150
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Figure 3-7. Frequency distribution of E. coli 0157:H7 levels in the core of
the faeces from colonised group 1 animals
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CFUg-1
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3.3.2 Post-mortem results
Overall E. coli 0157:H7 was present in 119 samples from contents or
tissue washings. On 54 occasions, samples of tissue and contents were
taken from the same gastrointestinal sites. On 25 occasions E. coli
0157:H7 was detected in both contents and tissue washings taken from
the same site (agreement in 46.3% of the samples, Kappa value 0.4,
p<0.001). Bacteria were exclusively found in contents in 16 samples and
only in tissues in 13 cases.
In the 22 animals still shedding the organism two weeks following
challenge and that were examined by post mortem, E. coli 0157:H7 was
detected in the rectum in 21 out of 22 (95.5%) tissue washes from the
terminal rectum (TR) and in 15 of 21 (71.4%) from the area 5 centimetres
proximally. For the other rectal areas, 6 out of 21 and 7 out of 22
samples were positive at either 10 or 20 centimetres (28.6% and 31.8%
respectively). Results for all animals are summarised in Annex Table III.
In the orally challenged group, E. coli 0157:H7 was isolated from
washings of the recto-anal junction (RAJ) and at concentrations up to 106
CFU cm 2 in 11 of the 12 animals (Figure 3-8). A proportion of the
gastrointestinal mucosal washings collected from the large intestine
contained E. coli 0157:H7 but the concentrations were several logarithm
ranges lower than from the corresponding rectal mucosal samples except
for case 691. In total, 5 individuals out of 12 had positive large intestine
tissue washings at concentrations of up to 103 CFU cm 2 of E. coli
0157:H7. Significant (p=0.009) high values in non-rectal tissue were
obtained from mucosal washings of the ileo-caecal valve lymphoid patch
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when compared with the rest of the counts obtained from the rest of the
colon, with the highest concentration of E. coli 0157:H7 obtained for one
individual at 103 CFU cm 2.
The statistical analysis of data showed that E. coli 0157:H7 counts from
tissue washings of the terminal rectum were significantly higher than
from tissues of the large colon (P=0.001). Significantly higher counts
(P<0.001) were detected in the terminal rectum when compared to counts
from tissue washings of the rest of the rectum (5, 10 and 20 cm distal to
the recto-anal junction).
Figure 3-8. Orally challenged animals. Statistical analysis of E. coli
0157:H7 levels from gastrointestinal mucosa washings






RM JP IPP ICJ CM PCI PCP SC DC R20RI0 R5 RAJ
RM Rumen SC Spiral colon
JP Jejunum DC Distal colon
IPP Ileum R20 Rectum (+) 20
ICJ lleo caecal junction R10 Rectum (+) 10
CM Caecum R5 Rectum (+) 5
PC Proximal colon TR Terminal Rectum
PCP Proximal colon patch
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In the calves challenged by direct rectal application E. coli 0157:H7 was
identified from mucosal tissue washings taken at the RAJ in all animals
at concentrations up to 106 CFU cm 2 (Figure 3-9). The E. coli 0157:H7
colonisation extended proximally in the rectum in the highest shedding
individuals and sites 10 cm and 20 cm proximal to the RAJ were positive
in 50% of individuals. Mucosal washings were occasionally positive for
large intestinal sites but never in more than two individuals and
consistently at concentrations lower than 102 CFU cm 2 E. coli 0157:H7.
For animals that were challenged per rectum, the statistical analysis of
data showed that counts from tissue washings of the terminal rectum
were significantly higher than from tissues of the large intestine
(P<0.001). Significantly higher counts (P<0.001) were detected in the
terminal rectum when compared to counts from tissue washings of the
rest of the rectum (areas comprising 5, 10 and 20 cm from the terminal
rectum).
95
3. Shedding and tropism
Figure 3-9. Rectally challenged animals. Statistical analysis of E. coli
0157:H7 levels from gastrointestinal mucosa washings
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RM JP IPP ICJ CM PCI PCP SC DC R20 RIO R5 RAJ
RM Rumen SC Spiral colon
JP Jejunum DC Distal colon
IPP Ileum R20 Rectum (+) 20
ICJ lleo caecal junction R10 Rectum (+) 10
CM Caecum R5 Rectum (+) 5
PC Proximal colon TR Terminal Rectum
PCP Proximal colon patch
Results of E. coli 0157:H7 counts from rectal contents taken post-mortem
in orally challenged calves were statistically significantly lower compared
to same day faecal counts (p=0.004). In contents samples, highly
significant lower bacterial counts were detected in the large intestine
than those in the rectum (P=0.004). Significant statistical differences
were not detected between faeces collected at the terminal rectum and
other areas of the rectum (p=0.610, Figure 3-10)
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Figure 3-10. Orally challenged animals. Statistical analysis of E. coli







RM B JM Tl CM PCI PC2 SC DC R20 RIO TR CF SF
RM Rumen SC Spiral colon
B Bile DC Distal colon
JM Jejunum R20 Rectum (+) 20
Tl Terminal Ileum R10 Rectum (+) 10
CM Caecum TR Terminal Rectum
PC1 Proximal colon at lleocaecal junction CF Faecal core
PC2 Proximal colon at proximal lymphoid patch SF Faecal surface
In animals that were challenged per rectum, significant lower values were
found in terminal rectum contents compared to same day surface faecal
counts (p<0.001), while significantly lower values (p<0.001) were detected
in the the large intestine compared to the rest of the rectum. A significant
p value of 0.011 was found for the higher E. coli 0157:H7 numbers at
terminal rectum compared to the rest of the rectum (Figure 3-11).
97
3. Shedding and tropism
Figure 3-11. Rectally challenged animals. Statistical analysis of E. coli







RM B JM Tl CM PCI PC2 SC DC R20 RIO TR CF SF
RM Rumen SC Spiral colon
B Bile DC Distal colon
JM Jejunum R20 Rectum (+) 20
Tl Terminal Ileum R10 Rectum (+) 10
CM Caecum TR Terminal Rectum
PC1 Proximal colon at llocaecal junction CF Faecal core
PC2 Proximal colon at proximal lymphoid patch SF Faecal surface
In both orally and rectally challenged animals the faecal surface samples
were always positive for E. coli 0157:H7 with concentrations over 104
CFU g-1 in 13 of the 21 collected samples. For the animals challenged by
direct rectal administration, E. coli 0157:H7 was not recovered from bile
or samples of digesta from non-rectal sites that included rumen, small or
large intestine. For the orally challenged group, E. coli 0157:H7 was not
recovered from bile. Although, samples of digesta from large intestinal
sites were occasionally positive the E. coli 0157:H7 concentrations were
always lower than from rectal or surface faecal samples.
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Discussion
A marked bacterial tropism for the terminal rectum in the bovine host
has been confirmed. For all cases, E. coli 0157:H7 principally colonised
the tissues of the last three centimetres of the terminal rectum. In the
contents, the highest numbers of E. coli 0157:H7 were also detected from
samples obtained from the last few centimetres of the rectum and greater
numbers were detected from the faecal surface after transit through the
terminal rectum.
Other minor sites were identified. These included the rumen, small
intestine and more frequently the proximal colon, in particular at the ileo
caecal junction. Nevertheless, the bacterial numbers were significantly
lower in tissues than in the ingesta. This was true even for proximal
rectum tissues compared to the terminal rectum. In two animals out of
the 24 orally challenged animals studied E. coli 0157:H7 was distributed
throughout the large intestine and was not localised specifically at the
rectal mucosa given the even distribution of the bacteria throughout the
faecal pat. This finding is consistent with previous reports (Naylor et al.,
2003a) and suggests that there is a different mechanism of colonisation
for a small number of animals. It is apparent that the colonisation of
other sites situated higher up in the intestinal tract may occur and its
relevance for sustaining infection has not been yet analysed. Although,
for the period of three weeks analysed in this study the patterns of
shedding were undistinguishable for animals orally and rectally
challenged, suggesting that colonisation of sites higher up in the large
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intestine do not play a determinant role in the magnitude or duration of
infection.
Several reasons could account for the reported sporadic shedding
described by many authors: it may be genuine, induced by repeated
reinfection, or influenced by factors that may alter detection capacity
affecting both magnitude and prevalence estimates. Factors that may
affect carriage estimates at an individual level are: differences in
detection techniques, sensitivity of tests, or the type of sample used
(entire faeces, faecal pat, faecal or oral swab (Pearce et al., 2004b; Rice et
al., 2003; Sanderson et al., 1995; Stanford et al., 2005). The significant
difference of bacterial counts found on the surface when compared to the
core of the faeces is also indicative that the contamination occurs at the
point where the intestinal contents move through the rectum. This
finding may explain the peculiar bimodal distribution of E. coli 0157:H7
CFU g-1 frequencies found for faecal cores. The first peak is at zero, and
could correspond to the true central tendency of the core values. The
source of the second peak, at 4xl02 CFU g1 of E. coli 0157:H7 may be a
result of contamination, resulting from the difficulties of obtaining totally
uncontaminated core for all samples given the varied shape and
consistency of the faeces. Furthermore, in colonised animals only 5.4% of
the samples were E. coli 0157:H7 negative on the surface compared with
30.6% negative in the core. Thus, sampling accuracy improves
considerably when faeces are sampled on the surface. The characteristic
distribution of E. coli 0157:H7 predominantly on the surface of the faeces
may explain the widely reported intermittent individual shedding in cattle
(Robinson et al., 2004; Stanford et al., 2005). In most of the studies
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faeces have been collected either directly from the ground or from the
rectum and therefore not taking into consideration the specific
distribution of E. coli over the faecal surface induced after final passage
through the terminal rectum.
This work also demonstrates that the experimental rectal challenge with
E. coli 0157:H7 is indistinguishable, with respect to the shedding
patterns, when compared with the natural oral route. Animals rectally or
orally challenged showed identical E. coli 0157:H7 shedding patterns.
There was no difference in average daily shedding, rectal colonisation
rates or bacterial distribution on the surface and core of the faeces,
which was highly statistically significant in this study and in previous
work undertaken by our group (Naylor et al., 2003b). Importantly the
rectal inoculation was more effective in establishing infection and
subsequent rectal colonisation. The efficacy of the rectal challenge to
establish infection is supported by another recent study where all
animals challenged rectally were colonised (Sheng et al., 2004), thus
supporting initial evidence identifying the terminal rectum as the
principal site for E. coli 0157:H7 colonisation (Naylor et al., 2003b).
The highest numbers of E. coli 0157:H7 in the intestinal contents were
detected in the rectum. Remarkably, a statistically significant increase
was detected in the surface of the faeces collected a few hours before the
necropsy when compared with rectal contents obtained inside the rectum
and before excretion. This finding suggests that the large intestine
discharge reaches its maximal contamination only after contacting the
epithelium of the terminal 2/3 centimetres of the rectum.
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The post-mortem examination of these colonised animals also allowed
the identification ofminor sites of E. coli 0157:H7 carriage. These sites
included the rumen, small intestine and most frequently, the proximal
colon, particularly at the ileo caecal junction. In the large colon, no clear
association was found between areas rich in lymphoid tissue and E. coli
0157:H7, a finding corroborated by a recent study on long-duration
culture-positive cattle (Lim et al., 2007). In this study, in all but one case,
E. coli 0157:H7 principally colonised the tissues of the last three
centimetres of the terminal rectum, while it was present less frequently
and in lower numbers, as the samples were taken further away from the
terminal rectum. Support of the importance of terminal rectum
colonisation also comes by a recent abattoir study carried out in
naturally colonised animals where the terminal rectum was detected as
the principal site of colonisation in 15 out of 16 E. coli 0157:H7 positive
animals (Low et al., 2005).
This study confirms the terminal rectum tropism of E. coli 0157:H7 and
clarifies the importance of different gastrointestinal areas for the
colonisation and persistence of the bacterium. The ability of bacteria to
colonise gastrointestinal tissues depends on its capacity to adhere or
invade host epithelia. These bacterial characteristics are ofmajor
importance in enteric infections and provide adequate grounds for the
investigations of the interactions of bacteria with the gastrointestinal




ultrastructural study of E. coli





Although enterohaemorraghic E. coli 0157:H7 causes no apparent
disease in cattle (Caprioli et al., 2005; Naylor et al., 2005a), epithelial
attachment of E. coli 0157:H7 is unlikely to be a neutral process. From
an understanding of the area of the gastrointestinal tract that E. coli
0157:H7 colonises, there is an opportunity to examine the interaction at
the terminal rectum to determine whether there is evidence of an
immune response to colonisation.
A feature of all typical EHEC strains is their close association to
intestinal epithelial cells where the bacterium causes rearrangement of
enterocyte actin cytoskeleton fibres to form pedestal like structures that
elevate the bacteria above surrounding cell surfaces (Roe et al., 2003).
This intimate bacterial association with the host induces important
alterations of the intestinal epithelium, which are potential triggers of
local inflammatory reactions mediated through the interaction of
pathogen-associated molecular patterns and host pattern recognition
receptors (Magalhaes et al., 2007). Intestinal epithelial cells are also
capable of expressing major histocompatibility complex type II molecules
and have also been involved in antigen presentation (Mallegol et al.,
2005; Van Niel et al., 2003).
To date the only reported immune reactions in the intestinal tract to E.
coli 0157:H7 colonisation have been described for experimental
infections of gnotobiotic, neonatal or immunosuppressed calves and in
sites other than the rectum (Dean-Nystrom et al., 1997; Sandhu and
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Gyles, 2002; Stoffregen et al., 2004; Woodward et al., 1999). This work
aims to investigate the pathological changes and innate immune
responses to E. coli 0157:H7 colonisation at its main tropism site: the
terminal rectum.
4.2 Aims and objectives
1- To review earlier findings that the tropism for the terminal rectum may
be related to the presence of lymphoid tissue.
2- To determine by immuno-gold labelling and electron microscopy
whether there is type III secretion-mediated mucosal attachment at the
terminal rectum.
3- To describe the bacterial adherence to the terminal rectal epithelium
by microscopic and ultrastructural examination.
4- To determine if colonisation of the terminal rectal epithelium induced
histopathological changes in the terminal rectum.
5- To establish if colonisation of the terminal rectum induces innate
mucosal immune responses.
6- To develop a method to sample terminal rectum tissue in infected
animals with minimal invasion.
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To achieve these objectives the following approaches were taken:
Gastrointestinal tissues from 22 animals from group 1 (section 2.5 M&M)
were histologically examined, and additionally 11 animals from the same
group had rectal biopsies taken pre-challenge and on two further
occasions at days 6 and 12 after challange.
Identification of E. coli 0157:H7 by indirect immunohistochemistry,
immunofluorescence and immunogold labelling.






The terminal rectum epithelial cells are phenotypically heterogeneous.
Morphologically, examination of Haematoxylin and Eosin (H&E) stained
tissues revealed an epithelial cell population composed of low, densely
packed, cuboidal follicle-associated epithelium covering lymphoid follicles
alternating with simple columnar absorptive epithelium with their
nucleus located in the basal third of the cytoplasm (Figure 4-1).
Figure 4-1. Terminal rectum histology H&E, bar = 120 pm. Low cuboidal
epithelium lines the lymphoid follicles domes (solid arrows), while simple
columnar epithelium rests upon the lamina propria (dotted arrows)
Widespread MHC class II expression was detected by
immunohistochemistry on irregular lamina propia cells underlying the
intestinal epithelium (Figure 4-2).
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Figure 4-2. Terminal rectum. Immunohistochemical staining for MHC class
II, bar = 60 pm. Extensive labelling of MHC class II was observed on cell
populations subjacent to the gastrointestinal epithelia
Examination of H&E stained tissues failed to detect bacteria or
pathological changes in the small intestine or large intestine except at
the terminal rectum. Microscopic inspection revealed sparse focal
clusters of granulocytes mostly associated with microcolonies of rod-like
bacteria, when bacteria at terminal rectal epithelium exceeded 10s CFU
cm 2 (Figure 4-3).
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Figure 4-3. Terminal rectum. H&E, bar = 20 pm. A granulocytic infiltrate is
present throughout the lamina propia (arrows), Note a bacterial colony on
the epithelial luminal surface (dotted circle)
Multifocally, moderate numbers of bacteria are present along the
enterocyte brush border and in the intestinal lumen. Occasionally, the
epithelium is shedding cells (Figure 4-4). Exuded granulocytes were
frequently observed (Figure 4-5).
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Figure 4-4. Terminal rectum, H&E, bar = 20 pm. Large numbers of bacteria
are noted on areas of sloughed epithelium (dotted circle) accompanied by
some granulocytes in the underlying lamina propria (arrows)




E. coli 0157:H7 could be readily detected associated with the epithelium
using immuno-staining and microscopy, in animals with bacterial counts
over 105 CFU g1 (Annex Table IV). In these positive tissues, collected
between 14 and 22 days after challenge, the immunopositive bacteria
were usually colonising focal areas of the absorptive epithelium or less
frequently, the scarcer follicle associated epithelium (FAE).
Bacterial micro-colonies ranged from those containing less than thirty
bacteria to those with several hundred. The distribution of the colonies in
the terminal rectum appeared random, with some micro-colonies close
together, and others separated by large areas of non-colonised rectal
tissue. In all cases affected epithelial cells had bacteria intimately
associated with their apical membranes. Occasionally, immunostained
bacteria were present without producing major morphological alterations
to the rectal epithelium.
The mucosal border in foci with attached bacteria was low columnar to
cuboidal (Figure 4-6 a and b) with frequent exfoliation of the mucosal
epithelium from the basal membrane (Figure 4-6 c) and bacteria often
seen in cavities of evacuated enterocytes (Figure 4-6 d).
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Figure 4-6. Terminal rectum. Immunohistochemical staining for E. coli
0157:H7 lipopolysaccharide; figures a and b bar = 10 pm; c bar = 20 pm; d,
bar = 30 pm. Bacterial colonies (arrows) are seen closely associated with
the epithelium (a, b). In some areas heavily colonised enterocytes are
sloughing off (c) and bacterial colonies are apparently colonising the
cavities of evacuated enterocytes (d)
Groups of loose immunopositve bacteria were also present in the mucus
40 to 100 microns from the luminal surface. On rare occasions E. coli
0157:H7 was also attached to areas of the squamous epithelium of the
perianal region and crypts of the rectal mucosa.
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On one occasion, labelling of 0157 LPS antigen was found by confocal
microscopy within the cytoplasm of a cell of dendritic morphology closely
associated with the gastrointestinal epithelium. The abundant
immunopositive material was amorphous and lacked the usual rod shape
morphology associated with 0157 LPS labelling in the other sections
examined (Figure 4-7).
Figure 4-7 Terminal rectum, bar = 2 pm. Confocal micrograph of
internalised immunofluorescent amorphous antigen.
Immunohistochemical staining for E. coli 0157:H7 lipopolysaccharide.
Biopsies: E. coli 0157:H7 micro-colonies were also detected by
immunostaining at day 6 from rectal biopsy samples from three animals
that were shedding 105 CFU g-1 E. coli 0157:H7 in faeces (Figure 4-8,
Annex Table V). The distribution and intimate bacterial attachment to
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enterocytes was similar to that observed in the cases examined at post¬
mortem on days 15 and 21 post-challenge.
Figure 4-8. Terminal rectum biopsies. Immunohistochemical staining for E.
coli0157:H7 lipopolysaccharide, figures a and b bar = 10 pm.
Immunolabeled bacteria are present closely adherent to the mucosal
epithelia.
Naturally colonised animal: Histological examination of the terminal
rectum tissue from a naturally colonised calf from group 1 (section 2.2
M&M) with over 105 CFU cnr2 ofE. coli 0157:H7 revealed similar bacterial
distribution and histological changes as described above for
experimentally colonised animals.
4.3.2 Ultrastructural analysis
Tissues from Group 1 animals examined by immunohistochemistry were
further analysed by SEM. Multi-focal clusters of rod-shaped bacteria of
up to two microns in length were distributed randomly over the surface
of the absorptive epithelium of the rectum (Figure 27).
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Figure 4-9 Terminal rectum, SEM. Bacterial microcolonies marked with
dotted circle. Bar = 100 |jm
Conventional TEM carried out on reprocessed Group II paraffin blocks,
and gold particle immuno-labelling TEM carried out on Osmium-free
fixative samples from Group 3 animals, allowed identification of E. coli
0157:H7 on pedestals as part of AE lesions, (Figures 4-10 and 4-11
respectively) and attaching intimately to the enterocyte apical surface
(Figure 4-12). All the electron micrographs were taken from animals




Figure 4-10. Terminal rectum, TEM. Section through an E. coli 0157:H7
micro-colony at the bovine terminal rectum. The bacteria are all intimately
attached (black arrows) to the damaged epithelium, inducing effacement
of the microvilli. Unaffected brush border is visible on the neighbouring
epithelia (white arrow), bar = 1 pm.
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Figure 4-11 Terminal rectum, TEM. Immunogold labelling of E. coli
0157:H7, bar = 250 nm, arrows point to gold particles.
Figure 4-12. Terminal rectum, TEM. Bacterium (B) intimately attached to
the apical membrane of an enterocyte (E) surrounded by microvilli (M),
bar = 500 nm.
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Pedestal heights varied but in some cases were up to 10 microns. Some
micro-colonies consisted of bacteria in layers, apparently forming a stack
and individual bacteria were observed in the process of dividing.
Bacterial micro-colonies were associated with different degrees of
enterocyte erosion (Figure 4-13).
Figure 4-13. Terminal rectum, TEM. Aggregates of bacteria accumulate
over the roughened surface of the colonised enterocytes. Note the severe
cytoplasmic alterations in the form of deep pits (black arrows). Bacteria
are intimately attached to the apical surface of the enterocyte (white




Microscopic examination of biopsy and post-mortem rectal tissue
colonised with E. coli 0157 demonstrated a diffuse, low to mild
granulocytic focal infiltration of the lamina propria. On occasions
granulocytes were present interspersed amongst enterocytes and exuded
leucocytes formed aggregations in the gut lumen (micro-abscesses).
In the terminal rectum, a significant (P<0.001) granulocytic infiltrate was
present in colonised animals (mean 7.0 ±1.4 per 0.25 mm2) when
compared with controls (mean 1.9 ± 0.9 per 0.25 mm2). For colonised
animals significantly more granulocytes (P<0.001) were found in the
terminal rectum compared to the proximal rectum (+20cm). In the area
twenty centimetres proximal to the terminal rectum, no significant
differences (p>0.42) in granulocytes counts were detected between
infected and non-infected cases (controls mean 1.2 ± 1.1 per 0.25 mm2,
cases 1.5 ± 1.0 per 0.25 mm2) (Figure 4-14, Annex Table VI).
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Figure 4-14. Box plot representation of neutrophils numbers obtained in
the terminal and distal rectum of exposed and unexposed animals
The boxes contain 50% of the data and the median count is illustrated by the black triangle.
Samples were prepared and granulocytes identified as described in section 2.13, M&M.
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However, no differences were detected between numbers of eosinophils,
mast cells and yS T-cells (P>0.65; P>0.69 and P>0.68) when compared in




E. coli 0157:H7 causes pathological changes to the mucosal epithelium
of the rectum and the changes are histologically detectable in the rectum
when numbers are over 105 CFU cnr1 of E. coli 0157:H7 on tissues. The
main histopathological findings at sites of bacterial attachment were: (i)
attaching and effacing lesions, (ii) in heavily colonised cells a reduction of
enterocyte cytoplasmatic height and degeneration, and (iii) frequent
enterocyte sloughing. The microscopic examination was made in animals
shedding bacterial numbers similar to those animals considered high
shedders in field studies (Stanford et al., 2005; Fegan et al., 2004) and
importantly, similar changes were detected in the terminal rectum of a
naturally infected animal. No alterations in the integrity of the epithelial
mucosa were observed in control animals or in colonised animals
shedding below the 105 CFU g1 threshold
In cell culture, E. coli 0157:H7 strains induce apoptosis in human
epithelial (HEp-2) cells resulting in increased surface-exposed
phosphatidylethanolamine levels and enhanced attachment (Barnett
Foster et al., 2000). In our study, examination by electron and light
microscopy of considerable areas of the rectal mucosa with varied levels
of colonisation, failed to detect the, certainly rapid event, of enterocyte
apoptosis. Given the severe nature of the enterocyte cytoplasmatic
changes observed during the different phases of bacterial colonisation, it
is possible that most of the mucosal damage inflicted by E. coli 0157:H7
may be due to enterocyte desquamation. In vitro studies have
consistently reported a decreased transepithelial resistance and opening
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of the tight junctions following E. coli Oi57:H7 colonisation of
monolayers (Philpott et al., 1998; Tomson et al., 2004).
We have confirmed that E. coli 0157:H7 persist in the bovine host
forming AE lesions in animals with bacterial counts over 105 CFU g 1 of
E. coli 0157:H7 in terminal rectum tissues collected two and three weeks
after experimental inoculation, allowing the bacteria to establish a long-
term persistence, similar in duration to the natural carriage observed in
animals in field studies (Besser et al., 1997). Similar lesions have been
previously reported in weaned calves four days post-challenge (Dean-
Nystrom et al., 1999), and bacteria closely associated to the terminal
rectum has also been reported in weaned calves (Naylor et al., 2003b). In
addition, in this work we present ultrastructural evidence of AE lesions
at the terminal rectum and specific immunogold labelling of E. coli
0157:H7 lipopolysascharide. This methods are considered definitive for
establishing the presence of AE lesions (Wales et al., 2001a, Wales et al.,
2005a).
The destructive alterations induced by E. coli 0157:H7 observed in the
bovine epithelial barrier induced a quantifiable neutrophilic response in
cattle. This type of inflammatory reaction has been previously described
in the intestinal tract for experimental infections of gnotobiotic or
neonatal calves (0 to 1 day old) that are not completely
immunocompetent. A quantified increase in neutrophils and eosinophils
in the lamina propria has been described in one occasion (Woodward et
al. 1999), while other studies report similar increases of leucocytes in
colon and caecum (Dean-Nystrom et al., 1997), sections of ligated ileal
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loops (Sandhu and Gyles, 2002) and perianal skin (Pohlenz and Dean-
Nystrom, 2004). This is the first report of neutrophilic responses at the
terminal rectum to E. coli 0157:H7 rectal colonisation in weaned calves.
In vitro adherence studies made with E. coli 0157: H7 in intestinal organ
cultures of human small and large intestine epithelium showed that
attachment was mediated by intimin gamma and restricted to follicle
associated epithelia of Peyer's patches (Phillips et al., 2000). The terminal
rectum is an area rich in lymphoid follicles (Mahajan et al., 2005) and
previous work has suggested a similar association to explain E. coli
0157:H7 tropism for the bovine terminal rectum (Naylor et al., 2003a). In
this study, extensive histological examination of terminal rectum tissues
did not reveal a prominent association between E. coli 0157:H7
microcolonies and follicle associated epithelium. Although the principal
site of E. coli 0157:H7 colinization is the lymphoid follicle-dense mucosa
of the terminal rectum, E. coli 0157:H7 attachment to the terminal
rectum was not restricted to any particular epithelia cell type (follicle
associated epithelium, simple columnar epithelium or goblet cells)
present in the area.
Enteropathogenic E. coli and non-0157:H7 enterohaemorrhagic strains
have a wide ranging tropism for the gastrointestinal tract and AE lesions
have been described in a wide range of species species including rabbits
(Cantey and Blake, 1977); dogs (Drolet et al., 1994a); goat (Drolet et al.,
1994b); calves (Hall et al., 1985); lambs (Janke et al., 1989);, cats
(Pospischil et al., 1987) pigs (Staley et al., 1969) and in the large intestine
and rectum of sheep (Wales et al., 2005b). The reason for the terminal
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rectum tropism of E. coli 0157:H7 in cattle is still obscure.
Characteristically, E. coli 0157:H7 expression of fimbria! adhesins is
precluded by gene mutations in all but three type IV fimbria! clusters,
and subsequent studies have concluded that these adhesins are not
involved in cattle colonisation (Low et al., 2006a), limiting the putative
adherence factors to other molecules of the cell wall. A possible
explanation for terminal rectum tropism may be related to friction and
the particular anatomy of the area. Two of the main features are the
reduced width of the mucous barrier over the Peyer's patches that
populate this particular area and that the terminal rectum junction is
subjacent to the anal sphincter (Sansonetti, 2004). This combined effect
of a reduced protective mucin barrier coupled with raised intrarectal
pressure during defecation, may facilitate the colonisation of the area, by
promoting cell to cell contact, one of the key mechanisms that induces
the expression of the type III secretion system (Roe et al., 2003).
The formation of attaching and effacing (AE) lesions, characterised by
elimination of the microvilli and intimate enterocyte attachment (Dean-
Nystrom et al. 1999; Ismaili et al. 1998, Moon et al., 1983) produces a
substantial damage to the host epithelial cell and is unlikely to be
unnoticed by the host adaptative immune system. This work provides
evidence for epithelial and inflammatory changes associated with
colonisation of the terminal rectum, similar to reported changes at other
sites in the intestinal tract (Woodward et al., 1999; Dean-Nystrom et al.,
1999; Wales et al., 2001), and inflammatory changes in response to E.
coli 0157: H7 carriage. These inflammatory responses are mild and affect
a limited area of the rectum. However, the changes may be indicators of
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the possible development of acquire immune responses to E. coli 0157:
H7 colonisation that may offer a means to control the carriage of this
important human pathogen and the development of acquired mucosal
immune response will now be investigated.
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Chapter 5
Mucosal antibody responses in
the terminal rectum of E. coli
0157:H7 colonised cattle
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5.1 Introduction
The presence of tissue damage and inflammation caused by pathogens, is
generally followed by a vigorous adaptive immune response (Hamburger
et al., 2006). The mucosal immune system is equipped with secretory
immunoglobulin type A, an acquired defence mechanism that provides a
first line of protection against enteric pathogens (Fagarasan, 2006).
Humoral immunity in mucosal secretions is mainly associated with
polymeric immunoglobulin A (IgA) bound to the secretory component as
secretory IgA (S-IgA). IgA is secreted into the intestinal lumen by an IgA-
specifrc Fc receptor called poly-IgG (pig) and are more resistant to
digestion by microbial and intestinal proteolytic enzymes than other
isotypes (Brandtzaeg, 2003). IgA produced by B cells in the lamina
propria is secreted as dimers or polymers bound to the joint (J) chain a
characteristic protein component of mucosal secreted antibodies. The pig
receptor has an associated extracellular molecule secretory component
(SC) that is responsible for binding and transport through the enterocyte
of poly-IgA and with less efficiency to poly-IgM than to poly-IgA. The SC-
Ig complex is found bound to secreted IgA (slgA) and IgM. The bovine
receptor has been well characterised biochemically (Butler, 1986).
Certain species such as cattle and horses also have equal amounts of
IgG in the intestinal fluid which is usually considered serum derived
(Snoeck et al., 2006; Widders et al. 1984). Importantly for E. coli 0157:H7
colonisation, IgA is the predominant isotype at the rectum with a ratio of
5:1 (McNeilly etal., 2007).
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Serological and mucosal immune responses have been reported
previously in cattle. Serum IgG-associated responses have been reported
against a variety of antigens, (Cray Jr. and Moon, 1995; Johnson et al.,
1996; Laegreid et al., 1999; Pirro et al., 1995; Potter et al., 2004; Wray et
al., 2000) while mucosal IgA-associated responses have been reported
against E. coli 0157:H7 intimin (Yokomizo et al., 2002) and flagellin
(McNeilly et al., 2007). Nevertheless, no attempt has been made to
characterise the gastrointestinal mucosal humoral response to E. coli
0157:H7 infection, in particular at the principal site of colonisation at
the terminal rectum.
5.2 Aims and objectives
1- To investigate the presence of local mucosal antibody responses.
2- To define those antigens recognised during colonisation.
3- To determine rectal mucosal levels of IgA and IgG following infection.
To achieve these objectives the following approaches were taken:
To establish a reliable method of extraction of mucosal antibody.
To establish a 1-D SDS-PAGE and immunoblotting system for whole E.
coli 0157 and cell fraction preparations (sections 2.19 and 2.21, M&M).
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To quantify by ELISA test the immune responses to two main E. coli
0157:H7 antigens, namely 0157 LPS and H7 flagellin (section 2.17
M&M).
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5.3 Results
5.3.1 Immunoblotting
To examine whether animals colonised by E. coli 0157:H7 at the terminal
rectum were generating specific mucosal antibody responses to E. coli
0157:H7 antigens, samples were taken initially from three animals from
Group 1 (204, 722 and 868) that shed E. coli 0157:H7 at levels
consistently over 104 CFU gram-1 for at least one week, as it was thought
that the concentration of specific antibodies would be higher in these
animals. Mucosal antibodies were extracted from rectal mucosal
homogenates as described in section 2.6 of M&M and used for
immunoblotting. The experiments were carried out using as antigens
whole cell samples from the challenge strain E. coli 0157:H7 (ZAP 198)
and a negative control laboratory strain E. coli K12 MG1655 (ZAP 185).
Initially the antigen was titrated by reducing 1-D SDS-PAGE gel
electrophoresis and the proteins visualised by Simply Blue stain (Figure
5-1) as described in section 2.19 ofM&M.
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Figure 5-1. Reducing 1-D SDS/PAGE analysis of whole cell samples of E. coli ZAP











Lanes 1-4 loaded with whole cell samples of ZAP 198 (1) 40pg, (2) 20pg, (3) 10pg, (4)
5pg
Lanes 5-8 loaded with whole cell samples of ZAP 185 (1) 40pg, (2) 20pg, (3) 10pg, (4)
5pg
It was considered that Simply Blue stain of proteins was likely to be less
sensitive than Western blotting and chemiluminescence detection of
protein bands. To minimise non-specific reactions the lowest antigenic
loads, which provided distinct visible bands, were used in subsequent
Western blotting experiments. Rectal tissue extracts of case 204 (Figure
5-2) were used to incubate the transfers at a tentative 1:150 dilution.
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Figure 5-2. Reducing 1-D SDS/PAGE Western blot analysis of serial
concentrations of whole cell samples E. coli ZAP 198 and E. coli ZAP 185
incubated with rectal mucosal extract form case 204. Dilution 1:150,
exposure 10 s bioting conjugated tertiary antibody.
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ZAP 198, lanes 1 (5Mg), 4 (10Mg), 6 (2C>Mg) and 8 (20Mg)-
ZAP 185, lanes 2 (5|jg). 3 (lOgg), 5 (20Mg) and 7 (20Mg).
In this blot, IgA reactivity against ZAP 198 was demonstrated as a
pronounced but indistinct area at approximately 38-98 kD, with an
additional strong band at 16 kD. In contrast, the reactivity to ZAP 185
was markedly less, showing two bands at 49 kD and at 16 kD. The total
protein antigen load chosen for further immunoblotting was 5gg.
To establish the working dilution of the extracts of rectal mucosa and to
test lower dilutions of antigen, a 1-D SDS/PAGE gel was loaded with
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serial dilutions of ZAP 198 antigen. The membrane transfer was then
incubated with serial dilutions of extracts from case 722. The
combination of 5 jig of antigen and extract dilution of 1:200 was selected
for further immunoblot detections (Figure 5-3).
Figure 5-3. Reducing 1-D SDS/PAGE Western blot analysis ofwhole cell
samples E. coli ZAP 198 incubated with serial dilutions of of rectal






ZAP 198. Lanes 1, 4, 7 (0.1 pg) 2, 5, 8 (1pg) 3, 6, 9 (5 pg)
Incubation transfers 1, 2 and 3 1:800; 4, 5 and 6 1:400; 7, 8 and 9 1:200
Rectal mucosal extracts from case 868 were incubated with transfers of
strain ZAP 198 with similar results as shown for case 204 and 722
(result not shown). Negative controls were carried out incubating without
pooled rectal extract.
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To evaluate the specificity of the immune reaction 1-D SDS-PAGE
Western blots were carried out with rectal mucosal extracts from a group
of unexposed calves (sections 2.2 and 2.4 M&M). No specific reactive
bands were observed (Figure 5-4).
Figure 5-4. Reducing 1-D SDS/PAGE Western blot analysis of whole cell
samples E. coli ZAP 198 incubated with rectal mucosal extracts from










722 C1 C2 C3
98 98 98 85 98 85 98 85
1 2 3 4 5 6 7 8
ZAP 198 (98), lanes 1,2 3, 5, 7; ZAP 185 (85) lanes 4, 6, 8
Strip 1 positive control ZAP 198 incubated with case 722, extract dilution 1:200. Strip 2
negative control no extract.
Strips 3-4 incubated with control 1 (C1), strips 5-6 control 2 (C2) and strips 7-8 control 3
(C3)
To further verily the specificity of the immune reaction and to asses the
contribution of the protein antigen to the immunoreactivity, extracts of
rectal mucosa were used to blot whole cell preparations of E. coli strains
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0157 ZAP 198, 026 and K12 ZAP 185. It can be seen that multiple
immunoreactive bands were detected from the E. coli 0157 strain by
comparison with E. coli 026 and K12. Trypsin digestion of the samples
removed most of the immunoreactive material, indicating the
immunodominance of the protein component in the blotted antigen.
Lanes six and seven are controls containing E. coli 0157 and K12
antigens incubated with all the reagents except the rectal homogenate in
order to detect non specific reactions (Figure 5-5).
Figure 5-5. Reducing 1-D SDS/PAGE Western blot analysis of whole cell
samples E. coli ZAP 198 incubated with rectal mucosal extracts from case
868, lanes 6 and 7 no extract. Exposure 10 s bioting conjugated tertiary
antibody.
Trypsinized
ZAP 185 ZAP 198 ZAP 185 ZAP 198 EC0:026 ZAP 185 ZAP 198 kD
1 2 3 4 5 6 7
Lanes (1) trypsinised ZAP 185, (2) trypsinised ZAP 198, (3) untreated ZAP 198, (4)
untreated ZAP 185, (5) untreated E. coli 026, (6) ZAP 185 (7) ZAP 198
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Having detected specific immune responses against whole cell antigens of
ZAP 198 in three animals with visible histological lesions at the rectum in
post-mortem samples, it was decided to extend the work and challenge a
second group of eight animals (Group 2, section 2.2 M&M). This second
group would enable us to sample animals pre-initial challenge to obtain
mucosal rectal samples by rectal biopsy, a technique that was developed
during the initial histological studies (section 2.4 M&M).
During this study, faeces were sampled 38 times from each animal
during a 50 day period after initial challenge. The counts obtained for
each animal are shown in Table 5-1. All animals had faecal samples with
detectable levels of E. coli 0157:H7 from day 6 and until day 21, with
average levels above 102 CFU g1. After rechallenges on day 35 and 36
animals shed similar levels of bacteria until day 40. Maximum levels
detected in individual animals ranged from 1.3><103 to 2.4xl05 CFU g 1 of
E. coli 0157:H7. The average bacterial count for all the samples collected
was 3.5xl03 CFU g 1 of E. coli 0157:H7. None of the calves reached the
continuous levels of shedding above 104 CFU g1 of E. coli 0157:H7
achieved by the animals with histological lesions from Group 1, and
therefore no histology was performed. Calves did not show any clinical
signs during this experiment. The following table shows the timetable of
challenges and sampling and the numbers of bacteria found on the
surface of the faeces during the period of study.
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Table 5-1. Group 2 calves, challenging / sampling procedures and daily








1 2 3 4 5 6 7 8
u
1 5,433 3,133 3,033 233 667 67 5,367 67
2 0 200 0 67 33 467 0 100
3 NC5 2,000 0 67 0 133 0 400
4 0 567 0 167 67 600 0 1,300
5 0 8,967 0 33 67 133 0 667
6 0 400 0 100 233 533 0 100
8 933 19,433 100 NC 3,533 700 33 0
9 500 2,500 67 0 133 7,467 0 0
10 0 5,033 1,267 267 5,467 21,700 67 0
11 100 0 21,233 67 NC 3,500 9,733 0
12 0 NC NC 200 NC 9,667 2,400 0
13 0 21,933 63,367 0 56,933 NC 73,133 0
14 0 33 10,700 167 NC 8,233 24,900 0
15 0 0 37,733 467 267 NC 8,367 0
16 0 667 50,133 33 11,100 433 1,533 0
17 0 NC 240,667 133 3,267 1,000 16,867 NC
18 0 67 51,433 133 67 0 333 NC
19 0 133 36,600 33 500 167 1,067 0
20 0 300 267 33 100 100 600 0
21 0 100 2,533 0 0 33 600 0
35 0 0 0 0 0 0 0 NC
36 533 100 2,600 3,300 3,400 2,267 2,300 167
37 167 0 8,333 3,200 1,900 0 1,467 233
38 967 33 867 500 NC 133 1,500 0
39 100 1,467 0 633 14,633 33 1,433 0
40 3,367 33 33 733 200 0 6,567 433
41 3,067 33 NC 467 3,633 0 533 0
42 7,700 0 0 1,133 233 0 7,933 0
43 2,333 133 0 0 0 0 1,200 0
44 33 NC 0 0 200 800 767 400
45 NC 0 67 100 0 100 33
46 33 67 0 0 0 0 0 100
47 0 0 0 0 0 0 0 0
48 67 0 0 0 0 0 133 67
49 0 167 0 0 33 0 0 0
50 0 0 0 0 0 0 0 0
(1)DPC: Days 1 to 50 post initial challenge
(2)CH E. coli 0157:H7 ZAP 198 oral challenge
(3) BS: Blood sample
(4) RB : Rectal mucosa biopsy
(5) NC: Sample not collected
Using mucosal extracts taken at post-mortem at day 50 post-challenge
IgA antibodies were detected that bound to antigens ofwhole E. coli
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0157:H7. Between 4 to 11 protein bands, with molecular weights ranging
from 38 and 98 kD were recognised. A fainter and less numerous
pattern of reactive bands was observed in pre initial challenge samples
from homogenates of rectal tissues obtained by rectal biopsy, as
presented in Figure 5-6.
Figure 5-6. Reducing 1-D SDS-PAGE Western blot of E. coli ZAP 198 whole
cell samples incubated with rectal mucosa extracts obtained from group 2







Transfer 0, pooled rectal extract from group 1 cases; transfers 1 to 8, group 2 cases.






Transfer N, no extract; 0, pooled rectal extract from group 1 cases; transfers 1 to 8,
group 2 cases. Exposure time 10 s
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To elucidate the immunological relevance of the protein antigens
compared to E. coli 0157:H7 lipopolysaccharide detected byWestern blot,
the whole cell antigen samples were submitted to enzymatic digestion.
Proteinase K digestion of the ZAP 198 (section 2.15 M&M) antigen
preparation removed most protein bands detected by IgA, leaving a
diffuse area of recognition at 71-55 kD for three cases (Figure 5-7).
Figure 5-7. Reducing 1-D SDS-PAGE Western blot of proteinase K treated
whole cell samples of E. coli ZAP 198 samples incubated with rectal






Transfers cases 1 to 8 group 2. Exposure time 10 s.
All lanes loaded with proteinase K treated ZAP 198.
Furthermore, most of the homogenate samples did not show reactivity to
LPS of E. coli 0157:H7, which appeared as a single diffuse band
migrating below the 70-kD marker (Figure 5-8).
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Figure 5-8. Reducing 1-D SDS-PAGE Western blot of E. coli 0157 LPS







Transfers cases 1 to 8 group 2
Exposure time 10 s. All lanes loaded with 0157 LPS.
8 7 6 5 4 3 2 1
After establishing the predominance of the protein component in the
overall immunoreactivity of the sample, a comparative study of the
different secreted and somatic protein fractions of the bacteria was carry
out.
Membrane and cytoplasm protein fractions were analysed by 1-D SDS-
PAGE immunoblotting. IgA antibody reactivity was predominantly
confined to the membrane fractions, although faint and indistinct
reaction against cytoplasmic proteins was observed from the pooled
material of highly colonised animals. The reactive membrane proteins
ranged from 30-90 kD, with three major bands showing at approximately
30, 40 and 70 kD (Figure 5-9).
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Figure 5-9. Reducing 1-D SDS-PAGE Western blot of E. coli ZAP 198
membrane and cytoplasmatic fractions incubated with rectal mucosa










Lanes 1, 3 and 5 loaded with outer membranes and lanes 2, 4 and 6 with cytoplasmatic
protein preparations. Both blots were similarly processed and all lanes were loaded with
1 pg of antigen.
Transfers 1 and 2 were incubated with a pool of mucosal supernatant from 3 animals
with histopathological lesions, whereas transfers 3 and 4 were incubated with
supernatants from animal 1 and lanes 5 and 6 with supernatants from animal 2
Exposure time lane 10 s. Lanes 1 and 2, were exposed for a shorter period due to the
relatively high intensity of the reaction
Supernatant proteins from ZAP 198 and a LEE4 deletion mutant (ZAP
984) were prepared as described in section 2.15 ofM&M and used to
determine if there were detectable IgA responses to type Ill-secreted
proteins. Reactive bands with molecular masses expected of EspA
(22/25kD) EspD-B (37/39kD) and Tir (100/llOkD) were detected when
samples were incubated with pooled rectal tissue extracts. No reactive
bands were observed when the same extracts were used to blot
supernatant proteins precipitated from the LEE4 mutant (Figure 5-10).
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Figure 5-10. Reducing 1-D SDS-PAGE Western blot of E. coli ZAP 198
secreted proteins and supernatants of a LEE4 mutant incubated with
rectal mucosa extracts obtained at post-mortem from group 1 and 2
animals
1 2 3 4 5 6
28
16
Lanes 1, 3 and 5 loaded with supernatants of a LEE4 mutant and lanes 2, 4 and 6 with
secreted proteins.
Transfers 1 and 2 were incubated with a pool of mucosal supernatant from 3 animals
with histopathological lesions, , whereas transfers 3 and 4 were incubated with
supernatants from animal 1 and lanes 5 and 6 with supernatants from animal 2
Exposure time lane 10 sees. Lanes 1 and 2, were exposed for a shorter period due to
the relatively high intensity of the reaction.
The detection of specific E. coli 0157:H7 antigens was also extended to
the flagellum. Flagella are with LPS one of the two antigens (O and H)
used for classifying the E. coli group. IgA reactivity was also investigated
against purified H7 flagellin, the protein that forms the filamentum, and
2-3 bands were visible between 60 and 200 kD on extracts from animal
1. A similar band pattern profile was observed following immunoreaction
with a commercial monoclonal antibody against H7 antigen, an example
from one animal is shown (Figure 5-11).
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Figure 5-11. Reducing 1-D SDS-PAGE Western blot of E. coli ZAP 198 H7
flagellin incubated with rectal mucosa extracts obtained at post-mortem
from group 2 animals
Lanes 1 to 3 H7 flagellin
Lane 1 no primary, lane 2 case 1-2 and lane 3 rabbit policlonal anti-0157 LPS antibody
5.3.2 ELISA
To understand better the development of immune responses after
infection a qualitative ELISA study was carried out from rectal biopsy
samples taken at four different time points during the 50 days of the
study, using purified 0157 flagellin and LPS as antigens. The assay
method is described in section 2.17 of M&M.
The mucosal antibody responses measured by ELISA showed an elevated
mucosal IgA response at day 50 in all animals against both 0157 LPS
and H7 flagellin. This response was particularly marked to H7 flagellin
when compared with LPS (Figure 5-12a and 5-13a).
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Figure 5-12. Levels of rectal mucosa H7 specific IgA (A) and lgG1 (B)
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Similarly, the readings for IgG 1 antibody were generally higher for H7
than for LPS (Figure 5-12b and 5-13b). Overall, the rectal mucosal
antibody titres increased after repeated E. coli 0157:H7 challenge.
Figure 5-13. Levels of rectal mucosa 0157 LPS specific IgA (A) and lgG1











T 34T t 54 DPC
OD Optic Density DPC Days post challenge Red arrows: Challenges
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5.4 Discussion
There have been other investigations of the serological immune responses
to E. coli 0157 (Hoffman et al., 2006; Johnson et al., 1996; Lissner et al.,
1996 and other EHEC (Widiasih et al., 2004a) in cattle. However, this
study demonstrates for the first time, that E. coli 0157:H7 infection in
cattle induces local IgA immune responses against membrane and
secreted proteins antigens at the terminal rectum, the principal site of E.
coli 0157 colonisation in the bovine species.
Immunoblotting showed a number of antigens in whole cell preparations
that were recognised by IgA in rectal mucosa extracts collected post-
challenge. These bands were more numerous and intensely stained than
those detected after reaction with mucosal extracts from pre-challenge
tissue, indicating a local IgA antibody response to the repeated E. coli
0157:H7 challenges. Shared antigens from other E. coli present in the
normal flora of farm reared calves, or cross reactivity with other antigens
(Stenutz et al., 2006; Westerman et al., 1997) are likely to explain the low
pre-challenge reactivity observed.
Proteinase K treatment of whole cell preparations removed almost all
reactive material, suggesting that a high proportion of the antibody
targets were protein rather than carbohydrate epitopes. In agreement
with this finding, Western immunoblot analysis of purified 0157 LPS
showed low reactivity. The lower reactivity of the 0157 LPS when
compared with protein antigens was also confirmed by ELISA analyses,
carried out with equal antigen loads and primary antibody
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concentrations. LPS is one of the main pathogen-associated molecular
patterns (PAMPs) employed by the mammalian's innate immune system
to detect Gram-negative bacteria (Backhed et al., 2003; Trent et al.,
2006), although pure LPS is considered a poor immunogen (Poxton,
1995). Thus, in this case LPS does not appear to be a dominant antigen
for the development of a mucosal response.
The rectal mucosal extracts labeled three major reactive bands in the
outer membrane preparations of E. coli 0157:H7, while the cytoplasmic
preparations reacted weakly, suggesting that the major immunogenic
proteins of the bacterium are surface-exposed. It is possible that like
most of the PAMPs that interact with the innate immune system (Blasi et
al., 2005; Rezaei et al., 2006), the main virulence determinants from non
invasive bacterial pathogens may be extracellular virulence factors
(Parsot, 2005) or membrane components (Kagnoff, 2006). A recent
analysis of an expression library recognised by IgG antibodies from
immune calves (Kudva et al., 2006) detected predominantly cytoplasmic
antigens. However, the work did not identify type III secreted proteins or
Shiga toxin against which specific IgG has been previously reported in
cattle (Johnson et al., 1996; Potter et al., 2004; Yokomizo et al., 2002).
The fact that membrane proteins were the main antigens detected in this
study could be a result of restriction site limitations (Rollins et al., 2005)
and/or the different tests employed, as well as the differences between
antibody isotype and local vs. systemic responses, could explain the
greater relevance given in this work to membrane proteins antigens.
147
5. Mucosal immune responses
In the present study, culture supernatants containing type III secreted
proteins where highly antigenic and reacted strongly with IgA antibodies
from infected animals. The proteins recognised were not detected in a
LEE4 mutant supernatant and had molecular masses that correlate with:
(i) the needle elongation filament protein, EspA; (ii) the pore generating
protein complex, EspB/D and (iii) the translocated intimin receptor, Tir.
These are all key proteins required for induction of attaching and effacing
lesions by E. coli 0157 and are exposed to the host immune system in
the early stages of colonisation (Cornelis, 2006). Serological IgG
responses against similar proteins have been reported during bovine
vaccine trails following vaccination with type III secretion system proteins
(Potter et al., 2004) and in human infection (Li et al., 2000). Recent
research has found that these proteins are essential for E. coli 0157:H7
colonisation of the terminal rectum (Naylor et al., 2005b).
H7 flagellin also elicited strong IgA immune responses, with ELISA values
higher than LPS for equal concentrations of antigen and primary
antibodies. Unlike LPS, flagellin may activate both innate and acquired
immune systems, through the activation of Toll-like receptor 5 and the
recruitment of dendritic cells (Honko et al., 2005; Rumbo et al., 2006;
Yang et al., 1997). This immundominance of flagellin has also been
reported in Crohn's disease patients (Lodes et al., 2004). Moreover, in
vitro studies have found that flagellin is the main inducer of the
neutrophil chemoattractant interleukin 8, through the activation of
intestinal epithelial cell NF-k(3 and MAP kinase pathways (Berin et al.,
2002), and E. coli 0157:H7 infection in cattle is characterised by the
induction in the rectal mucosa of neutrophil infiltrates. In contrast to E.
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coli 0157:H7 infection in cattle, H7 flagella antibodies have not been
detected in the sera of human patients (Chart et al., 1989; Jenkins and
Chart, 1999), which may indicate the lack of flagella expression during
human infection.
In summary, the present study has shown that E. coli 0157:H7
colonisation induces a strong local mucosal antibody response in the
rectum, which is directed at several membrane-associated and secreted
proteins. Since IgA has been selected through evolution as the main
protective element of the mucosal humoral immune response (Matsunga
and Rahman, 1998), the antigens detected may represent important




Mucosal antibody responses to
Escherichia coli 0157:H7 outer
membrane porin C
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6.1 Introduction
The current study has indicated that infection of cattle with E. coli
0157:H7 induces strong mucosal immune responses in the rectum to
different protein fractions of the bacteria. One-dimensional
polyacrylamide gel electrophoresis (ID-PAGE) offers very low resolution of
fractionated whole E. coli, a complex sample that can contain thousands
of putative antigens (Tonella et al., 1998; Tonella et al., 2001). The
strength of 2-D SDS/PAGE is its ability to separate the proteins present
in a sample in two dimensions by both charge and molecular weight.
This can increase the resolution of single proteins in complex samples.
Further immunoblotting and analysis of the immunogenic spots by
peptide mass spectrometry methods allows the identification of individual
antigens (Lilley et al., 2002). Despite well known limitations, such as spot
overlapping (Campostrini et al., 2005), 2-D SDS/PAGE is still the method
of choice for the analysis of complex protein samples (Gorg et al., 2004).
Membrane preparations contained some of the most immunogenic E. coli
0157 proteins detected in the earlier work. Gram negative bacterial
membranes are composed of two membranes, a cytoplasmic and an outer
membrane, with the peptidoglycan-containing periplasm situated
between these (Duong et al., 1997). The distinct Gram negative outer
membrane is composed of a phospholipid bilayer formed by an inner
leaflet of phospholipids and an outer leaflet of LPS (Raetz and Whitfield,
2002). This lipid portion of the outer membrane is largely impermeable to
all charged molecules (Nikaido and Vaara, 1985). Unique to Gram
negative bacteria, channels called porins are present in the outer
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membrane to facilitate nutrient transport and these constitute the most
abundant proteins in the cell membrane (Doerrler, 2006). These porins
account for nearly half of the total mass of the outer membrane (Osborn
et al., 1972). Other proteins found in cell membranes are hydrolytic
enzymes and binding proteins in the periplasm (Ruiz et al., 2006) and
lipoproteins anchored predominantly to the outer membrane but facing
into the periplasm (Tokuda and Matsuyama, 2004).
Of the outer membrane proteins the most abundant when bacteria are
grown in conventional media are OmpA, OmpF and OmpC (Nikaido,
1996). These porins are composed of eight (OmpA) or sixteen (OmpC and
OmpF) anti parallel f3-strands that transverse the outer membrane folded
in a characteristic (3-barrel structure surrounding a channel (Basle et al.,
2006; Sansom, 1999). The loops connecting membrane-traversing (3-
strands are between one to four residues long on the periplasmic side but
often longer on the transmembrane external side. The third external loop
folds inward narrowing the lumen of the (3-barrel in OmpC and OmpF
porins (Nikaido, 2003).
The external loops show much variability among enterobacteria (Nikaido
1996). Importantly they could be specific epitopes recognised by the
adaptive immune response. Specificity has been confirmed by abrogation
of the ability of the porins to serve as phage receptors by introducing
mutations into the external loops of OmpA (Morona et al., 1984) and
OmpF (Traurig and Misra, 1999), E. coli 0157:H7 OmpC-specific phages
have been reported on several occasions (Morita et al., 2002; Yu et al.,
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1998), although no studies have been carried out to define the site of
phage attachment.
6.2 Aims and objectives
1- To identify within the whole E. coli 0157:H7 proteome the most
antigenic proteins.
2- Following identification of OmpC as a putative immunodominant
protein, to construct an ompC mutant and confirm loss of antigen
recognition.
3- To define the transmembrane external epitopes of OmpC that are
recognised by the bovine host.
To achieve these objectives the following approaches were taken:
Optimisation of a 2-D SDS-PAGE gel electrophoresis and immunoblotting
system for whole E. coli 0157 preparations.
Identification of immune-reactive proteins by MALDI-TOF/TOF mass
spectometry analysis
Construction of an ompCmutant by allelic exchange followed by Western
blotting of the mutant to confirm loss of antigen recognition.
Peptide synthesis of the most relevant external structures of OmpC
identified from a published structure.
Western blotting and ELISAs to probe for antibody recognition of the
OmpC peptides.
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6.3 Results
6.3.1 Antigenicity analysis of the E. co//0157:H7 ZAP 198 proteome
by 2-D gel electrophoresis and Western blotting
Western blot analysis of transfers of 2-D SDS-PAGE (Section 2.21 M&M)
of antigen preparations of whole E. coli 0157:H7 strain ZAP 198, allowed
the detection of IgA antibodies against one spot identified by mass
spectrometry analysis (score 131, significance level 60) as outer
membrane porin C (OmpC). IgA antibody from mucosal tissue
homogenates collected from ten animals tested (animals 204, 722, 868
from group 1 and 7calves from group 2), all detected the OmpC protein
albeit with varying degrees of reactivity. A representative example is
shown below (Figure 6-1).
Figure 6-1. Reducing 2-D SDS/PAGE Western blot analysis of E. coli ZAP
198 incubated with rectal mucosal extracts (case 8, group 2) showing a
reactive spot later identify by mass spectrometry analysis as OmpC
(dotted circle). Exposure 15s biotin conjugated tertiary antibody.
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Although OmpC reacted strongly and was readily detected by MALDI-
TOF/TOF, several other weaker reactive spots were observed. However,
despite several attempts at identifying these through MALDI-TOF/TOF,
no significant identities were established.
Four 2-D gels were employed to separate the proteins and the gels were
stained with Simply Blue and matched with the immuno reactive spot
observed on the counterpart Western blots. The gel spots were excised
and identified by mass spectrometry analysis (score 131 ±3, significance
level 60) as outer membrane porin C (OmpC) (Figure 6-2).
Figure 6-2. Reducing 2-D SDS/PAGE analysis of E. coli ZAP 198
proteonome, showing several spots of Simply Blue positive stained










Confirmation that OmpC had focused on a single spot in the gel was
sought by sampling collateral areas and no match was found with any
peptide sequence. Sampling of another area where immunoblots from
three cases had presented an immunoreactive spot of about 17 kD did
Ph 10 Ph 3.5
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not match any protein spot on the 2-D SDS/PAGE gels. Another three
additional gel spots matching proteins DNAK, Cpn 60 and Ferritin were
sampled to verify the correct distribution of E. coli proteins in the 2-D
SDS/PAGE gel (Figure 6-3).
Figure 6-3. Reducing 2-D SDS/PAGE analysis of E. coli ZAP 198. The











Spot 3: no match. Spot 4: Outer membrane protein C; Spot 5: no match; Spot 7: no
match; Spots 1, 2 and 6 DNAK, Cpn 60 and Ferritin respectively.
To evaluate the specificity of the immune response to E. coli 0157 OmpC,
K-12 was analysed by 2-D Western blot. Immunobloting did not detect
any IgA reactive peptide spots on the OmpC area when the K-12 strain
was incubated with a pool of group 1 mucosal extracts (Figure 6-4).
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Figure 6-4. Reducing 2-D SDS/PAGE Western blot analysis of E. coli ZAP
185 incubated with rectal mucosal extracts from a pool of three animals
from group 1 (dotted circle, expected area of OmpC spot identification).
Exposure 15 s biotin conjugated tertiary antibody.











6.3.2 Targeted mutagenesis of ompC
To eliminate the possibility of insufficient separation and interference
from another protein present at levels below mass spectrometry detection
threshold, it was decided to construct an ompCmutant for further
immunoblot testing. The main steps followed for this process were
outlined in the section 2.42 of the M&M and are also represented in
Figure 6-5.
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Amplification of homologous regions. Using the primers described in
section 2.27 ofM&M both ompC flanking regions of 1,000 and 1,113 bp
were amplified from an E. coli 0157:H7 ZAP 198 DNA template, and the
correct final PCR products identified by their size by agarose
electrophoresis. The primers incorporated additional BamHI, SphL and
SacI restriction sites to facilitate sub-cloning into the corresponding
restriction sites in pIB307 (Figure 6-6).
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Figure 6-6. PCR amplification of right (1,000 bp) and left (1,113 bp)
flanking regions using E. coli ZAP 198 DNA as template. First lane marker,
second amplified product (arrow), third no template.








Cloning of the left and right inserts into pET100 and transformation of the new
plasmids pET100-R and pET100-L into host bacterial cells
After several failed attempts to introduce directly the right flanking region
into pIB307, it was decided to clone each fragment first into a TOPO
pETlOO plasmid for further excision and insertion into pIB370. This
strategy facilitates cloning for two reasons. First it takes advantage of the
higher copy number of this replicon. Secondly the addition during the
PCR of a single 3'-A overhang to each end of the products enables more
efficient cloning into the TOPO vector, that is prepared with 3'-T
overhangs. After 3'-A overhang amplification, both homologous regions
were cloned into two different sets of TOPO pETlOO plasmid (sections
2.24 and 2.36 M&M). The new plasmid constructs were introduced into
two different preparations of K-12 S185 host cells by heat shock
transformation (section 2.38 M&M) and plated onto LBA plates. For each
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6. Outer membrane porin C
set of transformants five colonies were selected and cultured overnight in
LB broth. Plasmids were purified (section 2.25 ofM&M) and submitted to
diagnostic digests (one hour at 37°C) with the following sets of enzymes:
EcoRl a restriction site situated at both ends of the cloning site,
BamHl/SpHl for the right flanking region and BamHl/Hindlll for the
left region. The size of the products expected was 3.9 Kb for the EcoR1
digestion with a second band containing the insert, and 1.0 and 1.1 for
right and left hand inserts respectively. 2 pi of the samples were run on a
1% agarose gel for one hour at 100 v. Several clones showed DNA
products of the size of the flanking regions, and clone 2 for the left hand
region and clone 3 (lanes 2 and 3, Figure 53) for the right hand region
were selected for subsequent sub-cloning into pIB307. The new plasmids
containing the right and left flanking regions were designated pETlOO-R
and pETlOO-L respectively (Figure 6-7).
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Figure 6-7. Diagnostic digestions of left (pET100-L) and right (pET100-R)






Subcloning of the left and right inserts into plB307.
To subclone the right flanking region from pETlOO-R into pIB307,
plasmid purified preparations were submitted separately to consecutive
digests with Sphl and BamHl. Insert DNA was identified by its molecular
size using agarose gel electrophoresis, excised and the DNA extracted as
previously described (section 2.34 M&M). The vector was then ligated
with digested pIB307. The proportion of DNA of vector to insert present
on the gel was estimated at a ratio of 1:3 and a similar proportion was
used for the ligation, which was performed as described in section 2.35 of
the M&M. Finally putative plasmids containing the right flanking region
were introduced into E. coli competent cells by heat shock transformation
(section 2.38 M&M) and plated onto LBC plates. Ten colonies were then
cultured overnight and plasmids extracted and digested. The expected
DNA size for the new plasmid construct was 5.2 Kb (pIB307 and right
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flanking region DNA sizes 4.2 Kb and 1 Kb respectively) (section 2.24,
table 2-7 M&M). Confirmation of successful inserts was obtained after
digestion of the preparations with either BamHl or Sphl. The new plasmid
containing the right flanking region was designated pPNl (Figure 6-8).
Figure 6-8. Diagnostic digestion with Sph1 and BamHl of plasmid
construct pPN1 and right flanking region purified from ten different clones
Sph 1 BamHl
4 2 3 4 § 6 7 6L9_1D 1 2 34.56 7 8 9 10
Estimated product size 5.2 Kb
To insert the left flanking region into pPNl, plasmid purified preparations
of pETlOO-L and pPNl clone 8 (Figure 6-8, lane 8), were submitted
separately to consecutive digestions with SacI and BamHl. The DNA of
the vector and insert were identified by molecular size using agarose gel
electrophoresis, the bands excised, and the DNA extracted as described
in section 2.34 of the M&M. The proportion of insert DNA to vector was
estimated at 1:3 and a similar proportion was used for the ligation, which
was performed as described in section 2.35 of the M&M. The ligation was
then introduced into E. coli competent host cells by heat shock
transformation (section 2.38 M&M). Five transformants were selected and
cultured overnight in LB broth, the plasmids were purified and two
aliquots of 2 pi submitted to overnight digestion with BamHl alone and
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with a combination of SacI and Sphl enzymes (Figure 6-9). The products
obtained were of the expected size (pPN 1 and left flanking region DNA
sizes 5.2 Kb and 2.1 Kb respectively) (section 2.24, table 2-7 M&M), and
the new plasmid containing the right flanking region was termed pPN2
(Lane 5, Figure 6-9).
Figure 6-9. Diagnostic digestion with BamH1 alone and a combination of
SacI and Sph\ of plasmid construct pPN2 with right and left flanking
regions purified from five different clones
SacI / Sphhl BamHl
1 23451 2345
Estimated total plasmid size 6.4 Kb, backbone 4.2 Kb, insert 2.1 kb
Purification and cloning of the sacB-Kan cassette to form pPN3
The construct pPN2 from preparation 5 was digested with BamHl and the
resultant linear DNA de-phosphoiylated with SAP (1.1.1.13). The sacB-
kart cassette was extracted from vector pKCl 1.04 by restriction digestion
with BamHl and gel purified from two different clones. Insert and vector
were ligated, transformed into calcium competent cells and the new
construct termed pPN3 confirmed by diagnostic digestion with BamHl
(Figure 6-10).
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Figure 6-10. Diagnositc digestion with BamHI of plasmid construct pPN3
from two different clones containing the sacB-Kan cassette
BamH1
Estimated total plasmid size 10.2kb, backbone 6.4 Kb and sacB-Kan 4 kb, lane 1 parent
plasmid, lanes 2 and 3 pPN3 digestions.
Elucidation of sacB-Kan position
The vector pPN3 obtained from the two clones was cleaved with the
enzyme Rsal for which there should be 15 sites in the vector and insert.
The insert could have been spliced into the plasmid in one of two
orientations. The expected size of the fragments for each configuration is
listed in Figure 57. Both orientations were obtained, the clone in lane 3
had the insert situated with the left flanking region on the 3' end and
clone number 1 on the 5' end (Figure 6-11). The clone analysed in lane 3
was used in the ensuing allelic exchange.
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Figure 6-11. Predicted fragement sizes and resulting diagnostic digestion
ofsacB-Kan position following cleaveage of the vector pPN3 with the
enzyme Rsa\.
Predicted Predicted
fragment size (bp), fragment size (bp).
Right flanking Left flanking

















Lane 1 parent plasmid, lanes 2 and 3 digestions.
Transformation into E. coli 0157:H7 electro-competent cells and sub-culturing
To replace in the host chromosome ompCwith the sacB-Kan cassette via
homologous recombination, clone 3 was transformed into E. coli 0157:H7
ZAP 198 electro-competent cells following the protocol described in
section 2.39 of M&M. After selection for plasmid integration by sub-
culturing repeatedly in LBC broth, followed by similar sub-culturing in
LBK broth to select for plasmid excision (section 2.42 M&M, Figure 2-7),
bacterial colonies were screened for transformants in which a secondary
recombination had induced the replacement of the ompC gene for the
sacB-Kan cassette. Serial dilutions (10 3 to 10 6) were plated and 300
colonies patched on both LBC and LBK plates. Ten clones that grew on
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LBK but not on LBC were tested by PCR for the absence of the vector
pIB307 and ompC, and presence of an area comprising the right flanking
region and a nearby downstream area. PCR amplification confirmed that
ompC had been successfully replaced with the sacB-Kan cassette in a
number of colonies tested (Figure 6-12). The clone analysed in lane
number 1 (Figure 6-12) was selected and further PCR amplifications were
carried out to confirm the absence of the parent plasmid pIB307 (Figure
6-13) and the replaced gene ompC (Figure 6-14). This clone was used
thereafter for proteomic analysis and Western blotting.
Figure 6-12. Results of the PCR amplification of the sacB-Kan cassette








Lanes 1,2,3 transformant clones; lane 4 pPN3, lane 5 E. coli ZAP 198; lane 6 no-
template.
166
6. Outer membrane porin C
Figure 6-13. Results of the PCR amplification of the plB307 backbone
from E. coli ZAP 198 transformant clone 1
12 3 4
Lanes 1 clone 1; lane 2 E. coli 0157:H7 ZAP 198; lane 3 no-template; lane 4 plB307
preparation.
Figure 6-14. Results of the PCR amplification of the ompC gene from E. coli
ZAP 198 transformant clone 1
1 2 3
Lanes 1 clone 1; lane 2 E. coli Q157:H7 ZAP 198; lane 3 no-template
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Finally, an agglutination test (section 2.3 M&M) was carried out on the
mutant strain and E. coli ZAP 198 and both were confirmed as E. coli
0157:H7. A similar phenotype for both strains was observed in
preparations examined by light microscopy, although a marked
resistance to the quinolone antibiotic nalidixic acid was observed in the
ompCmutant strain when using E-test strips (Figure 6-15). The strain
was termed E. coli ZAP 1187.
Figure 6-15. Minimum inhibitory concentrations of nalidixic acid observed
on strains E. coli ZAP 198 (left) and E. coli ZAP 1187 (right).
6.3.3 2-D SDS/PAGE analysis of E. coli ZAP 1187 and E. coli ZAP 198
proteome
Two-dimensional gel electrophoresis and Maldi ToF-ToF mass
spectrometry analysis of E. coli ZAP 198 identify OmpC on the wild type
strain, while E. coli 0157:H7 AOmpC E. coli ZAP 1187 proteome revealed
the absence of the OmpC spot in the same are of the gel (Figure 6-16).
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Figure 6-16. 2-D SDS/PAGE Simply Blue stained proteome profile of E. coli
ZAP 198 and E. coli ZAP 1187. OmpC is marked with a dotted circle on the
parent strain E. coli ZAP 198, while is absent in the mutant E. coli ZAP
1187 strain.
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6.3.4 Western blot detection of mucosal IgA antibodies against E.
coli ZAP 198 and 1187
An immunoblot of the OmpC deletion mutant strain E. coli ZAP 1187 did
not detect any IgA reactive peptide in the OmpC region, while the wild
type (WT) E. coli ZAP 198 did react. Incubation was carried out with
homogenates with the same pool of mucosal extracts from group 1. 2-D
Western blotting analysis showed the IgA reactive protein OmpC (Figure
6-17a). Immunoblot analysis of the mutant strain (AOmpC) indicated the
absence of OmpC (Figure 6-17b). Similarly, 1-D SDS immunoblot
analysis of outer membrane preparations of the parent WT and AOmpC
strain showed a reactive band in the WT preparation of 42 kD region
which was absent in the AOmpC preparation (Figure 6-17c). Thus,
confirming that the originally identified immunogenic protein was no
longer detectable in the ompC mutant.
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Figure 6-17. Reducing SDS-PAGE/Western blot analysis of E. coli ZAP 198
and mutant strain ZAP 1187. (a) 2-D immunoblot of E. coli ZAP 198
showing the IgA reactive protein OmpC; (b) 2-D immunoblot analysis of E.
coli ZAP 1187 indicating the absence of OmpC reactivity; (c) 1-D SDS
immunoblot analysis of outer membrane preparations of E. coli ZAP 198
and ZAP 1187. Exposure 15s biotin conjugated tertiary antibody.
a ) b) c )







6.3.5 Immunoblotting and ELISA testing of putative OmpC
immunogenic peptides
The peptides of the external hairpin loops of OmpC failed to elicit any
immunoreactivity by dot blotting (Section 2.18 of M&M) or ELISA (Section
2.17 ofM&M) on the external loops 1, 2, 4, 5 and 6 of OmpC (Section
2.40 ofM&M) incubated with nasal secretions, mucosal extracts and sera
from five animals of Group 4. These animals were selected for their high
ELISA titres to E.coli 0157:H7 flagellin antigen. A representative sample
of one of the blots is presented in Figure 6-18.
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Antigen blotted by columns in serial dilutions, as follows: column 1 loop 1, column 2 loop
2, column 3 loop 4, column 4 loop 5, column 5 loop, column 6 negative control, column 7
E. coli ZAP 198. Dotted proteins incubated with the mucosal extracts (0.3 mg/ml of
protein)
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6.4 Discussion
Following 1-D SDS-PAGE/Western blot analysis, further attempts to
define the reactive antigens was by 2-D SDS-PAGE/Western blotting.
Mass spectrometry analysis identified OmpC as a bacterial membrane
antigen detected by the IgA mucosal response. The immunodominance of
this protein has been demonstrated for patients with Crohn's Disease
where E. coli OmpC has been proposed as a reliable marker to
characterise infection (Spivak et al., 2006) and in Salmonella enterica, for
which there is a stronger response to OmpC compared with the other
major outer membrane porin, OmpF (Secundino et al., 2006).
The marked difference observed in the number of antigens detected by 1-
D and 2-D Western blotting may be due to differences in sensitivity,
denaturation (Harper et al., 1990) or to the reported absence in the 2-D
gels of some antigens (Madden et al., 2002). Membrane proteins and in
particular integral proteins that span the lipid bilayer such as porins, are
difficult to solubilise in the media used for isoelectric focusing and are
reportedly underrepresented on 2-D gels (Santoni et al., 2000).
Membrane proteins are soluble in lipid bilayers and not in water and are
very sensitive to different processing methods (Bunai and Yamane, 2005).
Changes in solubility or conformation, could explain the detection of
Transaldolase B instead of OmpC, when sample cleaning products were
intentionally avoided. This enzyme has also been identified in the
serological responses of immune calves (Kudva et al., 2006).
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Complete separation of proteins is still far from being achieved in 2-D
polyacrylamide gel electrophoresis and more than one protein can be
present at the same gel spot (Campostrini et al., 2005). Advanced
separation methodologies such as sample pre-fractionation (Gorg et al.,
2004) or subcellular fractionation (Stasyk and Huber, 2004) may
provided a more sensitive means of protein separation of complex
mixtures and facilitate immune detection. In this study, to avoid the
possibility of the identification method (mass spectrometry) being less
sensitive than the detection method (Western blot) and to confirm the
immunogenicity of OmpC, it was decided to generate an ompC knock out
strain AompC. The ensuing 2-D analysis showed that the AompC strain,
while having a similar proteome to the parent strain, was not expressing
the protein nor eliciting any reactive spot around the OmpC isoelectric
and mass area, thus confirming its specific antigenicity.
The finding that the AOmpC strain had increased resistance to nalidixic
acid is not in agreement with the few published works on this area. In
one study, resistance to nalidixic acid was linked exclusively to OmpF
mutants (Hirai et al., 1986), these authors also noted increased
resistance to the nalidixic acid in lipopolysaccharide deficient mutants
and suggested the passage of this highly hydrophobic quinolone through
OmpF and the lipid bilayer. Their hypothesis was that quinolones act as
membrane chelating agents (Chapman and Georgopapadakou, 1988).
However, a more recent study did not find any changes in MIC levels in
OmpF and OmpC single and double mutant strains (Mitsuyama et al.,
1992). This reasearch was carried out with the laboratory strain E. coli
K: 12 that may have differences in antibiotic permeability compared to the
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E. coli 0157:H7 strain, used in the present study and which originated
from a human clinical isolate. Further antibiotic resistance testing with
the OmpC deficient mutant and an OmpC complemented strain could
provide further evidence in support of this preliminary finding.
Unfortunately, there was no evidence of antigenicity to the external loops
as determined by dot blot and ELISA. It is generally accepted that these
structures are constantly changing due to the selective pressure of the
host immune system (Low et al., 2001; Nikaido, 2003) and OmpC
external loops are recognised epitopes in Salmonella typhimurium
infection of mice (Singh et al., 1996). Nevertheless, other studies suggest
that in E. coli these external loops are covered by the surrounding
lipopolysaccharide (Bentley and Klebba, 1988) and that most of the porin
antigens are buried (Singh et al., 1996). Other reasons that could explain
the lack of immunoreactivity to the peptides are conformational
differences between the synthesised products and their real presentation
shape as hairpins between beta sheets (Klebba et al., 1990), or
divergences between the sequences obtained from the public databases
for E. coli 0157:H7 used for peptide synthesis and the experimental
strain. The detection methods used in this work could have sensitivity
limitations that may preclude the detection of immune responses. Also,
due to the absence of tested candidates, it was not possible to use a
synthetic peptide as positive control. Nevertheless the amount of purified
protein used to coat or impregnate the matrix was considerable in
relation with known amounts or protein commonly used for these tests,
and similar assays with synthetic peptides and loads have been carried
out by a wide range of researchers (Ankelo et al., 2007; Tantrawatpan et
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It is important to fully understand bacterial colonisation mechanisms
and host-parasite interactions to be able to develop methods of
preventing bacteria from initiating an infectious process. It was not clear
at the initiation of this work whether the colonization ability of E. coli
0157:H7 depended on underlying mechanisms of bacterial adhesion and
whether host immune responses developed following colonization.
Evidence produced during the investigation presented in this thesis
demonstrates for the first time the following four findings: (i) the rectal
challenge route induced similar qualitative and quantitative patterns of
colonization at the terminal rectum to the oral route; (ii) bacterial
intimate adhesion to bovine rectal epithelium induces histopathological
changes, similar to those described elsewhere in the intestinal tract,
characterised mainly by severe alteration of the enterocyte apical surface;
(iii) rectal colonisation generates a quantifiable granulocytic response,
and finally (iv) colonisation leads to the production of a local immune
response in the terminal rectum predominantly against protein antigens.
The present study also confirms in a higher number of animals previous
seminal work carried out by our group demonstrating that E. coli
Oi57:H7 has a tropism for the terminal rectum.
The present study has two limitations: first the bolus administration of E.
coli 0157:H7 and second the use of an Stx-negative strain. Therefore, the
evidence provided in this study needs to be weighed considering the
validity of results obtained from our experimental model.
In this work the infection model used high single doses and repeated
doses to ensure maximum colonization rates, although during natural
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infection animals are presumably exposed to repeated lower doses of
bacteria from the environment, at different ages and in some cases
following previous episodes of colonization (Murphy et al., 2008; Shere et
al., 1998). Trickle dose (multiple smaller doses over time) would probably
have mimicked natural exposure conditions better, but it has not been
used before in experimental infections and its efficacy is still uncertain.
Indeed, even though high-bolus doses may favour higher colonization
rates, it did not induce higher shedding levels than those recorded for
naturally infected animals (Chase-Topping et al., 2007; Cobbold et al.,
2007), suggesting that, once the colonization is established, infection
follows a very similar course in terms of intensity and duration in both
scenarios. Thus, the shedding patterns and pathological changes
described in chapters three and four for experimentally challenged
animals may not be substantially different from the course of the disease
in naturally infected animals. Furthermore, histopathological
examination of two naturally-infected animals, one of them originally
purchased for this study and a steer described previously (Naylor et al.,
2003a; Naylor et al., 2005b), detected similar epithelial lesions and
granulocytic influx to those observed in the experimental group.
The other methodological characteristic of this work was that the
challenge strain ZAP 198 had been naturally cured of the shigatoxin
gene. Such a distinctive genotypic alteration could have influenced the
colonisation fitness of the bacteria by altering its ability to evade host
immune responses, thus affecting colonisation ability or persistence.
Previous work by our group had established that ZAP 198 was as
effective in colonising calves as its shigatoxin positive parent (Naylor et
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al., 2003a), and recent work by other groups with Stx isogenic deletion
mutants has corroborated that these strains colonised like the wild type
confirming the lack of requirement for Stx in the colonisation of cattle by
E. coli 0157:H7 (Sheng et al., 2006a) and sheep (Woodward et al., 2003;
Cornick et al., 2007). Although in human infection Stx is the main
pathogenic factor and necessary for HUS development, loss of the stx
gene during the early stage of an enterohemorrhagic E. coli 0157:H7 and
026 infection has been consistently reported (Bielaszewska et al., 2007;
Friedrich et al., 2007) strengthening the evidence that Stx is not needed
for E. coli persistence and therefore does not induce effective immune
evasion.
This work has confirmed previous work reporting that the terminal
rectum is the major colonisation site for E. coli 0157:H7 in cattle (Naylor
et al., 2003a). Nevertheless, the main mechanisms driving the terminal
rectal tropism and the selective advantage it provides are still unknown.
It has been shown that several mutations prevent the expression in E.
coli 0157:H7 of conventional E. coli fimbrial clusters that could mediate
bacterial adhesion (Low et al., 2006b; Roe et al., 2001; van Diemen et al.,
2005). Work with isogenic deletion mutants in cattle has corroborated
the importance of AE lesion formation and demonstrated that the only
virulence factors that hamper colonisation of the terminal rectum by E.
coli 0157:H7 were TTSS related or the lack of p0157 (Naylor et al.,
2005b, Sheng et al., 2006a). One hypothesis that could explain the rectal
tropism is cell-to-cell contact, one of the key mechanisms that induces
the expression of the type III secretion system (Roe et al., 2003). To test
the hypothesis that the colonization of the bovine terminal rectum could
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be caused by cell-to-cell contact (bacteria to rectal epithelium) induced
by the contraction of the sphincter muscle, a simple surgical procedure is
proposed. The procedure to test this hypothesis will be a chemical anal
sphincterotomy, using botulinum toxin, in a group of cattle to limit the
muscular pressure over the terminal rectum area. Chemical
sphincterotomy is less invasive and reduces the residual risk of
incontinence when compared with surgical sphincterotomy in humans
(McCallion and Gardiner 2001; Minguez et al. 2003). Animals would have
to be used because the in vitro work supports the claim that mechanical
forces induce bacterial adherence to cell cultures, but the validity of this
hypothesis, i.e. that the anal sphincter contraction is the cause of the
rectal tropism of E. coli 0157, can only be obtained by proving this
physiological mechanism in the living animal. Cattle are a major reservoir
of E. coli 0157 and the main target of intervention strategies aiming to
minimise the risk that this bacteria poses to public health. Clarification
of the mechanism that induces the initial bacterial adhesion to the host
cells will have a significant impact on the design of an effective vaccine. If
bacterial adherence was induced mainly by mechanical pressure the
efficacy of the vaccine could be better achieved by inducing antibodies
against molecules that could impair the fitness of the bacteria instead of
targeting putative adhesins.
Our data indicates that E. coli 0157:H7 colonisation and AE lesion
formation induces innate and immune responses in shedding calves.
Both findings have been recently corroborated by a bovine-specific cDNA
microarray used to characterise gene expression in the bovine terminal
rectum mucosa in response to E. coli 0157:H7 colonization (Li and
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Hovde, 2007). The latter study reported significant expression of the
NAPDH oxidase and PIGR genes, related with the neutrophil respiratory
burst, and the polymeric immunoglobulin A transepithelial transporter,
respectively.
The biological relevance of humoral responses is questioned by several
authors who report that previous exposure does not reduce shedding
(Bretschneider et al., 2007; Hoffman et al., 2006; Johnson et al., 1996;
Khaitsa et al., 2003) with re-infection being reported regularly in field
and experimental studies (Lahti et al., 2003; Mechie et al., 1997; Shere et
al., 2002; Wray et al., 2000), although some authors suggest that prior
infection induces partial protection and reduces posterior shedding
(Naylor et al., 2007; Sanderson et al., 1999). In general, the evidence is
that humoral responses are not an absolute requirement for clearing
infection, and that previous exposure does not prevent further re¬
infections or animals becoming high shedders again. Thus, suggesting
that adaptative responses play a limited role in preventing or controlling
E. coli 0157:H7 infection.
Acute intestinal inflammatory responses in the form of a neutrophilic
infiltrate were present at the terminal rectum. Marked neutrophilia is
also a hallmark of HUS patients and a predictor of outcome, with
patients showing high peripheral neutrophil counts at presentation
having poor prognosis (Buteau et al., 2000; Fernandez et al., 2000,
Roche et al., 2007). It would be interesting to determine if in high
shedding animals the neutrophil chemotaxis and microbicidial activity is
altered, and if there is a correlation between neutrophil fitness and host
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infection susceptibility. This could be achieved by measuring neutrophil
function to establish if their phagocytosis activity and oxidative burst
capacity is reduced or unchanged, and also if the neutrophils are
deactivated and therefore are differentiated towards an inflammatory
phenotype such as CD14-reduced and CD16-enhanced membrane
expression. It would also be interesting to determine the requirements for
complement and antibodies for E. coli 0157:H7 killing by an
opsonophagocytic assay using sera/homogenate from infected cattle to
see if restrictions in any of those components restricts bacterial killing.
Elucidation of the methods by which neutrophils respond to E. coli
Oi57:H7 colonisation will aid in the development ofmethods to enhance
their bactericidial efficiency.
In this work, evidence is presented of mucosal IgA immune responses
induced following infection at the bovine terminal rectum and directed
against multiple antigens, including TTSS-dependent proteins, 0157
lipopolysaccharide, H7 flagellin and OmpC. These isotype-specific
antibody responses against E. coli 0157:H7 secreted, and membrane
antigens were detected approximately three weeks after the final serial
challenge. Published research to date has examined serum responses:
some authors reported a negative correlation between titres and shedding
for 0157 LPS and H7 IgA (Naylor et al., 2007) and 0157 LPS (Johnson et
al., 1996; Wray et al., 2000) while other authors report a positive
relationship for specific IgGs anti 0157 LPS, H7 intimin and a number of
TTSS effectors (Bretschneider et al., 2007; Naylor et al., 2007). Although
not directly comparable, these studies offer different evaluations of the
relevance of the humoral immune responses in protection against E. coli
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0157:H7 infection. Future work would need to establish the duration of
the mucosal IgA titres and their correlation with protection.
This work has also attempted to determine if the external loops (see
M&M, sections 2.15, 2.40) of OmpC were recognised as reactive epitopes
by the immune sera of calves. Failure to prove the immune reactivity of
these sections of E. coli 0157:H7 OmpC may reflect an inadequate
elaboration or selection of the size of antigens, more than their true
potential as highly specific immunoreactive antigens of the porin
molecule. These strain-specific and most exposed sections of E. coli
0157:H7 OmpC could provide a viable alternative to the customary, but
prone to cross reactions 0157 LPS antigen (Chart and Jenkins, 1999;
Laegreid et al., 1998; Navarro et al., 2007; Nielsen et al., 2004b) in the
development of detection tests. Time constraints prevented the use of
alternative techniques of characterisation of immune responses, such as
anti OmpC antibody isolation to increase ELISA detection of the peptides
or laser scanning confocal microscopy examination.
Finally, it would be interesting to extend a similar work to other small
ruminants and in particular the ovine species. Sheep are a known
reservoir of E. coli 0157:H7 and are capable of shedding in amounts
exceeding the threshold for histopathological detection of 105 CFU g-1
(Cornick et al., 2000; Ogden et al., 2005; Wales et al., 2001a). Their
relevance for public health was highlighted by a study in the Grampians
that reported sheep as the main source of environmental contamination
followed by cattle (Strachan et al., 2005). Further evidence comes from
human outbreaks in Scotland associated with sheep faecal
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contamination of pasture (Ogden et al., 2002) and water supplies
(Licence et al., 2001). Also in Scotland, 0157 has been detected in sheep
meat and milk (Coia et al., 2001). Sheep meat and cheese is very popular
in the Mediterranean countries, South America, and extended areas of
Asia and Australia and have reported E. coli 0157:H7 in their flocks
(Blanco et al., 2003; Phillips et al., 2001; Vettorato et al., 2003; Wani et
al., 2003) and therefore any advance in the knowledge of E. coli 0157:H7
infection in small ruminants could have an international impact. Various
studies have reported data on numbers of E. coli 0157:H7 recovered from
the alimentary tract orally-challenged animals, including the large bowel
and the intrapelvic rectum (Cookson et al., 2002; Cornick et al., 2000 ;
Grauke et al., 2002 ; La Ragione et al., 2006; Wales et al., 2001b ; Wales
et al., 2001a; Woodward et al., 2003), thus the terminal rectum is
recognised in sheep and cattle to be part of the adhesion pattern in the
large bowel.
Final considerations
The investigations presented in this thesis have advanced the
understanding of E. coli 0157:H7 bovine infection via exploration of the
pathological processes and associated host immune responses. Many
new questions and potential areas for further work have opened up
during this research, indicating that this important and scientifically
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Escherichia coli 0157:H7 forms attaching and
effacing lesions at the terminal rectum of cattle and
colonization requires the LEE4 operon
Stuart W. Naylor,1 Andrew J. Roe,2 Pablo Nart,1,2 Kevin Spears,2
David. G. E. Smith,3 J. Christopher Low1 and David L. Gaily2
'Animal Health Group, Scottish Agricultural College, West Mains Road, Edinburgh EH9 3JG,
UK
2Zoonotic and Animal Pathogens Research Laboratory, Division of Veterinary Biomedical
Sciences, Teviot Place, Edinburgh University, Edinburgh EH8 9AG, UK
functional Genomics Unit, Moredun Research Institute, Pentland Science Park, Mid Lothian
EH26 0PZ, UK
Enterohaemorrhagic Escherichia coli 0157 : H7 is a human pathogen that causes no apparent
disease in cattle, its primary reservoir host. Recent research has demonstrated that E. coli
0157 : H7 predominately colonizes the distal few centimetres of the bovine rectum, and in this
study, the LEE4 operon encoding a type III secretion system translocon and associated proteins
was shown to be essential for colonization. A deletion mutant of LEE4 failed to colonize cattle,
in contract to a co-inoculatod otrain containing a chromooomal complomont of tho operon, thoroforo
fulfilling 'molecular' Koch's postulates for this virulence determinant. In addition, attaching and
effacing (A/E) lesions were detectable in £. coli 0157 : H7 microcolonies from the terminal rectum
of both naturally and experimentally colonized cattle when examined by transmission electron
microscopy. This study proves that type III secretion is required for colonization of cattle by E. coli
0157 : H7, and that A/E lesion formation occurs at the bovine terminal rectum within £. coli
0157 :H7 microcolonies. The research confirms the value of using type III secreted proteins as
vaccine candidates in cattle.
INTRODUCTION
Enterohaemorrhagic Escherichia coli (EHEC) has emerged
in developed countries over the past 20 years as an impor¬
tant cause ofhuman intestinal disease. In addition to bloody
diarrhoea, intestinal infection can lead to potentially fatal
systemic sequelae resulting from the activity of Shiga toxins.
Themajority of these infections in the USA, Canada, UK and
Japan are caused by E. coli 0157:H7 (Nataro & Kaper,
1998). This serotype has been frequently isolated from cattle
faeces, and most human E. coli 0157:H7 infections ori¬
ginate, either directly or indirectly, from this source (Besser
et al, 1999; Borczyk et al, 1987). It is widely acknowledged
that controlling E. coli 0157:H7 within the bovine popu¬
lation would be an effective method of reducing transmis¬
sion to humans (Stevens et al., 2002).
Abbreviations: A/E, attaching and effacinq; EHEC, enterohaemorrhagic
Escherichia coir, EPEC, enteropathogenic Escherichia coli; Esp, EPEC
secreted protein; FAE, follicle associated epithelium; LEE, locus of
enterocyte effacement; MPN, most probable number; TEM, transmis¬
sion electron microscopy; Tir, translocated intimin receptor; TTSS, type
III secretion system.
In common with other EHEC and EPEC (enteropathogenic
E. coli), E. coli 0157:H7 contains a pathogenicity island,
known as the locus of enterocyte effacement (LEE), that
confers the attaching and effacing (A/E) phenotype (Frankel
et al., 1998; McDaniel & Kaper, 1997). The LEE encodes a
type III secretion system (TTSS) (Hueck, 1998), various
translocators and effectors, the outer-membrane protein
intimin (Jerse et al., 1990) and its receptor, termed Tir
(translocated intimin receptor) (Kenny et al., 1997). The
LEE is arranged into several polycistronic operons termed
LEE1 to LEE5 (Elliott etal, 1998). The LEE4 operon encodes
several proteins essential for the A/E phenotype. These
include SepL (Kresse et al., 2000) and EscF (Wilson et al.,
2001), both essential components ofthe LEE TTSS, and Esps
(EPEC secreted proteins) A, B, D and F (Knutton etal., 1998;
Taylor et al., 1998; Wachter et al., 1999; McNamara 8c
Donnenberg, 1998). EspA forms filamentous extensions to
the TTSS with a hollow central channel through which Tir
and several other effector proteins arc translocated into the
host cell via a pore created by EspD and EspB. Amongst the
translocated effector molecules are the L££4-encoded EspF,
the L££5-encoded Tir, as well as EspG, EspH and Map
(Elliott et al., 2001; Tu et al., 2003; Kenny 8c Jepson, 2000),
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and the non-LEE-encoded Cif, EspI/NleA and TccP
(Marches et al., 2003; Mundy et al., 2004; Gruenheid et al.,
2004; Garmendia et al., 2004). Other than EspF, these are all
likely to be expressed in a LEE4 knock-out strain, but not
secreted or translocated into host cells. Deletion of LEE4
will preclude the formation of A/E lesions, as translocation
of Tir into the host cells is prevented. Importantly, intimin
expression on the bacterial surface will not be inhibited, thus
preserving any alternative functions of this molecule that
exist in addition to its interaction with Tir. The alternative
functions may include involvement in direct adherence to
the intestinal epithelium (Sinclair & O'Brien, 2002).
Recently, it has been demonstrated that the terminal rectum
is the primary colonization site for EHEC 0157: H7 in cattle
(Naylor et al., 2003; Rice et al., 2003). This has been con¬
firmed in slaughter cattle (Low et al., 2005), and successful
colonization can be induced by a rectal swab inoculated with
EHEC 0157: H7 (Sheng et al., 2004), although the factors
driving the rectal tropism remain unknown. A number of
experimental studies on neonatal animals or weaned-fasted
animals have demonstrated the formation of A/E lesions
in the gastrointestinal tract of animals (Dean-Nystrom
et al., 1997, 1999, 2000; Wales et al., 2001), but such lesions
have not been shown at the principal colonization site of
the terminal rectum in experimentally or naturally colo¬
nized cattle. The importance of intimin has been shown for
the colonization of cattle by several groups (Cookson &
Woodward, 2003; Cornick etal., 2002; Dean-Nystrom et al.,
1998), and an extensive series of signature-tagged mutagen¬
esis studies on both EHEC 0157: H7 and EHEC 026: H~
(Dziva et al., 2004; van Diemen et al., 2005) have identified
over 100 genes required for colonization of the bovine
intestine, including LEE genes, regulatory genes and surface
structures. In these studies, a different model from the cur¬
rent study was used, in which very young calves (1-2 weeks
of age) were colonized without the same apparent terminal
rectal tropism. In addition, it is not known whether non-
0157 EHEC have a tropism for this site. Two of the E. coli
0157 mutants in LEE genes, escN and map, were tested in
calves alongside the parent strain, and escN, but not map,
was shown to compromise colonization ability. Neither of
these mutations was complemented, and recent research has
highlighted potentially profound changes in the genome
that can occur as a result of the genetic manipulation. There¬
fore, despite the fact that EHEC type III secreted proteins
are being tested as a vaccine to prevent colonization of
cattle by EHEC 0157: H7 (Potter etal., 2004), there has not
been a definitive study testing a chromosomally comple¬
mented deletion of the TTSS or demonstrating A/E lesion
formation in normal cattle. The aim of this research was:
(1) to characterize the colonization potential in calves and
on in vitro organ culture of a L££4-deleted E. coli 0157: H7
strain compared against the same strain with the LEE4
operon replaced within the LEE; (2) to determine if A/E
lesions are formed by E. coli 0157: H7 at the predominant
colonization site of both experimentally and naturally
colonized cattle.
METHODS
Strains, primers and plasmids. A summary of the strains, pri¬
mers and plasmids used is provided in Table 1.
Generation of allelic exchange vectors. Primer pairs KO LHS
573' and KO RHS 5'/3' were used to amplify flanking regions of
Table 1. Strains, oligonucleotide primers and plasmids used in this study
Strain Description
ZAP 198 Nalidixic acid resistant, Shiga toxin-negative E. coli 0157:H7
(Naylor et aL, 2003)
ZAP984 ZAP198: LEE4 replaced with kanamycin resistance gene
ZAP985 ZAP984: kanamycin resistance cassette replaced with cloned LEE4
Primers Sequence Construct
KO LHS 5' cgagctcccatcctgcaactcctgg pHY3
KO LHS 3' cgggatcccattagccattggaaactcac pHY3
KO RHS 5' ggatcccttgaaggctaccagggagatattc pHY3
KO RHS 3' gactctagaccctcgctgtacgcttaccaa pHY3
Repair 5' cgcggatcccatcctgcaactcctggcgtattc pAJR162
Repair 3' cgcggatccccctcgctgtacgcttaccaac pAJR162
Plasmids Description
pIB307 pMAK705-based vector for allelic exchange; temperature-sensitive
replicon (Blomfield et al., 1991)
pUC4K Source of kanamycin resistance cassette (Pharmacia)
pHY3 pIB307 with 5' and 3' LEE4 flanking regions inserted
pHYlO pHYlO with kanamycin resistance cassette inserted between
flanking regions
pAJR162 pIB307 with cloned LEE4 inserted
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the LEE4 operon of E. coli 0157:H7 (stx—) ZAP198 (Naylor et al,
2003) under standard conditions. These were cloned into the
temperature-sensitive vector pIB307 (Blomfield et al., 1991), creating
pHY3. A sacB-kan cassette was cloned between the flanking regions
at the BamHl restriction site (Roe et al., 2003) to create plasmid
pHYlO. To allow subsequent 'repair' of any deletion, the LEE4
operon was amplified using primer pair Repair 5'/3' by long-range
PCR (Roche) and cloned into pIB307 to create construct pAJR162.
Creation of the LEE4 deletion and complemented strains.
The allelic exchange method of Hamilton et al. (1989) was used to
delete and then repair the entire LEE4 operon from E. coli 0157: H7
(ZAP198), generating strains ZAP984 and ZAP985, respectively. To
create ZAP984 (ALEE4), plasmid pHYlO was electroporated into
ZAP198 and transformants selected on Luria-Bertani (LB, Melford
Laboratories, UK)/chloramphenicol (C) (30 pg ml-1) agar plates
incubated at 30 °C. Transformants were passaged repeatedly in
LB/kanamycin (K) (12-5 pg ml-1) broth at 42 °C to obtain co-
integrates. Further passage at 30 °C in LB/K followed by replica plat¬
ing on LB/K and LB/C plates allowed identification of clones in
which a secondary recombination event resulted in the LEE4 operon
being replaced by the sacB-kan cassette. To generate the comple¬
mented strain ZAP985, plasmid pAJR162 was electroporated into
ZAP984 and the above procedure repeated with the following differ¬
ences: primary integrates at 42 °C were selected by C instead of K,
the second set of cultures at 30 °C was performed without anti¬
microbial selection, and the correct clones were identified by sensi¬
tivity to both K and C on replica plates.
Validation of genetically engineered strains. Both the LEE4
deletion mutant and its complemented derivative were compared
against the parent strain for their ability to grow in two liquid
media. Overnight stationary phase cultures in LB broth were inocu¬
lated at a dilution of 1 in 100 into both LB broth and minimal
essential medium (MEM)/HEPES (Sigma-Aldrich). Growth curves
at 37 °C (aerated) for all strains were shown to be similar by measure¬
ment of ODfton (1 cm cuvette path length in a Cecil 2021 spectro¬
photometer). Expression of LEE-encoded proteins was assessed by
the labelling of bacteria by indirect immunofluorescence. Samples of
mid-exponential-phase MEM/HEPES cultures were fixed in para¬
formaldehyde (4%, w/v) and processed for immunofluorescence
microscopy using specific EspA and intimin antibodies (Roe et al.,
2004). Larger volumes (50 ml) of cultures grown under the same
conditions were used to obtain secreted protein preparations for
SDS-PAGE followed by colloidal blue staining and Western blotting
with anti-EspD antibody (Roe et al., 2003).
In vitro adherence of ZAP198 wild-type, the LEE4 deletion
and complemented strains to bovine intestinal epithelium.
ZAP198, 984 and 985 were prepared for inoculation of mucosal
explants. Fresh colonies on LB agar plates were used to inoculate
5 ml MEM/HEPES that was incubated with shaking overnight
(37 °C). Fresh pre-warmed MEM/HEPES (4 ml) was inoculated with
1 ml of overnight culture and incubated for 3 h (37 °C). All strains
were standardized to OD60o 0-5 immediately prior to application
to tissue explants. Tissue was obtained from two conventionally
reared, weaned Holstein/Friesian male calves aged 10 and 12 weeks.
Following euthanasia with intravenous pentobarbitone, full-thick¬
ness pieces of normal terminal ileum and ileal Peyer's patch were
excised and placed into ice-cold MEM/HEPES with minimal delay.
After transport to the laboratory, 4x4 mm pieces of intestinal
mucosa were cut from the underlying muscle layers and placed on
individual sterile foam pads. Pre-warmed culture medium [90%
RPMI (Gibco-BRL) and 10%, v/v, fetal calf serum (Sigma-Aldrich)]
was added until the fluid surface was in contact with the tissue edge.
A 50 pi portion of standardized bacterial culture for each strain
in the mid-exponential growth phase was added to the explant
surface of different blocks (« = 4 for each strain), and the samples
were initially flushed with 100% 02, sealed, and then incubated in
5%, v/v, C02 for 5 h. Culture medium was changed every 2 h. At
the end of the culture period, the samples were washed briefly in
fresh culture medium and fixed in 4%, w/v, paraformaldehyde in
PBS (Oxoid). Fixed tissue was embedded in paraffin blocks and rou¬
tine histological sections prepared. Bacteria on the sections were
labelled by indirect immunofluorescence using rabbit anti-0157 anti-
sera (1 in 100) (Mast Diagnostics) and FITC-conjugated goat anti-
rabbit secondary antibody (1 in 1000) (Sigma-Aldrich). Tissue was
counterstained with propidium iodide (1 pg ml-1) (Sigma-Aldrich)
and viewed on a Leica DMLB fluorescence microscope using a 40 x
objective. The proportion of fields containing bacteria adhering to
intact epithelium was determined blind by assessing 10 sections from
each explant. One explant per strain per tissue type per calf was
assessed in this way.
Animals and experimental challenge. Experimental calf chal¬
lenges were performed at the Moredun Research Institute (MRI) in
containment level 3 large-animal housing facilities under Home
Office licence number 60/3179. Ethical approval was obtained from
the MRI Animal Experiments Committee. Calves were reared con¬
ventionally on the farm of origin until at least 2 weeks post-weaning
and transported to MRI, where they were acclimatised for 1 week
prior to challenge. Faecal samples from each calf prior to challenge
were confirmed negative for E. coli 0157:H7 by immunomagnetic
separation (IMS), performed as per manufacturer's instructions
(Dynal). At the time of challenge, the mean age of the calves was
19 weeks (range 13-25 weeks). The challenge bacterial strains were
grown separately in LB broth (18 h at 37 °C, with aeration) and
diluted in sterile PBS to achieve an inoculum of 109 c.f.u. of each
strain per animal in a total volume of 20 ml. The inoculum was
administered to the calves via a stomach tube and washed down
with 500 ml sterile PBS (Naylor et al., 2003).
Tissue for microscopy was obtained from separate studies. Two tissue
blocks were from calves (aged 3 and 5 months) challenged with the
wild-type E. coli 0157:H7 strain (ZAP198) administered orally as
described above. Post-mortems were performed at 14 and 21 days,
respectively, post challenge. The third tissue block was obtained from
a naturally colonized 12 month old steer, as described previously
(Naylor et al., 2003). Briefly, a known positive herd was identified by
field epidemiology conducted by the Scottish Agricultural College.
Faecal samples were screened on CT-SMAC plates, and an individual
shedding > 104 c.f.u. g-1 non-sorbitol-fermenting E. coli 0157 was
selected for post-mortem the following day.
Bacterial enumeration in faeces. Faeces were sampled and sepa¬
rated into surface and core components, as described by Naylor et al.
(2003). Ten-gram quantities of faeces were suspended in 90 ml ster¬
ile PBS and serially diluted in 10-fold steps in PBS. These serial dilu¬
tions were cultured as 100 pi aliquots spread in triplicate onto both
sorbitol MacConkey agar plates containing 15 pg ml-1 nalidixic
acid (N-SMAC) (Oxoid) and SMAC plates containing 15 pg nali¬
dixic acid ml-1 and 12-5 pg kanamycin ml-1 (NK-SMAC). All
inoculated media were incubated overnight at 37 °C. Non-sorbitol-
fermenting colonies were counted, and a colony from each sample
tested for 0157 LPS using a latex agglutination test kit (Oxoid). The
most probable number (MPN) of recovered bacteria was determined
as described previously (Naylor et al., 2003). The LEE4 deletion
mutant was enumerated by the MPN obtained from NK-SMAC
plates, whereas the complemented strain was enumerated by sub¬
tracting the NK-SMAC MPN from the N-SMAC MPN. Enrichment
cultures of samples negative by direct culture were established from
1 ml of the neat faecal suspension added to 9 ml of LB containing
15 pg nalidixic acid ml-1. Following 37 °C incubation for 24 h,
100 pi of enrichment culture was spread onto N-SMAC and NK-
SMAC plates and incubated overnight at 37 °C.
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Electron microscopy. Blocks chosen for processing had
> 104 c.f.u. cm-2, correlating with similar levels per gram in faeces.
No E. coli 0157:H7 microcolonies were detected on tissues from
which the levels of E. coli 0157 were below 1 x 104 cm-2. Blocks
were formalin fixed and paraffin-embedded (Wales et al., 2001).
Sections (5 pm) were prepared for immunofluorescence analysis
using anti-0157 antisera (Mast Diagnostics). From this, the posi¬
tions of E. coli 0157 microcolonies within the tissue blocks were
determined. In total, three such regions from two animals were then
deparaffinized with xylene, rehydrated in graded dilutions of etha-
nol, and post-fixed in osmium tetroxide. After dehydration in
graded dilutions of acetone, the samples were infiltrated and embed¬
ded :n Araldite. Seven ultrathin sections (80 nm) were cut from
each of the three regions identified above and mounted on copper
grids (Agar Scientific). Random regions negative for E. coli 0157
microcolonies were similarly processed, and no A/E lesions were
detectable by transmission electron microscopy (TEM). Specimens
were viewed and photographed on a Philips CM 12 transmission
electron microscope. Tissue blocks from experimentally challenged
calves and a naturally colonized steer described previously (Naylor
et al, 2003) were processed by this method.
RESULTS
Examination of LEE4 phenotype in wild-type,
deletion and complemented strains
The presence or absence of LEE4-encoded proteins in the
wild-type and derived strains (ZAP984 and ZAP985) was
confirmed by two methods. The first involved direct
labelling of EspA filaments on whole bacterial cells using
immunofluorescence. Both the parent and the comple¬
mented strains produced EspA filaments under culture
conditions (MEM/HEPES) known to stimulate expression
of LEE-encoded factors (Roe et al., 2003). No filaments were
observed in the L££4-deleted strain ZAP984 (Fig. 1A-C). In
comparison, intimin was detected on the surface of all three
strains by indirect immunofluorescence, indicating that the
genetic manipulation of LEE4 did not prevent the pro¬
duction of the adjacent LEE5 proteins (data not shown).
Secreted proteins from these strains cultured in MEM/
HEPES were harvested and examined by SDS-PAGE.
Colloidal blue staining of secreted proteins demonstrated
a marked reduction in levels produced by the deletion
mutant (Fig. ID). Western blotting for EspD confirmed the
absence of this £££4-encoded protein from the deletion
mutant and its presence in the supernatant fluids from the
wild-type and complemented strains (Fig. IE). Several other
proteins were absent from the secretion profile of the
deletion strain but present in the parent and complemented
strain preparations.
Bacterial adherence to bovine tissue explants
The wild type and both derived strains were placed on tissue
explants of ileal Peycr's patch, containing a high proportion
of follicle associated epithelium (FAE), and non-Peyer's
patch terminal ileum containing no FAE. The level of
adherent bacteria on intact epithelium was determined
(Fig. 2). For both tissue types, the level of adherence was
significantly decreased for the L££4-deletion and restored to
wild-type levels for the complemented strain.
I 2 .3 4
(E)
Fig. 1. Phenotypic confirmation of LEE4
deletion and complementation. Immuno¬
fluorescence staining of EspA filaments: (A)
wild-type E. coli 0157:H7 ZAP198; (B)
ALEE4 (ZAP984); (C) ALEE4 complemen¬
ted with LEE4 (ZAP985). (D) Colloidal blue
staining of supernatant proteins: lane 1,
molecular mass marker; lane 2, E. coli
0157 :H7 ZAP198; lane 3, ALEE4
(ZAP984); lane 4, ALEE4 with LEE4 reintro¬
duced (ZAP985). (E) Western blotting for
EspD in bacterial supernatants; lanes as
above.
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TI WT TIL4 KO TIL4 PP WT PP L4 KO PP L4
COMP COMP
Tissue type and E. coli 0157 strain
Fig. 2. Adherence of wild-type (ZAP198),
ALEE4 (ZAP984) and Z.£E4-complemented
(ZAP985) E. coli 0157:H7 strains to
bovine explant tissues. COMP, complemen¬
ted; KO, knockout; L4, LEE4\ PP, Peyer's
patch; TI, non-Peyer's patch terminal ileum;
WT, wild-type. Assays were carried out as
described in Methods. The percentage of
fields containing adherent bacteria on intact
epithelium is shown by the black bar area.
Numbers above the bars show the ratio of
positive fields to the total counted. Error
bars show the standard error of the
between-section mean for each strain
(n = 10).
Experimental colonization of weaned calves
The LEE4 deletion and complemented strains were simul¬

























0 2 4 6 8 10















y A ■ ▲
0 2 4 6 8 10 12 14






A Day 1 & 2
▲ Days 3 to 5
• Days 6 to 14
A '
A 3 4 5 (
Faecal level [log10(c.f.u. g1)]
samples obtained daily until day 14 post challenge.
Bacterial counts for both the faecal-surface and core samples
were calculated for the two strains. The level ofshedding and
therefore colonization within an animal using the surface
counts (Fig. 3A, B), and the surface:core ratio provide
information on terminal rectal-restricted colonization
(Fig. 3C). Shedding by the L££4-deleted strain was impaired
severely relative to the complemented strain. This strain
was not detected from any of the calves beyond day 2 post
challenge, indicating a total failure to establish mucosal
colonization. In contrast, the complemented strain was
consistently shedding beyond day 7 post challenge in four of
the six calves. This difference in colonization ability was
significant, as determined by Fisher's exact test (one-sided)
with a P value of 0-03. In separate calf experiments, the
parent strain has been shown to establish persistent infec¬
tions (S. W. Naylor and others, unpublished results), and
shedding of the LEE4 mutant was clearly reduced when
compared to this strain: for example, the same oral challenge
dose of the wild-type strain results in faecal shedding
(> 103 c.f.u. ml-1) beyond 5 days in 17/22 animals (77 %),
compared to 0/6 for the LEE4 deletion in this study.
Flowever, as the experiments were not carried out under
identical conditions, the extent of attenuation caused by
deletion of LEE4 cannot be stated conclusively. It is clear
however that trans-complementation of the LEE4 mutant
Fig. 3. Experimental colonization of weaned calves. The MPN
(c.f.u. g~1) of each strain within surface faecal samples from six
calves orally inoculated with (A) the ALEE4 E. coli 0157:H7
(ZAP984) strain and (B) its LEE4 chromosomal complement
(ZAP985). Individual calves were designated A to F: O, A; •,
B; □, C; ■, D; A, E; A, F. A y axis value of 0 represents
samples negative by broth enrichment and giving no c.f.u. by
direct plating. (C) ZAP985 data with the surface:core ratio
plotted against the surface count. This only includes samples in
which at least one of the separated components contained
102 c.f.u. g-1 or greater. Samples with negative core compo¬
nents are assigned a default ratio of 103. Three different post-
challenge time ranges are indicated.
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enhances colonization markedly, confirming a key role for
LEE4 in intestinal colonization.
The temporal pattern of terminal rectal-restricted coloniza¬
tion exhibited by the complemented strain was qualitatively
similarly to that observed for the parent strain in our calf
colonization model (unpublished data). As indicated in
Fig. 3C, the surface: core ratio was low at early time points,
but in almost all samples beyond day 6 post challenge,
the ratio was greater than 10, indicating that the majority
of E. coli 0157:H7 within these samples originated from
the terminal rectal mucosa (Naylor et al., 2003).
Electron microscopy '
Previous research has demonstrated the terminal rectum as
the principal site of colonization for E. coli 0157:H7 in
cattle (Naylor et al, 2003). LEE-mediated A/E lesions have
not been demonstrated at this important site in naturally or
experimentally colonized cattle. Therefore, TEM was carried
out on terminal rectal mucosa obtained from two animals
experimentally colonized with the wild-type strain and one
naturally colonized steer. Initially, immunofluorescence was
used to locate regions containing E. coli 0157 microcolonies
that were reprocessed for electron microscopy. A/E lesions
were detected in all positive regions examined («= 21) from
the three animals (Fig. 4). No attached bacteria were detec¬
ted in regions negative by immunofluorescence (data not
shown). E. coli 0157 :H7 microcolonies at the terminal
rectum comprise bacteria intimately attached to the epi¬
thelial surface (Fig. 4). Cells with attached bacteria display
the typical features of an effaced brush border and clear
pedestal formation below, the attached bacteria.
DISCUSSION
In this study, the role of the E. coli 0157 : H7 LEE4 operon in
the colonization of cattle is examined by the use of allelic
exchange for both deletion and complementation. The data
clearly confirm the role of LEE4 in mediating the colo¬
nization of calves in a model that reproduces the restricted
colonization of the terminal rectum described previously
in both experimentally challenged and naturally colo¬
nized cattle (Naylor et al., 2003). A strain lacking LEE4,
which encodes factors essential for the translocation of
Tir and other effector proteins, failed to colonize conven¬
tionally reared, weaned calves. When the LEE4 operon was
exchanged back into the deletion strain, this restored the
capacity of the strain to secrete effector proteins, produce
EspA filaments, adhere to bovine epithelium in vitro and
colonize cattle at the terminal rectum. As the distribution
of a LEE among A/E pathogens has been clearly demon¬
strated (McDaniel et al., 1995), the present study completes
'molecular' Koch's postulates (Falkow, 2004) for this deter¬
minant in the E. coli 0157:H7 colonization of the main
natural host, cattle.
A common deficiency in many previous animal studies is
the lack of any form of molecular complementation. To
(A)
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Fig. 4. Transmission electron micrographs of regions containing
£ coli 0157-positive microcolonies. (A) R1 indicates a normal
region of mucosa with microvilli. R2 indicates a region with
attached bacteria and effaced microvilli on the terminal rectal
mucosa of an experimentally colonized calf (x1000). (B) A
higher magnification than (A), showing intimately attached bac¬
teria within an £ coli 0157 microcolony present on the ter¬
minal rectal mucosa of an experimentally colonized calf
(x 5000). (C) A pedestal formed (R4) beneath an attached
bacterium within an £ coli 0157 microcolony on the terminal
rectal mucosa of a naturally colonized steer (x 10 000).
assess the functional requirement of a micro-organism
for genes or groups of genes, the region of interest can be
deleted. This manipulation can introduce unknown but
significant mutations. To ensure that this has not occurred,
it has become established practice to complement the
mutation with the region of interest. This is most commonly
achieved by transformation with a plasmid including the
cloned region. However, this approach has a number of
limitations, including plasmid stability and copy number.
Therefore, single-copy chromosomal complementation is
more desirable, as it can replace the region of interest into
its original site. In this study, the whole of LEE4 was deleted
and the complement engineered to precisely replace the
operon. To our knowledge, this is the first time that this
approach has been used for the assessment of a bacterial
colonization determinant in vitro and in vivo. Moreover,
comparison of mutant and complement shedding profiles
within the same animals removed between-animal variation
in the experiment, and therefore limited the number of
study animals required. One possible limitation with the
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approach taken in this study is that in order to complement
back the wild-type LEE4 region into the strain contain¬
ing the deletion and compare direct lineage strains in the
experimental colonization study, the deletion strain con¬
tained a sacB-karf cassette. This also marked the strain for
comparison with the complement. While there is no evi¬
dence in the literature that high sucrose levels would be
present in the bovine gastrointestinal tract, it is possible that
the sacB gene could have a negative impact on the strain.
Against this, viable bacteria containing the cassette were still
detected in the faeces at early time points following oral
inoculation, yet no colonization at the terminal rectum
occurred (Fig. 3A).
TEM of E. coli 0157 microcolonies confirmed the presence
of A/E lesions for the first time in a naturally colonized
animal, and for the first time at the terminal rectum of
experimentally colonized animals. A high level of coloniza¬
tion is required to locate microcolonies by this method. The
affinity of E. coli 0157: H7 for the terminal rectal mucosa
results in sufficiently high levels to locate A/E lesions. In
addition, lesions were detected within individuals exhibiting
sustained colonization, rather than the transient widespread
distribution likely to occur soon after a high-dose oral
challenge (e.g. Dean-Nystrom et al., 1999). A/E lesions were
detected in all regions containing E. coli 0157 microcolonies
and not in regions where E. coli 0157 was absent. Taken
together with the LEE4 data, these images confirm the
importance of type III secretion and A/E lesion formation in
the colonization of cattle by E. coli 0157: H7. Our findings
support the investigation of type III secreted proteins as
vaccine candidates to limit colonization of cattle (Potter
et al., 2004).
Extensive work by a number of groups has shown the
importance of intimin in the colonization of animals by
EHEC (Cornick et al., 2002; Dean-Nystrom et al., 1998,
2002; Judge et al., 2004; McKee et al., 1995), but it is unclear
from previous work whether its role is limited to Tir
interaction or to binding to host cellular receptors, such as
nucleolin (Sinclair 8c O'Brien, 2002). The present study has
demonstrated that in the absence of type III secretion, but
with intimin expressed, the bacteria are unable to colonize
cattle, confirming the pivotal role of the intimin-Tir inter¬
action. By comparison with other studies, the absence of a
type III secretion system appears to have a more profound
effect on colonization .than either intimin (Cornick et al.,
2002) or Tir (Stevens et al., 2004) deletions alone. This
implies a role for other type III translocated effector pro¬
teins in ruminant colonization. While Map has been shown
not to be essential for colonization in cattle (Dziva et al.,
2004), a number of other secreted proteins have been iden¬
tified in attaching and effacing pathogens (Kenny et al.,
1997; Knutton et al., 1998; Taylor et al., 1998; Wachter et al.,
1999; McNamara 8c Donnenberg, 1998; Elliott et al., 2001;
Tu et al., 2003; Kenny 8c Jepson, 2000; Marches et al., 2003;
Mundy et al., 2004; Gruenheid et al., 2004; Garmendia et al.,
2004) and some of these may be translocated by E. coli
0157:H7 into host cells. Most evidence from cell culture
and mouse model systems points to translocated effector
proteins modifying host cell functions to favour bacterial
persistence in the host: for example, EspF inhibiting apop-
tosis and disrupting tight junctions (Crane et al., 2001;
McNamara 8c Donnenberg, 1998). These effects may be
essential to ensure that any adherent E. coli 0157:H7 are
able to survive within a hostile niche, regardless of the
mechanism of adherence.
All three strains were compared for attachment to ileal
explant cultures, and these studies confirmed the impor¬
tance of LEE4 for attachment over a 5 h incubation period.
While the LEE4 deletion would need to be tested by direct
application to the terminal rectum of cattle to confirm an
essential role for type III secretion in the colonization of this
site by E. coli 0157: H7, the combined colonization, explant
and microscopy data presented here do confirm a key role
for type III secretion at the bovine terminal rectum. Our
ongoing research suggests an increased affinity of E. coli
0157: H7 for other FAE-rich sites along the gastrointestinal
tract, and we cannot rule out that initial localization at these
or other sites increases the likelihood of terminal rectal
colonization. An analogous situation has been demon¬
strated recently for Citrobacter rodentium in mice (Wiles
ef al., 2004). Ileal FAE was used for the explant studies rather
than terminal rectal FAE, as the latter cannot be reliably
obtained (Mahajan et al., 2005). FAE contains M or M-like
cells that sample antigens from the gastrointestinal lumen
(Owen, 1999; Nicoletti, 2000). All bacteria in the gut may
be sampled by these cells, but certain bacteria, such as
Salmonella, Shigella, EPEC and EHEC may use them to
invade or establish colonization (Siebers 8c Finlay, 1996).
The type III secretion system is likely to be a key factor in
the interaction of these bacteria with this cell type: for
example, inhibiting function to allow colonization or
usurping function to allow invasion.
The electron micrographs show classical brush border
effacement and degeneration of the cells to which the
bacteria are attached, and the host response to and role in
this pathology are currently being investigated. Ongoing
research into the epidemiology of E. coli 0157:H7 and
shedding dynamics supports the concept of'supershedders',
a small proportion of E. coli 0157: H7-positive animals that
contribute the majority of environmental load (Low et al.,
2005). These animals are shedding in excess of 104 c.f.u.
(g faeces)-1 and exhibit the terminal rectal colonization
previously observed. Specific treatment of this animal sub¬
set or vaccination approaches to prevent supershedding,
for example using preparations including EHEC type III
secreted proteins, are likely to prevent cattle-to-cattle trans¬
mission and protect human health.
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Abstract
The aim of this work was to characterize adaptive mucosal immune responses to
Escherichia coli 0157:H7 at the principal site of colonization in the bovine species.
Following experimental infection, extracts from terminal rectum mucosal samples
were tested for IgA antibodies by immunoblotting against different bacterial
antigens including: whole-cell E. coli 0157:H7 with and without proteinase
treatment, outer membrane and cytoplasmic preparations, secreted protein super-
natants and purified E. coli 0157 lipopolysaccharide and H7 flagellin. Lipopoly¬
saccharide and H7 flagellin preparations were also used to coat enzyme-linked
immunosorbent assay plates to determine mucosal IgGl and IgA antibody titers.
In this work, evidence is presented of strong local IgA immune responses induced
following infection at the bovine terminal rectal mucosa directed against multiple
antigens including type III secretion-dependent proteins, 0157 lipopolysacchar¬
ide, H7 flagellin and OmpC.
Introduction
Escherichia coli 0157:H7 is the most frequently isolated
serotype of verocytotoxigenic E. coli (VTEC) worldwide (Ca-
prioli et al., 2005). It is associated with serious human disease
and infection can result in neurological or renal damage and
death (Razzaq, 2006). Human infection is known to induce a
vigorous systemic immune response (Li et al., 2000; Currie
et al., 2001). Cattle are considered a primary reservoir of these
bacteria, and infection may be transmitted to humans through
contaminated food, water or by direct animal contact (Beutin,
2006). While E. coli 0157:H7 is generally considered asympto¬
matic in the bovine host due to a different distribution of
Shiga-like toxin Gb3 receptors in cattle as opposed to humans
(Pruimboom-Brees et al., 2000), recent research has identified
histopathological damage and lesion formation in the bovine
terminal rectal mucosa (Naylor et al., 2005). This is the
principal site of E. coli 0157:H7 colonization in cattle (Naylor
et al., 2003; Low et al., 2005; Sheng et al., 2006).
Because of the worldwide human incidence of E. coli
0157:H7, there is a growing interest in developing strategies
that prevent the transmission of this bacteria from the
ruminant reservoir. One such approach is in the vaccination
of cattle that could prevent or limit bovine infection.
Evidence that vaccination may be a viable control option
has come from recent studies, in which cattle have been
immunized systemically with type III secreted proteins and
this partially reduced shedding of E. coli 0157 following
experimental challenge (Potter et al., 2004), although these
same authors reconsider this conclusion in a subsequent
study (Van Donkersgoed et al., 2005).
It is likely that an effective stimulation of both systemic
and local responses will be required and particularly stimu¬
lation of IgA responses that play a key role in the immune
protection of mucosal surfaces and provides an important
line of defense against invading pathogens (Fagarasan &
Honjo, 2003; Hamburger et al., 2006). Previous work in
cattle has reported serological IgG responses against a
variety of antigens following E. coli 0157 colonization (Cray
& Moon, 1995; Pirro et al., 1995; Laegreid et al., 1999; Wray
et al., 2000; Potter et al., 2004), and IgA responses against
E. coli 0157:H7 intimin have been detected in nasal
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secretions following nasal inoculation during a vaccine trail
(Johnson et al., 1996; Yokomizo et al., 2002). Nevertheless,
there is little information on the gastrointestinal mucosal
humoral response to E. coli 0157:H7, in particular following
colonisation of the terminal rectum. The objective of this
study was therefore to investigate the local mucosal antibody
response to E. coli ,0157:H7 following colonization and to
define those antigens recognized.
Materials and methods
Bacterial strains and media
The challenge strain was ZAP 198, an E. coli 0157:H7 isolate
from a human patient in Washington State and used in
experimental studies previously (Naylor et al., 2003). ZAP
198 has been naturally cured of the Shiga-toxin (Stx2)-
carrying bacteriophage and the strain was selected for spon¬
taneous resistance to nalidixic acid to facilitate recovery from
feces and tissues. Bacteria for oral inoculation were cultured
overnight in a shaking incubator at 37 °C in Luria-Bertani
(LB) medium. Escherichia coli 0157:H7 per gram of feces was
enumerated by plating triplicate 10-fold serial dilutions onto
sorbitol MacConkey agar plates (SMAC; Oxoid) containing
15pg— nalidixic acidmL-1 (Sigma-Aldrich). To obtain bac¬
terial supernatants containing proteins secreted by type III
secretion ZAP 198 was cultured in minimum essential
medium (MEM)-HEPES medium as described previously
(Roe et al., 2004). Escherichia coli AAEC185 (Blattner et al.,
1997) is an E. coli K-12 derivative that is used routinely as a
recipient strain for cloning procedures, in this instance, for
the generation of a plasmid used to delete ompC from E. coli
0157:H7 ZAP 198. Cloning steps used LB medium and
plates containing the relevant antibiotics: chlormaphenicol
(25jtgmL_l) andkanamycin (50 jigmL~l).
Oral challenge of calves
All animal experiments were performed in accordance with
the Animals (Scientific Procedures) Act of 1986 and were
approved by the local Ethical Review Committee. For this
study, eight weaned Holstein-cross calves reared conven¬
tionally on a farm and between 8 and 14 weeks old were
challenged with E. coli 0157:H7 isolate ZAP 198 on four
consecutive occasions: 1 x 109 (day 0), 1 x 1010CFU (day
7), 2 x 1010 CFU (day 35) and 2 x 1010 CFU (day 36). Calves
were housed together and fed concentrate twice daily and
had access to ad lib hay and water. Shedding of E. coli 0157
in feces was regularly monitored by bacterial culture for a
total period of 54 days following the first oral challenge.
Rectal tissue and blood sampling
Serum samples were collected at days - 28, 14, 35 and 49. A
total of 32 rectal mucosal samples were taken prechallenge
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(— 28) and at days 6, 34 postchallenge as well as at
postmortem on day 54. On the first three occasions, tissue
was excised under local epidural anesthesia achieved by
administration of 1 mL of Lidocaine into the intercoccygeal
space between CI and C2. The rectal mucosal samples each
weighed between 50 and 75 mg. Excised tissue was mixed
with 1 mL of ice-cold phosphate-buffered saline (PBS, pH
7.2) in ribolyzer1M tubes (Hybaid, UK), and then processed
in a Hybaid ribolyzer™ for 10 s at 5.5 ms_1. The supernatant
of the resultant extracts was removed and centrifuged to
remove tissue remnants. The protein content of the super¬
natant was then determined with the bicinchoninic acid
(BCA) protein assay kit (Pierce) according to the manufac¬
turer's instructions. For Western blotting, tissue superna¬
tants averaged 3 mgmL-1 of total protein and were used at a
1:200 dilution (or 0.013mgmL~'). For enzyme-linked
immunosorbent assays (ELISAs) the supernatants were
standardized to a final concentration of 0.5 mgmL-1 in PBS
containing 0.5 M NaCl and 0.5% Tween 80 (PBS/NaCl/T80).
In addition, rectal extracts from three animals with E. coli
O157-induced histopathological lesions of the rectal mucosa
were used as positive controls.
Antigen preparation
Whole-cell E. coli 0157:H7 (ZAP 198) were harvested from
overnight LB broth cultures following two consecutive
centrifugation steps (4000g for 5min). The bacteria were
then suspended in PBS. Total protein was measured using a
Coomassie Protein Assay Kit (Pierce Biotechnology). Two
micrograms of lysates of E. coli 0157 were loaded per gel
lane. The same amounts of crude bacterial preparations
were also incubated with 11 jiL ofproteinase K (25 mg mL"1,
specific activity: >30Umg_1) (Roche) at 60 °C for 1 h.
Bacterial membranes and cytoplasmic proteins were ob¬
tained by centrifugation of whole-cell samples (13 000 g for
5min) with the bacterial pellet suspended in sonication
buffer (lOmM Tris-HCl, pH 7.5, 0.5 mM phenylmethane-
sulfonyl fluoride, aprotinin 0.5jigmL_1) and sonicated on
ice twice for 10 s at 15jim with 10-s pauses (Soniprep 150,
MSE). This preparation was then centrifuged (13 000g for
15min at 4°C) and the supernatant was ultra-centrifuged
for 1 h at 50 000 g at 4 °C. The pellet was washed twice and
resuspended in sonication buffer. The resultant supernatant
containing the cytoplasmic proteins was collected and
stored at — 20 °C. Bacterial supernatants containing a type
III secretion system were generated as described previously
(Roe et al., 2004); the proteins were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and silver staining as published previously (Kenny
8c Finlay, 1995). An LEE4 mutant of ZAP198 was used as
a comparative control (Kenny 8c Finlay, 1995). Flagellin
was purified by the differential ammonium precipitation
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method (Sherman et al., 1988). 0157 lipopolysaccharide
was obtained from commercial sources (List Biological
Laboratories). Mouse monoclonal antibodies against H7
flagellin (Mast Assure) were used to detect H7 antigen by
Western blotting as described below.
ELISA
Lipopolysaccharide and H7 flagellin preparations were
used to coat ELISA plates to determine mucosal and
serological IgGl and IgA antibody titers. To coat ELISA
plates (Thermoelectron 3455), 0157 lipopolysaccharide
(List Biological Laboratories) was conjugated to polymyxin
B as described previously (Currie & Poxton, 1999). Wells
were coated with 0.1 pg of H7 or lipopolysaccharide in
0.05 M carbonate buffer, pH 9.6. Blocking was performed
with 3% fish gelatin (Sigma G7765) followed by sequen¬
tial incubation with dilutions of test mucosal biopsy
preparations for 1 h at 37 °C in PBS/NaCl/T80, secondary
anti-bovine IgA or IgG horse radish peroxidase (HRP)
conjugated (Serotec) antibody (1/1000 PBS/NaCl/T80) for
1 h at 37 °C and Sigma Fast OPD was added until color
developed (usually 5-20 min depending on the antigen
isotype). Between each incubation step, the plates were
washed six times with PBS containing 0.5% Tween 20.
Finally, the reaction was stopped with 25 pL of 3 M sulfuric
acid (Fisher S/9160/PB15), and the OD readings were
obtained at 492 nm. Controls consisted of similar dilutions
of preinfection mucosal samples, or the omission of the
primary test sample.
One-dimensional (1-D) SDS-PAGE and
immunoblotting
Proteins were separated using 4-12% NuPAGE Novex Bis-
Tris gels (Novex, Invitrogen) with 2-(N-morpholino) ethane
sulfonic acid (NuPAGE) MES SDS running buffer under
reducing conditions, according to the manufacturer's in¬
structions. Proteins were transferred onto nitrocellulose
membranes using a semi-dry transfer apparatus at room
temperature. After transfer, the membranes were incubated
in PBS/T80/NaCl buffer for 60min at room temperature to
block nonspecific protein binding. The transferred proteins
were incubated with the mucosal extracts (0.03 mg g_1 of
mucosal protein). After three washes, the membranes were
incubated sequentially with mouse anti-bovine IgA (Dako,
1/500 in PBS/T80/NaCl), biotinylated goat anti-mouse im¬
munoglobulin (Dako 1/2500 in PBS/T80/NaCl) and strep-
tavidin-HRP (Dako, streptavidin-HRP, 1/4000 in PBS/T80/
NaCl). The incubation steps were performed for 60min
at room temperature with three washes between each step.
Peroxidase activity was revealed by chemiluminescence
using an enzyme chemiluminescence (ECL)-reagent (Amer-
sham Life Sciences, Bucks, UK). Control Western blots
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consisted of incubations with bovine rectal mucosal extracts
at the same concentration from: (1) a pool of three animals
with histopathological lesions (positive controls) and (2)
from unexposed animals (negative control). Western blots
in which no primary antibody was added were also carried
out as controls.
Two-dimensional (2-D) SDS-PAGE and
immunoblotting
Separation of proteins was carried out by isoelectric focus¬
ing using the ZOOM IPGRunner System, followed by SDS-
PAGE utilizing the NuPAGE Novex 4-12% Bis-Tris
ZOOOM gels (Invitrogen) according to the manufacturer's
instructions. Two sample loads were used: 170 pL of sample
containing 100 pg of crude bacterial protein and 35 pL of
sample containing 20 pg of crude bacterial protein. Interfer¬
ing charged molecules and DNA were removed by submit¬
ting the samples to a 2-D Clean-Up kit (Ettan kit,
Amersham) according to the manufacturer's instructions.
Samples were subsequently resuspended in 155 pL of buffer
containing 20 mM dithiothreitol, 8 M urea, 2% 3-[(3-chola-
midopropyl)dimethylammonio] -1 -propanesulfonate and
2% ZOOM carrier Ampholytes, pH 3.5-10 (Invitrogen).
Isoelectric focusing (IEF) pH 3-10 strips were rehydrated
overnight with the sample buffer and IEF was performed for
4 h at 500 V. Following protein separation by charge, the IEF
strips were incubated for 15 min in reducing buffer (Nu¬
PAGE, Invitrogen), followed by 15 min in an alkylating
solution at room temperature. Two-dimensional separation
by protein size was carried out on Bis-Tris Zoom gels. The
resultant high-load gel was stained for protein by Simply
Blue stain (Novex, Invitrogen) and the low-load gel was
submitted to protein transfer and immunoblotting per¬
formed as described for 1-D SDS-PAGE gels.
Maldi-ToF-TOF MS
Immunoreactive spots were excised from 2-D gels, destained
and digested overnight with porcine trypsin (Promega). The
resultant digests were analyzed on a Broker Ultraflex II
biospectrometry workstation (Applied Biosystems). The
fragmentation data obtained were handled using the mascot
software package and Mowse scores were calculated. Scores
> 74 were indicative of significant protein identity.
Genetic manipulation
The allelic exchange method (Emmerson et al., 2006) was
used to replace the ompC gene with a sacB-kan marker
cassette in E. coli 0157:H7 (ZAP198) to generate strain
ZAP 1187. ompC flanking regions and the marker cassette
were cloned into pIB307 (Blomfield et al., 1991) to create
pPN2. The flanking regions were amplified using the
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primer sequences: ACGTGAGCTCATCCGTTGAGTCATCT
CAAGC and GCGGATCCTTAACCCTCTGTTATATGCCT
(left flanking region) CGGGATCCTCTCGATTGATATCGA
ACAAAGG and AATTGCATGCCGGTGCAATCACCGTC
ACG (right flanking region). The sacB-Kan cassette was
subcloned into the created BamHI site from pKCl 1 (Holden
& Gaily, 2004). For the exchange, transformants of pPN3 in
ZAP 198 were selected on LB plates containing chloramphe¬
nicol (25pgmL~') and incubated at 28 °C. Resistant colo¬
nies were grown -in LBC broth (LB broth containing
25 |tg mL-1 of chloramphenicol at 42 °C and subcultured
three times to obtain primary integrates. Further subcul-
turing into LBK (LB broth containing 12 pgmL_I of kana-
myacin) at 28 °C selected for plasmid excision. ompC
replacements were screened for by replica plating on LBK
and LBC agar plates and confirmed by PCR.
Results
Fecal shedding
Each animal was sampled a total of 38 times during a 50-day
period after initial challenge. The counts obtained for each
animal are shown in Table 1. All animals had fecal samples
with detectable levels of E. coli 0157:H7 from day 6 and
until day 21, with average levels above 102. After rechallenges
Table 1. Concentrations of Escherichia coli 0157 (CFU g 1) on the surface of feces from shedding cattle
Calves
CH SR BP DPC 1 2 3 4 5 6 7 8
X X X 0
1 5433 3133 3033 233 667 67 5367 67
2 0 200 0 67 33 467 0 100
3 NC 2000 0 67 0 133 0 400
4 0 567 0 167 67 600 0 1300
5 0 8967 0 33 67 133 0 667
6 0 400 0 100 233 533 0 100
8 933 19433 100 NC 3533 700 33 0
9 500 2500 67 0 133 7467 0 0
10 0 5033 1267 267 5467 21 700 67 0
11 100 0 21 233 67 NC 3500 9733 0
12 0 NC NC 200 NC 9667 2400 0
13 0 21 933 63 367 0 56933 NC 73133 0
14 0 33 10 700 167 NC 8233 24900 0
15 0 0 37 733 467 267 NC 8367 0
16 0 667 50133 33 11 100 433 1533 0
17 0 NC 240667 133 3267 1000 16 867 NC
18 0 67 51433 133 67 0 333 NC
19 0 133 36600 33 500 167 1067 0
20 0 300 267 33 100 100 600 0
21 0 100 2533 0 0 33 600 0
35 0 0 0 0 0 0 0 NC
36 533 100 2600 3300 3400 2267 2300 167
37 167 0 8333 3200 1900 0 1467 233
38 967 33 867 500 NC 133 1500 0
39 100 1467 0 633 14 633 33 1433 0
40 3367 33 33 733 200 0 6567 433
41 3067 33 NC 467 3633 0 533 0
42 7700 0 0 1133 233 0 7933 0
43 2333 133 0 0 0 0 1200 0
44 33 NC 0 0 200 800 767 400
45 NC 0 67 100 0 100 33
46 33 67 0 0 0 0 0 100
47 0 0 0 0 0 0 0 0
48 67 0 0 0 0 0 133 67
49 0 167 0 0 33 0 0 0
50 0 0 0 0 0 0 0 0
Days 1-50 postinitial challenge (DPC) and cases 1-8. Shedding expressed in CFU g 1 of feces.
CH, challenge: BP, biopsy: DPC, days postchallenge: NC, not collected.
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on day 35 and 36, animals shed similar levels of bacteria
until day 40. The maximum levels detected in individual
animals ranged from 1.3 x 103 to 2.4 x 105CFUg~' of feces.
The average bacterial count for all the samples collected was
3.5 x 103CFUg-1 of feces. Calves did not show any clinical
signs during this experiment.
Western blot detection of mucosal IgA
antibodies against whole-cell antigens, protein
lysates and 0157 lipopolysaccharide
Initial analysis of whole E. coli 0157 responses was per¬
formed by 1-D immunoblotting. Depending on the animal,
this showed a variable pattern of up to 11 bands of between
38 and 98 kDa that were strongly reactive with IgA when
incubated with rectal tissue extracts obtained at 54 days after
challenge. For comparison, the prechallenge rectal tissue
extracts obtained by biopsy generated a weaker blot with less
Fig. 1. Reducing SDS-PAGE Western blot of Escherichia coli 0157
whole-cell preparations showing the IgA-reactive antigens at preinfec-
tion (a) and 54 days postinitial infection (b). Blot (c) as for (b), but treated
with proteinase K showing diffuse IgA reactivity to areas between 55 and
71 kDa. Each lane was probed with rectal extracts from eight infected
calves (1-8). Lane 0 is a positive control, lane NP was as lane 0 but
incubated without pooled rectal extract. Protein separation, Western
blotting and detection were carried out as described in 'Materials and
methods'.
(< 5) reactive bands (Fig. la and b). Proteinase K digestion
of the E. coli 0157:H7 antigen preparation removed the
majority of the reacting bands, leaving a diffuse area of
recognition at 71-55 kDa for three cases (Fig. lc). The
majority of the extract samples did not show reactivity to
lipopolysaccharide, which appeared as a single weak diffuse
band migrating below the 70 kDa marker (Western blot not
shown).
Western blot detection of mucosal IgA
antibodies responses to E. coli 0157-secreted
proteins, outer membrane proteins and H7
flagellin
Membrane and cytoplasm protein fractions were analyzed
by 1-D immunoblotting. IgA antibody reactivity was pre¬
dominantly confined to the membrane fractions, although
a faint and indistinct reaction against cytoplasmic proteins
was observed from the pooled material of highly colonized
animals. The reactive membrane proteins ranged from 30 to
90 kDa, with three major bands showing at c. 30, 40 and
70 kDa (Fig. 2a). Supernatant proteins from E. coli 0157:H7
ZAP198 and an LEE4 deletion mutant (ZAP984) were
prepared as described in 'Materials and methods' and used
to determine whether there were detectable IgA responses to
type Ill-secreted proteins. Reactive bands with molecular
masses expected of EspA (22/25 kDa), EspD-B (37/39 kDa)
and Tir (100/110 kDa) (Fig. 2b) were detected when samples
were incubated with pooled rectal tissue extracts. No
reactive bands were observed when the same extracts were
used to blot supernatant proteins precipitated from the
LEE4 mutant. IgA reactivity was also investigated against
purified H7 flagellin, and two to three bands were visible
between 60 and 200 kDa on extracts from animal 1. A
similar band pattern profile was observed following immu-
noreaction with a commercial monoclonal antibody against
H7 antigen; an example from one animal is shown (Fig. 3).
All animals were positive (Fig. 5) for this response.
Characterization of a mucosal IgA response
to OmpC
Two-dimensional SDS-PAGE, followed by Western blotting,
allowed the detection of IgA antibodies against one spot
subsequently identified by MS analysis as outer membrane
porin C (OmpC) (Fig. 4a). The mucosal samples of all
animals showed an IgA response to the OmpC protein. The
other two reactive spots were not successfully characterized.
A deletion of the gene was then constructed by allelic
exchange of ZAP 198 to generate ZAP 1187. The absence of
OmpC was confirmed by PCR (data not shown). Compara¬
tive immunoblotting of the wild type and ompC-deleted
strains was then carried out from both 1-D and 2-D SDS-
PAGE gels. These confirmed that the originally identified
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Fig. 2. Reducing SDS-PAGE Western blot of Escherichia coli 0157
showing mucosal IgA reactivity to different antigen preparations. For
blot (a), outer membrane antigens (lanes 1, 3 and 5) and cytoplasmic
proteins (lanes 2, 4 and 6). Blot (b), secreted proteins (lanes 2, 4 and 6)
and supernatant of an LEE4 mutant (lanes 1, 3 and 5). Both blots were
similarly processed and all lanes were loaded with 1 pg of antigen. For
both blots, Lanes 1 and 2 were incubated with a pool of mucosal
supernatant from 3 animals with histopathological lesions as positive
controls, whereas lanes 3 and 4 were incubated with supernatants from
animal 1 and lanes 5 and 6 with supernatants from animal 2. Peroxidase
reactions were detected by chemiluminescence although blot (a), lanes 1
and 2 were exposed fpr a shorter period due to the relatively high
intensity of the reaction.
immunogenic protein was no longer detectable in the ompC
mutant (Fig. 4b and c).
Detection of mucosal antibody responses
by ELISA
The mucosal antibody responses measured by ELISA
showed an elevated mucosal IgA response at day 54 in all
188
Fig. 3. Reducing SDS-PAGE Western blot showing IgA reactivity to
Escherichia coli 0157 FI7-purified flagellin. Lane 1 no primary, lane 2
probed with rectal extracts from case 1 and lane 3 incubated with an
anti-H7 monoclonal antibody. Protein separation, Western blotting and
detection were carried out as described in 'Materials and methods'.
animals against both 0157 lipopolysaccharide and H7
flagellin. This response was particularly marked to H7
flagellin when compared with lipopolysaccharide (Fig. 5a
and b). Similarly, the readings for IgG antibody were
generally higher for H7 than for lipopolysaccharide (Fig. 6a
and b). Overall, the rectal mucosal antibody titers increased
after repeated E. coli 0157:H7 challenge.
Discussion
There have been other investigations of the serological
immune responses to E. coli 0157 (Johnson et ah, 1996;
Lissner et ah, 1996; Hoffman et ah, 2006) and other EHEC
(Widiasih et ah, 2004) in cattle. However, this study
demonstrates for the first time, that E. coli Ol57:H7 infec¬
tion in cattle induces local IgA immune responses against
membrane and secreted protein antigens at the terminal
rectum, the principal site of E. coli 0157 colonization in the
bovine species.
Immunoblotting showed a number of antigens in whole-
cell preparations that were recognized by IgA in rectal
mucosa extracts collected postchallenge. These bands were
more numerous and intensely stained than those detected
after a reaction with mucosal extracts from prechallenge
tissue, indicating a local IgA antibody response to the
repeated E. coli 0157:H7 challenges. Shared antigens from
other E. coli present in the normal flora of farm-reared
calves, or cross-reactivity with other antigens (Westerman
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Fig. 4. Reducing 1D and 2-D SDS-PAGE/Western blot analysis of Escherichia coli 0157. 2-D blot (a) shows the IgA reactive protein OmpC. Immunoblot
analysis (b) of the mutant strain (AOmpC) indicated the absence of OmpC. Similarly, 1-D SDS immunoblot analysis of outer membrane preparations (c)
of the parent wild type (WT) and AOmpC strain show in the WT preparation a reactive band on the 42 kDa region absent in the AOmpC preparation.
Blots were incubated with the pool of mucosal supernatant from three animals with histopathological lesions. Four to twelve per cent Bis-Tris gels,
IEF pH 3.5-10. Protein separation, Western blotting and detection were carried out as described in 'Materials and methods'.
r Challenge
Challenge
Fig. 5. Levels of rectal mucosa H7-specific IgA (a) and IgG (b) after
repeated challenge with Escherichia coli 0157.
et ah, 1997; Stenutz et ah, 2006) are likely to explain the low
prechallenge reactivity observed.
Proteinase K treatment of whole-cell preparations re¬
moved almost all reactive material, suggesting that a high













Fig. 6. Levels of rectal mucosa 0157-specific IgA (a) and IgG (b) after
repeated challenge with Escherichia coli 0157.
carbohydrate epitopes. In agreement with this finding,
Western immunoblot analysis of purified 0157 lipopolysac-
charide showed low reactivity. The lower reactivity of the












FEMS Immunol Med Microbiol 52 (2008) 59-68 © 2007 Moredun Research Institute
Journal compilation © 2007 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd.
66 P. Narteta/.
antigens was also confirmed by ELISA analyses, carried
out with equal antigen loads and'primary antibody concen¬
trations. Lipopolysaccharide is one of the main pathogen-
associated molecular patterns (PAMPs) used by the
mammalian innate immune system to detect Gram-negative
bacteria (Backhed et ah, 2003; Trent et ah, 2006), although
pure lipopolysaccharide is considered to be a poor immuno-
gen (Poxton, 1995). Thus, in this case lipopolysaccharide
does not appear to be a dominant antigen for the develop¬
ment of a mucosal response.
The rectal mucosal extracts labeled three major reactive
bands in the outer membrane preparations of E. coli
Oi57:H7, while the cytoplasmic preparations reacted
weakly, suggesting that the major immunogenic proteins of
the bacterium are surface-exposed. It is possible that like
most of the PAMPs that interact with the innate immune
system (Blasi et ah, 2005; Rezaei, 2006), the main virulence
determinants from non invasive bacterial pathogens may be
extracellular virulence factors (Parsot, 2005) or membrane
components (Kagnoff, 2006). A recent analysis of an expres¬
sion library recognized by IgG antibodies from immune
calves (Kudva et ah, 2006) detected predominantly cytoplas¬
mic antigens. However, the work did not identify type III
secreted proteins or Shiga toxin against which specific IgG
have been reported previously in cattle (Johnson et ah, 1996;
Yokomizo et ah, 2002; Potter et ah, 2004). The fact that
membrane proteins were the main antigens detected in this
study could be a result of restriction site limitations (Rollins
et ah, 2005) and/or the different tests used, as well as the
differences between antibody isotype and local vs. systemic
responses, could explain the greater relevance given in this
work to membrane protein antigens.
In the present study, culture supernatants containing type
III secreted proteins were highly antigenic and reacted
strongly with IgA antibodies from infected animals. The
proteins recognized were exported by the type III secretion
system as they were not detected in an LEE4 mutant super¬
natant and had molecular masses-that correlate with: (1) the
needle elongation filament protein, EspA; (2) the pore-
generating protein complex, EspB/D and (3) the translo¬
cated intimin receptor (Tir). These are all key proteins
required for induction of attaching and effacing lesions by
E. coli 0157 and are exposed to the host immune system in
the early stages of colonization (Cornelis, 2006). Serological
IgG responses against similar proteins have been reported
during bovine vaccine trails following vaccination with type
III secretion system proteins (Potter et ah, 2004) and in
human infection (Li et ah, 2000). Recent research has found
that these proteins are essential for E. coli 0157:H7 coloni¬
zation of the terminal rectum (Naylor et ah, 2005).
H7 flagellin also elicited strong IgA immune responses,
with ELISA values higher than lipopolysaccharide for equal
concentrations of antigen and primary antibodies. Unlike
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lipopolysaccharide, flagellin may activate both innate and
acquired immune systems, through the activation of Toll¬
like receptor 5 and the recruitment of dendritic cells (Yang
et ah, 1997; Honko & Mizel, 2005; Rumbo et ah, 2006). This
immundominance of flagellin has also been reported in
experimental murine colitis and Crohn's disease patients for
IgG (Lodes et ah, 2004; Duck et ah, 2007) and IgA (Sitara-
man et ah, 2005). Moreover, in vitro studies have found that
flagellin is the main inducer of the neutrophil chemoattrac-
tant interleukin 8, through the activation of intestinal
epithelial cell NF-k(3 and mitogen-activated protein kinase
pathways (Berin et ah, 2002), and E. coli 0157:H7 infection
in cattle is characterized by the induction in the rectal
mucosa of neutrophil infiltrates. In contrast to E. coli
0157:H7 infection in cattle, H7 flagella antibodies have not
been detected in the sera of human patients (Chart et ah,
1989; Jenkins & Chart, 1999), which may indicate the lack of
flagella expression during human infection.
Following 1-D SDS-PAGE/Western blot analysis, further
attempts to define the reactive antigens were made by 2-D
SDS-PAGE/Western blotting. MS analysis identified OmpC
as a bacterial membrane antigen detected by mucosal IgA
from all positive animals. The immuno-dominance of this
protein has been demonstrated for patients with Crohn's
disease where E. coli OmpC has been proposed as a reliable
marker to characterize infection (Spivak et ah, 2006). OmpC
elicited higher and prolonged responses that the other major
outer membrane protein OmpF, following infection with
Salmonella enterica (Secundino et ah, 2006). The marked
difference observed in the number of antigens detected
by 1-D and 2-D Western blotting may be due to differences
in sensitivity, denaturalization (Harper et ah, 1990) or to
the absence in the 2-D gels of some antigens (Madden
et ah, 2002).
In summary, the present study has shown that E. coli
0157:H7 colonization induces a strong local mucosal anti¬
body response, which is directed at several membrane-
associated and secreted proteins. Because IgA has been
selected through evolution as the main protective element
of the mucosal humoral immune response (Matsunaga &
Rahman, 1998), the antigens detected may represent
important vaccine candidates. However, further work is
required to determine their relevance in protection.
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Recent research has established that the terminal rectum is the predominant colonization site of
cntcrohcniorrhagic Escherichia coli Ot57:H7 in cattle. The main aim of the present work was to investigate
pathological changes and associated immune responses at this site in animals colonized with E. coli
0157:H7. Tissue and gastrointestinal samples from a total of 22 weaned Ilolstcin-eross calves challenged
with E. coli C)157:H7 were analyzed for bacterial colonization and pathology. Five unexposed age-matched
calves were used as comparative negative controls. E. coli 0157:H7 bacteria induced histopathological
alterations of the rectal mucosa with cntcrocytc remodeling. This was often associated with removal of the
colonized epithelial layer. Immunogold labeling and transmission electron microscopy (TEM) showed E.
coli 0157 bacteria on pedestals, as part of attaching and effacing lesions. These pathological changes
induced a local infiltration of neutrophils that was quantified as larger in infected animals. Rectal mucosal
immunoglobulin A responses were detected against the E. coli 0157:117 antigen. This work presents
evidence that E. coli 0157:117 is not a commensal bacteria in the bovine host and that the mucosal damage
produced by E. coli 0157:117 colonization of the terminal rectum induces a quantifiable innate immune
response and production of specific mucosal antibodies.
Enterohemorrhagic Escherichia coli (EHEC) infection has
emerged in the last 20 years as a cause of diarrhea that can lead
to the more serious consequence of hemolytic-uremic syn¬
drome and thrombotic microangiopathy. The majority of
EHEC infections are caused by E. coli 0157:H7 (24), and this
serotype has been isolated frequently from cattle feces. Many
human EHEC 0157 infections originate, either directly or
indirectly, from exposure to cattle feces (17), and a key step in
protecting humans from EHEC infection is to understand and
control E. coli 0157:H7 colonization of cattle.
Experimental challenges have suggested a variety of coloni¬
zation sites in cattle (4, 5, 12). However, more recently, the
terminal rectal mucosa has been identified as the major site of
E. coli 0157:H7 colonization (25), and this finding has been
confirmed in slaughter animals (20). From an understanding of
where E. coli 0157:H7 colonizes the bovine intestinal tract,
there is an opportunity to examine pathological changes at the
site and to determine whether these changes correlate with
the development of immunological responses. The main aim of
the research is to underpin methods to control this pathogen in
its main animal reservoir.
A feature of E coli 0157:H7 infection is the formation of
attaching and effacing (A/E) lesions, characterized by the elim¬
ination of the microvilli and intimate enterocyte attachment (7,
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16). In vivo, A/E lesions are present at the terminal rectum of
naturally and experimentally infected cattle, and inactivation
of the type III secretion apparatus that is essential for this
phenotype prevents E. coli 0157:H7 colonization of cattle
(27). The profound alteration of enterocyte morphology asso¬
ciated with A/E lesions has also been reported to be accom¬
panied by an increase in neutrophils and eosinophils in the
lamina propria of the large intestine (37), the colon and cecum
(6), the gall bladder (35), and sections of ligated ileal loops
(32). This type of inflammatory reaction has been described in
the intestinal tract exclusively for experimental infections of
gnotobiotic, neonatal, or immunosuppressed calves and in sites
other than the terminal rectum. However, to date, the response
to colonization at the principal colonization site has not been
investigated.
Identification of the terminal rectum as the tissue targeted
by E. coli 0157:H7 in cattle allows the study of the pathological
changes and associated innate and adaptive mucosal re¬
sponses. Thus, this study had two objectives: first, to determine
if E. coli 0157:FI7 colonization of the bovine terminal rectum
induces pathological changes, in terms of both ultrastructural
change to the mucosal epithelium and evidence of inflamma¬
tion, and second, to investigate local immune responses to
colonization. Additionally, this work aimed to confirm in a
larger number of animals the previously reported findings of £.
coli 0157:H7 tropism for the terminal rectum.
MATERIALS AND METHODS
Animals. Fifty-four weaned Holstein-cross calves were reared conventionally
on a farm before transfer to Moredun Research Institute for the experimental
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procedures (authorized by Home Office license 60/3179). The animals were
between 8 and 14 weeks of age on arrival and were then penned individually for
the study. Calves were fed concentrate twice daily and had access ad libitum to
hay and water. Feed, water, and bedding were provided separately for each
animal to minimize cross-contamination, and each was haltered to reduce the
opportunity for fecal-oral transmission. Five unexposed calves of similar age,
breed, and background were used as controls for the histopathological studies,
and a separate group of four calves was challenged specifically for ultrastructural
investigations of the colonized rectal mucosae. •
Bacterial strains. The challenge strain of E. coli 0157.H7 was ZAP 198
isolated from a human patient in Washington state and was used previously in
experimental studies (25). ZAP 198 has been naturally cured of the verocyto-
toxin-carrying bacteriophage, and the strain was selected for spontaneous resis¬
tance to nalidixic acid to facilitate recovery from feces and tissues. ZAP 198
possess genes for enterohemolysin, intimin-y, EspA. and EspB. For the prelim¬
inary examination of adaptive responses, whole-cell extracts of E. coli K-12
MG1655 (2) and E. coli 026 ZAP 1082 (28) were used as controls in Western
blots.
Calf colonization. Fecal samples were taken at least twice from each calf, prior
to experimental challenge, and were confirmed negative forE. coli 0157:H7 by
immunomagnetic separation. The challenge E. coli 0157:H7 strain was grown
overnight in Luria-Bertani (LB) broth at 37°C with aeration and diluted in sterile
phosphate-buffered saline (PBS) to achieve an inoculum of 109 CFU per animal
in a total volume of 10 ml. The oral inoculum was administered to the calves via
stomach tube and washed down with 500 ml of sterile PBS or by direct admin¬
istration through a cannula to the rumen in six calves. Initial analysis showed that
the ruminal inoculation and the challenge via nasogastric tube did not differ in
terms of efficacy, and the former method was halted. Therefore, for analytical
purposes the ruminally challenged animals are included within the orally chal¬
lenged group. Rectal challenge was carried out by loading a large cotton swab
with the challenge inoculum, followed by direct application to the mucosal
surface of the recto-anal junction (RAJ). In total, 24 calves were challenged via
the rectal route and 30 by oral-or ruminal administration.
Postmortem examinations were carried out with 22 animals shedding detect¬
able levels ofE. coli 0157:H7 bacteria beyond day 14 postchallenge. Ten of these
animals had been experimentally challenged with E. coli 0157:H7 by direct rectal
application and 12 by oral administration as described recently (26). Tissue
samples were collected from the gastrointestinal tract for bacterial counts and
histopathology. Tissue samples were taken from the rumen, jejunum. Peyer's
patch, cecum, ileocecocolic valve lymphoid patch, proximal colon, proximal co¬
lon lymphoid patch, spiral colon, and distal colon and at the proximal, mid, and
distal rectum (at 20, 10, and 5 cm proximal to the RAJ) and from the RAJ itself.
Luminal contents were collected from the same sites for bacterial culture, to¬
gether with bile from the gall bladder.
Rectal biopsy samples were taken from 11 animals, under local epidural
anesthesia, at prechallenge and on two further occasions at 6 and 11 days after
challenge. Local anesthesia was achieved by epidural administration of 1 ml of
lidocaine into the intercoccygeal space between CI and C2. The biopsies con¬
sisted of pieces of rectal mucosa weighing between 50 and 75 mg that were
excised from the terminal rectum.
Isolation of E. coli OI57:H7 and enumeration. Feces were caught upon def¬
ecation and separated into core and surface components. The concentrations of
E. coli 0157:H7 bacteria in feces, intestinal contents, and tissues were estimated
as described previously (25).
Histopathology. Tissues taken at postmortem examination for histopathol¬
ogy were immediately fixed in 4% paraformaldehyde. Thirteen animals were
selected for histopathological"examination. Cell counts were made of total
granulocytes, eosinophils, neutrophils (total granulocytes minus eosinophils),
mast cells, and y5 T cells from the lamina propria of the rectum and large
intestine. Total granulocyte numbers were obtained from sections stained
with hematoxylin and eosin, mast cells from sections stained with toluidine
blue (0.5% in 0.5 N HCI [pH 0.5]) for 1 h (9), and eosinophils from sections
stained with carbol chromotrope solution for 1 h and counterstained for 10 s
with hematoxylin (18). IL A29 was used to detect the T-cell marker
BoWCl (15) in immunostained sections.
Paraffin sections (5 pm) of paraformaldehyde-fixed tissues were used to detect
E. coli 0157:H7 by the horseradish peroxidase (HRP)-streptavidin method. The
primary antibody was rabbit anti-0157 polyclonal antibody (1:100 for 60 min at
room temperature; Mast-Assure), followed by HRP-streptavidin-conjugated
mouse anti-rabbit monoclonal antibodies (Sigma-Aldrich). In some studies,
paraformaldehyde-fixed tissues were used to detect E. coli Ol57 by immunoflu-
orescent antibody labeling. These cells were processed as described above, ex¬
cept that the secondary antibody was a fluorescein isothiocyanate-conjugated
goat anti-rabbit antibody (Sigma-Aldrich).
Cell counts. These were performed for eosinophils, neutrophils, mast cells,
and y5 T cells from the lamina propria of the rectum and large intestine. Using
a power calculation of 0.8 and 95% significance level, we counted five fields and
two different areas for each of the sections. Cell counts were expressed as cells
per 0.25 mm2. Bacterial counts were obtained after counting 10 colonies in two
different RAJ tissues from each of five animals.
Electron microscopy. Two different techniques were used to identify E. coli
0157 in ultrastructural studies. From the group of thirteen animals selected
for histological examination, areas of three tissue sections from two animals
where E. coli 0157 had been identified by immunofluorescent antibody were
circumscribed, and the tissue in the matching areas of the paraffin blocks were
precisely excised and reprocessed for transmission electron microscopy
(TEM). From the group of four calves challenged specifically for electron
microscopy studies, tissues were fixed in 2% formaldehyde and 0.1% glutar-
aldehyde, and bacteria were labeled with the same primary antibody used for
light microscopy, with a secondary goat anti-rabbit immunoglobulin G (IgG)
10-p.m gold-labeled antibody (1:500 for 60 min at room temperature; British
Biocell). Images were processed with PaintShop Pro (Jasc Software).
Determination of mucosal antibody responses. Rectal mucosa (weighing ap¬
proximately 2 g) samples were excised at postmortem examination from nine
animals and stored at -70°C. After being thawed, 50 to 75 mg of the biopsy
sample or rectal mucosal tissue was mixed with 1 ml of ice-cold PBS (pH 7.2) in
RiboLyzer tubes (Hybaid, United Kingdom) and then processed in a Hybaid
RiboLyzer for 10 s at 5.5 ms-1. The supernatant of resultant homogenate was
removed and centrifuged to remove the tissue. The protein content of the
supernatant was then determined with the bicinchoninic acid protein assay kit
(Pierce) according to the manufacturer's instructions and standardized to a linal
concentration of 5 mg gram-1. Whole-cell samples of E. coli 0157:H7. E. coli
026. and E. coli K-12 were prepared from overnight LB broth cultures, and
heated for 10 min at 70°C in loading buffer, 5 p.1 of sodium dodecyl sulfate, and
2 p.1 of reducing agent (Invitrogen), and each lane was loaded with 10 pg of
bacterial protein and separated using 4% to 12% NuPAGE Novex bis-Tris gels
(Novex, Invitrogen) with NuPAGE morpholineethanesulfonic acid-sodium do¬
decyl sulfate running buffer. Lysates ofE. coli Ol57:H7 were made by trypsiniza-
tion of whole-cell samples for 45 min at 70°C with sequencing-grade-modified
trypsin (Promega). Gels were transferred onto nitrocellulose membranes, using
a semidry transfer apparatus at room temperature. After being transferred, the
membranes were incubated in a PBS-T80-NaCl buffer consisting of PBS. 0.5%
Tween 80, and 0.5 M NaCl for 60 min at room temperature to block nonspecific
protein binding. The transferred proteins were incubated with the supernatant
from the mucosal homogenates (0.03 mg gram-1 of mucosal protein). Following
three washes, the membranes were incubated sequentially with mouse anti-
bovine IgA (1/500 in PBS-T80-NaCl; Dako), biotinylated goat anti-mouse Ig
(1/2500 in PBS-T80-NaCI; Dako), and streptavidin-HRP (streptavidin-HRP.
1/4,000 in PBS-T80-NaCl; Dako). The incubation steps were performed for 60
min at room temperature with three washes between each step. Peroxidase
activity was revealed by chemiluminescence using ECL (Amersham Life Sci¬
ences, Bucks, United Kingdom) reagent. Control Western blots consisted of
incubations of bovine rectal homogenate at the same concentration from unex¬
posed animals and Western blots in which no primary antibody was added.
Statistical analyses. E. coli 0157:H7 cell counts within fecal and tissue sam¬
ples were calculated by determining the mean plate count at the most relevant
dilution for each sample and bymultiplying the dilution factor to convert to CFU
g-1 (feces or gastrointestinal tract contents) or to CFU cm-2 (mucosal samples).
The concentration (CFU g"1 plus 1) was logto transformed. Student's t test was
used to compare means of samples, with a paired / test used where a natural pair
existed. The chi-square test was used to analyze proportions. Where the number
of observations was low in some categories, Fisher's exact test was used. The
kappa test was used to qualify the level of agreement, where the null hypothesis
is that there is no more agreement than might occur by random chance. Data
were processed using Excel (Microsoft) and Minitab (Minitab Inc.) software.
RESULTS
Site of colonization. Out of a total of 54 animals, 46 became
colonized for longer than 5 days, and a postmortem examina¬
tion was carried out on 22 animals still shedding detectable
levels of E. coli 0157:H7 bacteria beyond day 14 postchallenge.
Ten of these animals had been challenged by direct rectal
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FIG. 1. Histopathological changes induced by E. coli 0157:H7 colonization at the terminal rectum of cattle. (A) Apical surface of the
enterocyte partly eroded by an E. coli 0157 microcolony (arrow). (B) A larger E. coli 0157 microcolony causing further erosion of the cytoplasm.
An E. coli 0157 colony is illustrated (arrow). (C) Enterocytes (arrows) heavily colonized with E. coli 0157 are shown sloughing off from the basal
membrane. Bacterial aggregates surround the enterocyte. (D) A larger E. coli 0157 microcolony is shown on the lamina propria, following the
shedding of the epithelial layer. Histopathology was carried out as described in Materials and Methods.
application and 12 by oral administration. E. coli 0157:H7 cell
counts from tissue washings of the terminal rectum were sig¬
nificantly higher than from tissues of the large intestine (P <
0.001), irrespective of the challenge route. Significantly higher
counts (P < 0.01) were detected in the other rectal sites (5, 10,
and 20 cm proximal to the RAJ) compared to counts from
tissue washings of large-intestinal tissues. For the animals chal¬
lenged by the direct rectal administration method, E. coli
0157:H7 bacteria were not recovered from bile or samples of
digesta from nonreclal sites that included the rumen and the
small or large intestine. For the orally challenged group, E. coli
0157:H7 bacteria were not recovered from bile (data not
shown). Terminal rectal tissue collected from colonized ani¬
mals allowed us to study pathological changes.
Pathological changes at the terminal rectum. When bac¬
terial concentrations exceeded 10s CFU per cm2, E. coli
0157:H7 bacteria could be readily detected in association with
the epithelium by immunostaining and microscopy. In these
positive tissues, at 15 to 21 days after challenge, the immu-
nopositive bacteria were usually but not exclusively colonizing
focal areas of the absorptive epithelium or the scarcer follicle-
associated epithelium. Bacterial microcolonies ranged from
those containing less than 30 bacteria to those with several
hundred. The distribution of the colonies appeared random,
with some microcolonies close together and others separated
by large areas of noncolonized rectal tissue. In all cases, af¬
fected epithelial cells had effaced microvilli, and bacteria were
intimately associated with their apical membranes. Occasion¬
ally, immunostained bacteria were present without producing
major morphological alterations of the rectal epithelium. Gen¬
erally, the mucosal border in foci with attached bacteria was
low columnar to cuboidal (Fig. 1A and B). There was frequent
exfoliation of the mucosal epithelium from the basal mem¬
brane, and bacteria were often seen in cavities of evacuated
enterocytes (Fig. 1C and D). Groups of loose bacteria were
also present in the mucus 40 to 100 (cm from the intestinal
surface and were not always associated with adherent micro-
colonies. On rare occasions, E. coli Oi57:H7 bacteria were also
attached to areas of the squamous epithelium of the perianal
region and crypts of the rectal mucosa. Rarely, an immunopo-
sitive bacterium was detectable along lymphatic lacteals of the
lamina propria in areas lacking an epithelial surface. E. coli
0157:H7 microcolonies were also detected by immunostaining
at day 6, from rectal biopsy samples from three animals that
were shedding >105 CFU g"1 of feces of E. coli 0157:H7
bacteria. The distribution and intimate bacterial attachment to
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FIG. 2. Ultrastructure analysis of E. coli 0157 interaction with the bovine terminal rectum. (A) Immunogold staining of E. coli 0157 organisms.
The image shows a single bacterium intimately attached through a pedestal to the host enterocyte, as part of an A/E lesion. Immunolabeling and
TEM were carried out as described in Materials and Methods. (B) Cross-section of an E. coli 0157 microcolony at the bovine terminal rectum.
The bacteria are all intimately attached to the damaged epithelium (black arrows), inducing effacement of the microvilli. Unaffected brush border
is visible on the neighboring cell (white arrow). (C) Aggregates of bacteria eroding the apical surface of colonized enterocytes (black arrows).
Bacteria are intimately attached to the apical surface of the enterocyte (white arrows). (D) Extravasated polymorphic mononuclear leukocyte
(N) adjacent to a bacterial cluster (black arrow).
enterocytes were similar to those observed for the cases exam¬
ined at postmortem at days 15 and 21 postchallenge.
The pathological changes were further examined by scan¬
ning electron microscopy, which revealed multifocal clusters of
rod-shaped bacteria of up to 2 pun in length, distributed ran¬
domly over the surface of the absorptive epithelium of the
rectum. TEM studies and gold particle immunolabeling al¬
lowed us to identify E. coli 0157:117 bacteria on pedestals as
part of A/E lesions (Fig. 2A and B). Pedestal heights varied but
in some cases were up to 10 p.m long. Some microcolonies
appeared to consist of bacteria in layers, forming a stack, and
individual bacteria were observed in the process of dividing
while attached to the host cells. Bacterial microcolonies were
associated with different degrees of enterocyte erosion (Fig.
2C). On occasion, granulocytes were present, interspersed
among enterocytes, and exuded leukocytes formed aggrega¬
tions in the gut lumen (microabscesses) (Fig. 2D). Lateral and
basal membrane detachment and enterocyte exfoliation were
often evident but present only when the bacteria had caused
enough damage to approach the cell basal nucleus.
Cellular infiltration and inflammation. When E. coli 0157:
H7 was isolated from mucosal washings of tissues at levels
higher than 105 CFU cm-2 or from biopsy samples taken from
colonized animals that had similar numbers of E. coli Oi57:H7
bacteria in feces, there was a diffuse, low to mild granulocytic
focal infiltration of the lamina propria of the rectum (Fig. 3A).
In the terminal rectum, a significant (P < 0.001) leukocytic
infiltrate was present in E. coli 0157:H7-colonized animals
(mean, 6.6 ± 1.4 per 0.25 mm2) compared with controls (mean,
1.9 ± 0.9 per 0.25 mm2). However, no differences were de¬
tected between the numbers of eosinophils, mast cells, and yS
T cells (P > 0.65, P > 0.69, and P > 0.68, respectively) in
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FIG. 3. Histological granulocyte quantification. (A) Hematoxylin-
and-eosin-stained bovine rectal mucosa colonized with E. coli 0157:
H7. The dashed outline highlights colonized epithelium. Arrows indi¬
cate infiltration of granulocytes. (B) Box plots show the granulocyte
counts in the terminal t ectums of exposed and unexposed animals. The
boxes contain 50% of the data, and the median count is illustrated by
the black triangle. ♦, 1st quartilc; ■. minimum; A, median; O, mean;
x, maximum; •, 3rd quartiie. Samples were prepared and granulocytes
identified as described in Materials and Methods.
colonized animals compared with those in control animals. For
colonized animals, significantly more granulocytes (P < 0.001)
were found in the terminal rectum than in the proximal rectum
(+20 cm). However, in the area 20 cm proximal from the
terminal rectum, no significant differences (P > 0.42) were
detected between the neutrophil count of infected cases and
that of noninfected cases (controls/mean of 1.5 ± 1.1 per 0.25
mm2; cases/mean of 1.7 ± 1.0 per 0.25 mm2) (Fig. 3).
Adaptive responses to E. coli 0157:117 colonization in the
rectal mucosa. Mucosal antibodies were extracted from rectal
mucosal homogenates to determine whether animals colonized
by E. coli 0157:H7 at the terminal rectum were generating
specific mucosal antibody responses to the E. coli 0157:H7
antigen. Samples were taken from three animals that shed E.
coli 0157:H7 at levels consistently higher than 104 CFU
gram-1 for at least 2 weeks. In these samples, IgA antibodies
were detected that bound to antigens of whole E. coli 0157:H7
cells. Between 4 and 11 protein bands, with molecular masses
ranging from 38 to 98 kDa, were recognized. The same ho-
mogenate samples showed no immune response to whole-cell
extracts of the E. coli 026 or E. coli K-12 strains. Trypsiniza-
tion of the E. coli K-12 and 0157:H7 samples removed most of
the immunoreactive material and resulted in the detection of a
14-kDa band for both strains (Fig. 4). No specific reactive
bands were observed for four noninfected controls or from
Western blots where the rectal mucosal homogenate was omit¬
ted (data not shown).
DISCUSSION
Work carried out by our group has demonstrated that E. coli
0157.H7 has a tropism for the terminal rectum of cattle (25).
The present study has confirmed this finding by examination of
over 50 animals colonized by different challenge routes. The
postmortem examination of these colonized animals also al¬
lowed the identification of minor sites of E. coli 0157:H7
carriage. These sites included the rumen, small intestine, and
most frequently, the proximal colon and, in particular, the
lymphoid-rich tissue immediately distal to the ileocecal valve.
In 2 animals out of the 54 studied, E. coli 0157:H7 bacteria
were distributed throughout the large intestine, given the even
distribution of the bacteria throughout the fecal part. This
finding is consistent with previous reports (25) and suggests
that there is a different mechanism of colonization for a small
number of animals, maybe due to the existence of multiple E.
coli 0157:H7 genetic types with different colonization strate¬
gies within one animal (11).
The postmortem and rectal biopsy materials collected from
the colonized animals enabled a detailed study of the histolog¬
ical and ultrastructural changes associated with rectal coloni¬
zation. A/E lesions were detected in animals with bacterial
counts of more than 10s CFU g-1 in rectal tissues several
weeks after experimental inoculation, and this is consistent
with the previous finding that bacterial type III secretion sys¬
tem and A/E lesion formation are essential for the colonization
and persistence of the organism in cattle (26). The long-term
persistence is of a duration similar to the natural carriage
observed for animals in field studies (1). The "shotgun" distri¬
bution of the microcolonies on the rectal mucosa may be
caused by the dispersion of cells from the microcolonies into
the surrounding environment, in the same manner proposed
for E. coli spreading from biofilms (36) formed in response to
shear forces and turbulent flow (8). In addition to A/E lesions,
the major histopathological changes consisted of a reduction in
enterocyte cellular width, a degeneration of cytoplasm in
heavily colonized cells, and a frequent sloughing of entero-
cytes. These alterations were associated with a quantifiable
neutrophilic response. The microscopic examination was made
in animals shedding bacterial numbers similar to those animals
considered super-shedders in field studies (10, 22, 34). Similar
lesions have been reported in weaned calves 4 days postchal-
lenge (7). Given the severe nature of the enterocyte changes
observed, it is possible that most of the mucosal damage ob¬
served is due to enterocyte desquamation. In vitro studies have
consistently reported decreased transepithelial resistance and
opening of the tight junctions following E. coli 0157:H7 colo-
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Animal 1 Animal 2 Trypsinized Animal 3 No primary
FIG. 4. Detection of mucosal antibody responses to protein antigens of E. coli 0157. Mucosal antibody was obtained from homogenates of
rectal mucosa sampled from three animals that had histopathological lesions detectable by microscopy. The homogenates were used to blot
whole-cell preparations of E. coli strains 0157 and K-12 and, in one case. 026. Multiple E. coli 0157 immunoreactive bands were detected in
comparison to either E. coli K-12 or £. coli 026. Ttypsin digestion of the bacterial preparations removed most of the immunoreactive material.
This is demonstrated with a blot using the homogenate from animal 3 (lanes labeled "Trypsinized"). Lanes marked "no primary" are controls
containing E. coli 0157 and K-12 preparations incubated with all the reagents, except for the rectal homogenate. Mucosal homogenates and
Western blots were prepared as described' in Materials and Methods.
nization of monolayers (29), and similar findings have been
reported in vivo in a mouse model of enteropathogenic E.
co/t'/EHEC infection (13). The destructive alterations induced
by E. coli 0157:H7 infection in the bovine epithelial barrier
induced a quantifiable neutrophilic response. This type of in¬
flammatory reaction has been described previously in the in¬
testinal tract for experimental infections of gnotobiotic or neo¬
natal calves (0 to 1 day old) that are not immunocompetent. A
quantified increase in neutrophils and eosinophils in the lam¬
ina propria has been described on one occasion (37), while
other studies report similar increases in leukocytes in the colon
and cecum (6) and sections of ligated ileal loops (32). In
weaned calves, an eosinophilic infiltrate was reported for the
perianal skin that bounds the rectal epithelium and in areas
where A/E lesions were present (30). However, the quantified
response in this study is the first for the predominant coloni¬
zation site in experimentally challenged cattle.
The work also determined that E. coli 0157:H7 infection
induces a mucosal humoral immune response in cattle. West¬
ern blot analysis indicated 4 to 11 IgA-reactive bands of be¬
tween 38 and 98 kDa. This pattern of bands was almost entirely
removed by protein lysis of the bacterial cell sample. These
responses may be the result of the high-level experimental
challenge with E. coli 0157:H7. However, this seems unlikely
given that other experimental work has shown no immunolog¬
ical response to nonpathogenic strains of E. coli (14) and that
challenge by E. coli O I57.H7 leads to serological responses to
proteins encoded by the locus of enterocyte effacement (3).
This study has, therefore, provided evidence that cattle de¬
velop specific mucosal antibodies following colonization. Fur¬
ther studies and the application of more sensitive mucosal
antibody detection methods (23) are required to determine
whether these mucosal antibodies are involved in a protective
immune response.
The terminal rectum is an area rich in lymphoid follicles
(21), and it has been suggested that adherence to these sites
may explain the tropism. of E. coli 0157:H7 bacteria for the
bovine terminal rectum (25). In this study, extensive histolog¬
ical examination of terminal rectal tissues did not reveal a
prominent association between E. coli 0157:H7 microcolonies
and follicle-associated epithelium. Thus, the reason for the
terminal rectum tropism of E. coli 0157:H7 is still obscure
(19). Two of the main features of this area are a potentially
reduced width of the mucous barrier, based on measurements
taken with mice over Peyer's patches (33) and the fact that the
recto-anal junction is adjacent to the anal sphincter. The com¬
bined effect of a reduced protective mucous barrier coupled
with raised intrarectal pressure during defecation may facili¬
tate colonization by the promotion of cell-to-cell contact that is
one of the key mechanisms considered to induce type III se¬
cretion (31).
For many years, E. coli 0157:H7 has been regarded as caus¬
ing no clinical signs of infection in cattle. This study identifies
pathological change and production of a local immune re¬
sponse in the terminal rectum in animals shedding high num¬
bers of E. coli 0157:117 bacteria and infiltration of granulo¬
cytes and production of local IgA antibodies. This is the first
report of local innate immune responses to E. coli 0157:H7
rectal colonization in weaned calves, and so E. coli 0157:H7
should not be regarded as a commensal organism in this host
species. The findings may be of value in the development of
methods for the control of E. coli 0157:H7 carriage by cattle.
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